Original Article
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
N Engl J Med 1994; 331:1173-1180November 3, 1994
- Abstract
Background and Methods
Maternal-infant transmission is the primary means by which young children become infected with human immunodeficiency virus type 1 (HIV). We conducted a randomized, double-blind, placebo-controlled trial of the efficacy and safety of zidovudine in reducing the risk of maternal-infant HIV transmission. HIV-infected pregnant women (14 to 34 weeks' gestation) with CD4+ T-lymphocyte counts above 200 cells per cubic millimeter who had not received antiretroviral therapy during the current pregnancy were enrolled. The zidovudine regimen included antepartum zidovudine (100 mg orally five times daily), intrapartum zidovudine (2 mg per kilogram of body weight given intravenously over a one-hour period, then 1 mg per kilogram per hour until delivery), and zidovudine for the newborn (2 mg per kilogram orally every six hours for six weeks). Infants with at least one positive HIV culture of peripheral-blood mononuclear cells were classified as HIV-infected.
Results
From April 1991 through December 20, 1993, the cutoff date for the first interim analysis of efficacy, 477 pregnant women were enrolled; during the study period, 409 gave birth to 415 live-born infants. HIV-infection status was known for 363 births (180 in the zidovudine group and 183 in the placebo group). Thirteen infants in the zidovudine group and 40 in the placebo group were HIV-infected. The proportions infected at 18 months, as estimated by the Kaplan-Meier method, were 8.3 percent (95 percent confidence interval, 3.9 to 12.8 percent) in the zidovudine group and 25.5 percent (95 percent confidence interval, 18.4 to 32.5 percent) in the placebo group. This corresponds to a 67.5 percent (95 percent confidence interval, 40.7 to 82.1 percent) relative reduction in the risk of HIV transmission (Z = 4.03, P = 0.00006). Minimal short-term toxic effects were observed. The level of hemoglobin at birth in the infants in the zidovudine group was significantly lower than that in the infants in the placebo group. By 12 weeks of age, hemoglobin values in the two groups were similar.
Conclusions
In pregnant women with mildly symptomatic HIV disease and no prior treatment with antiretroviral drugs during the pregnancy, a regimen consisting of zidovudine given ante partum and intra partum to the mother and to the newborn for six weeks reduced the risk of maternal-infant HIV transmission by approximately two thirds.
Media in This Article
Figure 1
Kaplan-Meier Plots of the Probability of HIV Transmission, According to Treatment Group.Figure 2
Mean (±SD) Hemoglobin Concentrations at Birth, 6 Weeks, and 12 Weeks in the Two Treatment Groups.Article Activity
- Article
Maternal-infant transmission is the primary means by which young children become infected with human immunodeficiency virus type 1 (HIV)1,2. From 15 to 40 percent of infants born to infected mothers become infected in utero, during labor and delivery, or by breast-feeding3-5. Current evidence suggests that most maternal-infant HIV transmission occurs late in pregnancy or during labor and delivery5-11.
Despite treatment, pediatric HIV infection remains a fatal disease whose prevention is of paramount importance. Animal models of retroviral infection demonstrate that zidovudine may prevent or alter the course of maternally transmitted HIV infection12-16. Phase 1 studies in pregnant women suggested that this medication is safe when used for short periods and that it crosses the placenta well17-21.
To assess the safety and efficacy of zidovudine for the prevention of maternal-infant HIV transmission, the Pediatric AIDS Clinical Trials Group conducted a multicenter clinical trial (Protocol 076) in the United States and France. At the first interim analysis of efficacy, the Data and Safety Monitoring Board recommended that the enrollment of additional patients be discontinued and that all patients receiving a study drug in blinded fashion be offered zidovudine treatment. This recommendation was based on the demonstration of efficacy of zidovudine in reducing the risk of maternal-infant transmission of HIV. We report the results of this trial through December 20, 1993, the date of the data cutoff in the first interim efficacy analysis.
Methods
Trial Design
Our double-blind, placebo-controlled, randomized study enrolled pregnant, HIV-infected women between 14 and 34 weeks' gestation whose CD4+ T-lymphocyte counts were above 200 cells per cubic millimeter and who had no indication for antiretroviral therapy in the judgment of their health care providers. All the women had to meet the following laboratory criteria: hemoglobin concentration, ≥ 8 g per deciliter; absolute neutrophil count, ≥ 1000 cells per cubic millimeter; platelet count, ≥ 100,000 cells per cubic millimeter; serum alanine aminotransferase concentration, ≤ 2.5 times the upper limit of normal; and serum creatinine concentration, ≤ 1.5 mg per deciliter (130 μmol per liter), or eight-hour urinary creatinine clearance, >70 ml per minute. Women with any of the following ultrasonographic findings were excluded: life-threatening fetal anomaly or anomaly that might increase the fetal concentration of zidovudine or its metabolites; oligohydramnios in the second trimester or unexplained polyhydramnios in the third trimester; and fetal hydrops, ascites, or other evidence of fetal anemia. Women who had received any antiretroviral treatment during this pregnancy and those who had received immunotherapy, anti-HIV vaccines, cytolytic chemotherapeutic agents, or radiation therapy were excluded.
The protocol was approved by the institutional review board at each center in the United States and by the Committee for the Protection of Persons in Biomedical Research in France. Each woman (and the father of the child, when available) gave written informed consent for her participation and that of her child.
The women were stratified according to gestational age (from 14 to 26 weeks or greater than 26 weeks) and were randomly assigned to receive either zidovudine or placebo. The zidovudine regimen consisted of antepartum zidovudine (100 mg orally five times daily) plus intrapartum zidovudine (2 mg per kilogram of body weight given intravenously for 1 hour, followed by 1 mg per kilogram per hour until delivery) plus zidovudine for the newborn (2 mg per kilogram orally every 6 hours for six weeks, beginning 8 to 12 hours after birth).
The women were monitored every 4 weeks until 32 weeks' gestation and then weekly until delivery. Sonograms were obtained before entry into the study and every 4 weeks after the 28th week of gestation. A nonstress test was performed at 34 weeks and repeated weekly thereafter until delivery. Treatment was discontinued if severe preeclampsia, disseminated intravascular coagulation, recurrent thrombocytopenia, life-threatening or recurrent severe toxic effects, or progressive HIV disease requiring treatment with open-label zidovudine developed in the mother, or if fetal death occurred. The women were seen six weeks and six months after delivery.
The infants were evaluated at birth and at 1, 2 or 3, 6, 12, 24, 36, 48, 60, 72, and 78 weeks of age. The study drug was not instituted if an immediately life-threatening condition or any of the following conditions developed: hyperbilirubinemia that required treatment other than phototherapy, an absolute neutrophil count below 750 cells per cubic millimeter, a hemoglobin concentration below 8.0 g per deciliter, a platelet count below 50,000 cells per cubic millimeter, and an alanine aminotransferase concentration more than five times the upper limit of age-adjusted normal values. Newborn therapy was discontinued if any of the above conditions or any type of severe toxic effect developed in the infant, or if the infant received an experimental anti-HIV vaccine or drug.
Peripheral-blood mononuclear cells obtained from infants were cultured for HIV at birth and at 12 and 78 weeks of life. HIV serologic testing (an enzyme immunoassay and a Western blot assay) was performed at 72 and 78 weeks. In September 1992 the protocol was amended to incorporate an additional HIV culture at 24 weeks of age. Infants with at least one positive HIV culture of peripheral-blood mononuclear cells were classified as HIV-infected.
Laboratory Methods
HIV cultures of peripheral-blood mononuclear cells and lymphocyte phenotyping were performed in certified laboratories according to published standard methods22,23. The French sites used an equivalent program to ensure quality24. Enzyme immunoassays and Western blot assays for HIV antibody were performed in certified laboratories by commercially available methods.
Statistical Analysis
The comparison of efficacy between treatment groups was based on the percentage of infants who were infected at 18 months, as estimated by the Kaplan-Meier method25. The P value was determined with a Z statistic calculated from the difference between the Kaplan-Meier estimates at 18 months and their standard errors in the two groups. This approach increased the statistical power of the comparison of treatments by including information from all available HIV cultures without requiring an 18-month follow-up of all infants. The time to the first positive HIV culture was considered as the time to a verified end point for an infant determined to be HIV-infected. Data on all the other infants were censored in the analysis, with their follow-up times set to the latest negative cultures or negative serologic tests. Prognostic factors for the risk of transmission were evaluated and treatment effects adjusted with logistic-regression analyses26. The results of intention-to-treat analyses of all available data from eligible subjects are reported. All P values are two-sided.
The target sample was 636 assessable mother-infant pairs. Prospectively, three interim analyses were planned, with the O'Brien-Fleming boundary27,28.
Results
Enrollment
From April 1991 through December 1993, 477 pregnant women were enrolled at 59 centers. Of the eligible women, 409 gave birth during this period to a total of 415 live-born infants, including 403 singletons and 6 sets of twins (Table 1Table 1
Status of Mothers and Infants in the Study, as of December 20, 1993.). Two women had a history of HIV seropositivity but were later found not to be infected. These two women and an infant born to one of them were excluded from the analysis. Twelve women (one of whom had a creatinine concentration outside the specified range) withdrew from the study before delivery; data on these women were included up to the time of withdrawal.Characteristics of the Mothers and Infants and Treatment with Study Drugs
There were no significant differences between study groups in the characteristics of the pregnant women and the live-born infants (Table 2Table 2
Characteristics of Women and Infants in the Study.). The median gestational age at entry was 26 weeks. Fifty-nine percent of the mothers had CD4+ T-lymphocyte counts greater than 500 cells per cubic millimeter. Only 19 women had received any antiretroviral treatment before the current pregnancy. The median gestational age of the live-born infants was 39 weeks (range, 27 to 43), and the median birth weight was 3160 g (range, 1040 to 5267). Specific intrapartum factors that might be associated with an altered risk of maternal-infant transmission were balanced between the study groups. Only one mother (in the placebo group) reported that she breast-fed her infant; the infant was not infected.The women received the study drug for a median of 11 weeks (range, 0 to 26) before giving birth. The study groups were balanced with respect to the proportion of women whose dose of the study drug was modified during treatment (26.4 percent in the zidovudine group and 32.0 percent in the placebo group) and with respect to the proportion who received intrapartum infusions of study drug (85.4 percent in the zidovudine group and 84.2 percent in the placebo group). Only 24 women (5 percent) did not complete their treatment as planned, 9 in the zidovudine group and 15 in the placebo group. Open-label zidovudine was prescribed for one woman in each group before delivery.
Twelve live-born infants never started treatment (five in the zidovudine group and seven in the placebo group). The reasons included neonatal death (two infants), the mother's refusal to participate (five), withdrawal from the study (three), and delivery at a nonstudy hospital (two). Four other infants had their treatment assignments disclosed because they were potential candidates for an initial pharmacokinetics study, and they did not receive placebo. Among the remaining infants, treatment was started within 12 hours for 84 percent and within 24 hours for 96 percent. Forty-six infants (22 in the zidovudine group and 24 in the placebo group) stopped treatment before completing six weeks of therapy; 7 had reached a study end point (1 in the zidovudine group and 6 in the placebo group), and 22 stopped because of toxic effects (11 in each group).
Analyses of Efficacy
The primary analysis of efficacy was based on all 409 eligible deliveries of live infants, and a failure of therapy was recorded if any infant from a given delivery (a singleton or either twin) was found to be infected. Forty-six infants were excluded from the analysis because no data on HIV culture were available in the data base at the time of this interim analysis (Table 1). The estimated proportions of infants infected were based on the Kaplan-Meier evaluation of 363 births for which at least one HIV culture was performed: 180 infants randomly assigned to zidovudine and 183 randomly assigned to placebo (Figure 1Figure 1
Kaplan-Meier Plots of the Probability of HIV Transmission, According to Treatment Group.).Thirteen children in the zidovudine group had at least one positive HIV culture and were classified as infected, as compared with 40 children in the placebo group. None of the twins were infected. On the basis of the Kaplan-Meier analysis at 18 months, the estimated proportion of infants infected was 8.3 percent in the zidovudine group (95 percent confidence interval, 3.9 to 12.8 percent) and 25.5 percent in the placebo group (95 percent confidence interval, 18.4 to 32.5 percent). The standard errors for these estimates, based on Greenwood's formula, were 2.25 and 3.60 percent, respectively29. The estimated absolute difference between the two study groups in the percentage who were infected was 17.2 percent (95 percent confidence interval, 8.9 to 25.5 percent), corresponding to a 67.5 percent relative reduction in the risk of transmission (95 percent confidence interval, 40.7 to 82.1 percent). The difference in 18-month Kaplan-Meier percentages was significant (Z = 4.03, two-sided P = 0.00006). This result crossed the interim stopping boundary for the monitoring of efficacy (Z = 3.47, two-sided P = 0.0005).
Two alternative analyses were performed in order to estimate the percentage of infected infants with a simple ratio (Table 3Table 3
Alternative Efficacy Analyses.). These analyses were based on a more stringent definition of HIV-infected infants. The estimated probabilities of transmission were consistent with those obtained with the Kaplan-Meier method.HIV infection was detected by culture within the first six months of life in nearly all the infants. Only 2 of the 53 infants classified as infected (both in the placebo group) had their first positive culture reported after the first 24 weeks. Treatment with zidovudine was not associated with a delay in the detection of HIV by viral culture; the estimated intervals before the first positive culture were virtually identical in the two groups. None of the 105 infants in the zidovudine group who had repeatedly negative cultures before the 24th week of life had evidence of HIV infection after 24 weeks.
For 91 infants, results of serologic testing at 72 to 78 weeks were available (47 infants in the zidovudine group and 44 in the placebo group). Among these, all the infants who were counted as uninfected in the Kaplan-Meier analysis had negative serologic results (43 in the zidovudine group and 37 in the placebo group). Two infants classified as infected had negative enzyme immunoassays and Western blot assays; one infant in the placebo group had a single positive culture at birth, and one infant in the zidovudine group had positive cultures at 1 and 21 weeks, but negative serologic results at 78 weeks.
Evaluation of Efficacy in Subgroups
We assessed the influence on the risk of maternal-infant HIV transmission of various factors, including treatment, race and ethnic background, maternal base-line CD4+ T-lymphocyte count, maternal age at entry into the study, gestational age at entry, maternal history of injection-drug use, previous adverse outcomes of pregnancy, history of sexually transmitted diseases, duration of labor, duration of ruptured membranes, intravenous administration of a study drug during labor and delivery, mode of delivery, parity, duration of antepartum therapy, maternal compliance with treatment, ultrasonographic abnormalities, gestational age at delivery, birth weight, and sex of the newborn. The efficacy of zidovudine was observed in all the subgroups. It was impossible to identify prognostic factors for HIV transmission (other than treatment) in this interim analysis because of the small number of infected infants in the zidovudine group.
Evaluation of Maternal Safety
Adverse Effects
Six women (three in each group) discontinued their treatment because of toxic effects. Thirty-five women (18 in the zidovudine group and 17 in the placebo group) had anemia of more than moderate severity, neutropenia, or thrombocytopenia, and 15 women (8 in the zidovudine group and 7 in the placebo group) had abnormalities of serum electrolytes and liver function of more than moderate severity. Toxic effects were defined according to standard toxicity tables modified for pregnancy and defined in the protocol. The majority of the adverse effects were judged to be related to labor and delivery. None of the mothers died during the study.
Effects on Maternal Health
Changes in CD4+ T-lymphocyte counts from base line could be assessed in 291 women at six weeks post partum and in 168 women at six months post partum. A significant increase in these cell counts was observed in both study groups, but the increase was greater in the zidovudine group. The median increase from base line to six weeks post partum was 141 cells per cubic millimeter in the zidovudine group, as compared with 101 cells per cubic millimeter in the placebo group (P = 0.02 by the Wilcoxon test). By six months post partum, the median increase from base line was 53 cells per cubic millimeter in the zidovudine group, as compared with 14 cells per cubic millimeter in the placebo group (P = 0.12 by the Wilcoxon test). At six months post partum, the CD4+ T-lymphocyte count was greater than 300 cells per cubic millimeter for 95 percent of the women in both groups; counts for four women (one in the zidovudine group and three in the placebo group) fell below 200 cells per cubic millimeter during the study. Among 189 women for whom data were available from their six-month visit, 40 (19 in the zidovudine group and 21 in the placebo group) were being treated with open-label zidovudine.
Evaluation of Infants' Safety
Deaths
There were eight fetal or neonatal deaths (five in the zidovudine group and three in the placebo group). None of these deaths were considered attributable to the study drug. The causes of death in the zidovudine group were congenital diaphragmatic hernia (one death), Dandy-Walker syndrome (one), premature labor and chorioamnionitis at 24 weeks' gestation (one), inevitable abortion at 18 weeks' gestation in a mother with a history of incompetent cervix (one), and premature labor and abruptio placentae at 28 weeks' gestation (one). The causes of death in the placebo group were cytomegalovirus infection in utero (one death), abruptio placentae associated with cocaine use (one), and hypoplastic right ventricle (one). There were seven deaths in infants who were beyond the neonatal period; six of these (two in the zidovudine group and four in the placebo group) were due to HIV infection, and one (in the zidovudine group) was due to trauma.
Prenatal and Neonatal Evaluation
Serial ultrasonographic examinations and nonstress tests revealed no differences between the study groups. Zidovudine treatment was not associated with premature birth. Examination of the newborns showed normal anthropometric measurements. Length, weight, and head circumference were similar in uninfected infants in the two groups through 18 months of age.
Structural Abnormalities
The incidence of minor and major abnormalities was similar in the two groups. Congenital cardiac anomalies were confirmed in 10 infants (5 in each group). Congenital abnormalities of the central nervous system were reported in five infants (three in the zidovudine group and two in the placebo group). Eighteen other major anomalies were reported, nine in each group. No specific minor or major abnormalities were clustered in either group.
Adverse Experiences
The hemoglobin concentration at birth of infants in the zidovudine group was significantly lower than that of infants in the placebo group (Figure 2Figure 2
Mean (±SD) Hemoglobin Concentrations at Birth, 6 Weeks, and 12 Weeks in the Two Treatment Groups.). Whereas only 4 infants in either group had a hemoglobin concentration of less than 7.0 g per deciliter, 44 infants in the zidovudine group and 24 infants in the placebo group had hemoglobin concentrations below 9.0 g per deciliter. The maximal difference in the mean hemoglobin concentration between the two groups occurred at three weeks of age and was 1 g per deciliter. The lowest mean value for hemoglobin, 10.0 g per deciliter, occurred at six weeks of age in the zidovudine group. By 12 weeks of age, hemoglobin values for both groups were similar. No significant differences in other safety measures were observed between the study groups.Discussion
We found that administering zidovudine to the mother during pregnancy and during labor and delivery and giving it to the infant for the first six weeks of life reduced the risk of maternal-infant transmission of HIV by approximately two thirds. We chose to study a regimen that combined antepartum, intrapartum, and neonatal therapy, because the timing of maternal-infant HIV transmission is uncertain. The standard recommended dose and schedule of zidovudine for adults were chosen for maternal antepartum treatment. This dose has been associated with a reduction in circulating levels of HIV and has minimal toxicity30,31. Intravenous infusion of zidovudine during labor maintained drug levels and averted the need for oral medication. The intrapartum dosing scheme was derived by pharmacokinetic modeling of data previously obtained in pregnancy20. Zidovudine was administered to infants for six weeks at a dose established in studies of zidovudine in newborns,32 since infected maternal cells may persist in the infant's circulation after birth.
Women were enrolled after the first trimester of pregnancy to avoid fetal exposure to zidovudine during organogenesis, because of the lack of prospective safety data on the use of this medication in humans during the first trimester. In the murine model, zidovudine has been associated with the resorption of preimplantation embryos33. In other studies of animal reproduction, low and moderate doses of zidovudine were not associated with teratogenic malformations,34 but pregnant rats given nearly lethal doses of zidovudine (3000 mg per kilogram) had an increased risk of malformations among their offspring35.
A single positive culture was used to define an infant as HIV-infected. In current clinical practice, however, a single positive culture is often confirmed by a second culture or by the polymerase chain reaction. For the study group, adopting more stringent definitions of infection (two positive cultures) and noninfection (at least two negative cultures, one at ≥ 24 weeks of age, and no positive cultures) yielded results similar to those obtained in the primary Kaplan-Meier analysis.
The possibility that zidovudine would delay the detection of HIV infection by culture was a theoretical concern. People with established HIV infection who are treated with zidovudine typically remain culture-positive, but the effect of zidovudine on cultures from people with early (primary) HIV infection is unknown30,36. To date, we have no evidence that zidovudine treatment delayed the detection of HIV by culture in this group of infants.
Minimal short-term toxic effects were observed. Few women in either study group discontinued therapy because of toxic effects. At six months post partum, there were no differences between the two groups of women with respect to mean CD4+ T-lymphocyte counts or progression to AIDS. Among infants, the only short-term toxic effect directly attributable to zidovudine was anemia, which was mild and reversible.
The mechanism by which zidovudine reduced the risk of maternal-infant HIV transmission is not established. Maternal zidovudine treatment may have reduced the viral load and diminished the viral exposure of the fetus in utero, of the infant at delivery, or both. Stored samples are being studied to determine whether changes in the maternal viral burden or the virologic characteristics of the infecting strains of HIV can predict the success of the treatment regimen. In addition, there is substantial transplacental passage of zidovudine18-20,37. Therapeutic concentrations of the drug in the fetus and the newborn may have prevented HIV infection.
Some infants became infected despite treatment with zidovudine. These infections may have occurred as a result of (1) HIV transmission before treatment, (2) inefficient suppression of maternal viral replication by zidovudine, (3) noncompliance with the treatment regimen, or (4) unique characteristics of the infecting maternal strain of HIV, such as decreased susceptibility to zidovudine. Susceptibility testing of isolates from these mother-infant pairs has not yet been performed. High-level resistance to zidovudine is unlikely, however, considering the relatively short duration of the maternal treatment,38 the lack of previous maternal exposure to zidovudine in most cases, and the relatively high median CD4+ T-lymphocyte count of the mothers at entry.
In general, the women in this study had mildly symptomatic HIV disease and, with 19 exceptions, no prior treatment with antiretroviral drugs. Women with more advanced disease and those who have had prolonged treatment with zidovudine may have a higher viral burden and may also be infected with zidovudine-resistant strains of HIV. Thus, it is not clear whether the results of this trial can be extrapolated to these groups. In addition, the risks and benefits of initiating zidovudine therapy during the first trimester of pregnancy, after 34 weeks' gestation, or in labor or of treating only the newborn were not assessed. Follow-up of the mothers and infants enrolled in the study will continue to assess the effect of zidovudine in subgroups of women, to try to identify factors (other than treatment) that influence maternal-infant HIV transmission, and to assess long-term safety.
Our study indicates that substantial reduction in the rate of maternal-infant transmission of HIV is possible with minimal short-term toxicity to mother or child. Now it is important to understand the mechanism of protection, to determine whether the treatment regimen can be simplified, and to assess the use of the regimen in women and infants with characteristics other than those of the people we studied.
Note added in proof: Since submitting this paper, we have updated the data on HIV cultures to September 6, 1994. Data were available on at least one HIV culture for each of 400 births in the data base: 200 in the zidovudine group and 200 in the placebo group. Sixteen children in the zidovudine group had at least one positive culture, as compared with 52 children in the placebo group. The Kaplan-Meier estimates of the proportions of children infected at 18 months were 7.9 percent (95 percent confidence interval, 4.1 to 11.7 percent) for the zidovudine group and 27.7 percent (95 percent confidence interval, 21.2 to 34.1 percent) for the placebo group. The difference remained statistically significant (Z = 5.13, two-sided P<0.001). These updated results support the findings of the interim analysis.
Supported by the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Human Development, and the Burroughs Wellcome Company in the United States and the Agence Nationale de Recherche sur le SIDA in France.
We are indebted to Elizabeth Hawkins (protocol specialist), Bethann Cunningham (data manager), Lynn Morrow (data manager), Michael Wulfson, M.D. (statistician), and John Modlin, M.D. (protocol team member), for their critical contributions; to the women who participated in the trial; and to the many AIDS Clinical Trials Group investigators and personnel who contributed to the successful conduct of the study.
Source Information
From the Department of Pediatrics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark (E.M.C.); Department of Obstetrics, Gynecology and Reproductive Science, Mt. Sinai School of Medicine, New York (R.S.S.); Statistical and Data Analysis Center of the AIDS Clinical Trials Group, Harvard School of Public Health and the Dana-Farber Cancer Institute, Boston (R.G., P.K.); Department of Pediatrics (G.S.) and Department of Obstetrics and Gynecology (M.J.O.), University of Miami School of Medicine, Miami; Department of Pediatrics, Tulane University School of Medicine, New Orleans (R.V.D.); Department of Obstetrics and Gynecology, Louisiana State University School of Medicine, New Orleans (M.B.); Department of Pediatrics, Baylor College of Medicine, Houston (W.S.); Department of Obstetrics and Gynecology, University of Texas School of Medicine, Houston (R.L.J.); Department of Pediatrics (E.J.) and Department of Obstetrics and Gynecology (E.O.), San Juan City Hospital, San Juan, P.R.; Agence Nationale de Recherche sur le SIDA, Paris (B.B., J.-F.D.); University of Washington School of Medicine, Seattle (R.C.); Burroughs Wellcome Company, Research Triangle Park, N.C. (M.E.); National Institute of Child Health and Human Development, Bethesda, Md. (J.M., P.S.); and Pediatric Medicine Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Md. (M.C., J.B.).
Address reprint requests to Dr. Connor at MedImmune, Inc., 35 W. Watkins Mill Rd., Gaithersburg, MD 20878.
The members of the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group are listed in the Appendix.
Appendix
The following institutions and persons participated in the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. University of Miami School of Medicine, Miami: C. Mitchell, J. Gourley, and K. Halldorsdottir; Tulane University School of Medicine, New Orleans: T. Alchediak, J. Pramberg, and W.R. Robinson; Texas Children's Hospital, Baylor College of Medicine, Houston: M. Kline, M. Doyle, and H.A. Hammill; Agence Nationale de Recherche sur le SIDA Protocol 024 Study Group, Paris: S. Blanche, L. Mandelbrot, and C. Rouzioux; San Juan City Hospital, San Juan, P.R.: M. Carrer, A. Cordero, and E. Abreu; Children's Hospital of Michigan, Wayne State University, Detroit: T.B. Jones, E. Moore, and D.D. Harrison; University of Puerto Rico, San Juan: C. Zorrilla, G. Hyllier, and C. Rivera; St. Jude's Children's Research Hospital, Regional Medical Center, Memphis, Tenn.: W. Hughes, P.M. Flynn, and D. Lancaster; University of Massachusetts Medical Center, Worcester, and Baystate Medical Center, Springfield, Mass.: J.L. Sullivan and B.W. Stechenberg; University of California, San Diego: S.A. Spector, M.J. Besser, and M. Caffery; Mt. Sinai School of Medicine, New York: D. Hodes, E. Chusid, and H. Sacks; University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark: A. Bardeguez, J. Oleske, and G. McSherry; Children's Hospital and Medical Center, Seattle: S. Burchett, D.H. Watts, and C. McLellan; University of North Carolina Hospital at Chapel Hill: W. Lim, V. Katz, and G. Dudek; New York University Medical Center, Bellevue Hospital Center, New York: W. Borkowsky, M. Allen, and M. Mintor; Ramon Ruiz Arman University Hospital, Bayamon, P.R.: V. Bayron, E.J. Reyes, and D.E. Garcia-Trias; Children's Hospital at Albany Medical Center, Albany, N.Y.: R. Samelson, M. Lepow, and N. Wade; University of Illinois at Chicago: K.C. Rick, M. Vajaranan, and P. Horn; UCLA School of Medicine, Los Angeles: Y.J. Bryson, P.J.J. Boyer, and E.R. Stiehm; Johns Hopkins University School of Medicine, University of Maryland, Baltimore: R. Livingston, N. Hutton, and P. Vink; Columbia University, New York: A. Gershon, J. Pitt, and H. Fox; Albert Einstein College of Medicine, New York: A. Rubinstein, M. Landor, and J. Youchah; Children's Medical Center at Stony Brook, Stony Brook, N.Y.: S. Nachman, D. Baker, and A. Vomero; Howard University, Washington, D.C.: D. Smith, S. Rana, and A. Kamara; Children's Hospital, Brigham and Women's Hospital, Beth Israel Hospital, Boston: K. McIntosh, R. Tuomala, and B. Sachs; Duke University Medical Center, Durham, N.C.: E. Livingston, R. McKinney, and M. Donnelly; University of Cincinnati College of Medicine, Cincinnati: K.J. Skahan, R. Baker, and T.A. Siddiqi; Los Angeles County, University of Southern California Medical Center, Los Angeles: A. Kovasc, S. Kjos, and M. Khoury; Boston City Hospital, Boston: S. Pelton, E. Cooper, and P. Donegan; University of California, San Francisco: D. Wara and D.V. Landers; Northwestern University School of Medicine, Children's Memorial Hospital, Chicago: R. Yogev, P. Garcia, and D. Stanislawski; University of Colorado Health Sciences Center, Denver: M. Levin, E. McFarland, and C. Salbenblatt; State University of New York Health Science Center, Brooklyn: S. Fikrig, H. Minkoff, and E. Handelsmen; State University of New York Health Science Center, Syracuse: L.B. Weiner, C.K. Cunningham, and J.H. Hagen; University of Rochester Medical Center, Rochester, N.Y.: J.S. Lambert, J.S. Abramowicz, and L. Frenkel; Children's Hospital of Philadelphia, Jefferson Medical College, Philadelphia: N. Silverman, I. Frank, and E. Anday; Bronx Lebanon Hospital Center, New York: A. Wisnia, L. Solomon, and A. Steiner; New York Medical College, Westchester Hospital, Valhalla: A. Gupta, N. Kirshenbaum, and K. Li; University of Alabama at Birmingham, Birmingham: J. Hauth and M.J. Crain; Cornell Medical Center, New York: J. Cervia, K.D. LaGuardia, and C.M. Schauer; Medical University of South Carolina, Charleston: R.B. Turner, G.M. Johnson, and R.B. Newman; Rhode Island Hospital, Women and Infants Hospital, Brown University, Providence: C. Flynn, P.J. Sweeney, and M. Carpenter.
Statistical and Data Analysis Center of the AIDS Clinical Trials Group: Harvard School of Public Health and Dana-Farber Cancer Institute, Boston. Data Management Center: Frontier Science and Technology Research Foundation, Inc., Amherst, N.Y. Operations Office: Social and Scientific Systems, Inc., Rockville, Md.
- References
References
1
Newell ML ,Peckham C . Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children. AIDS 1993;7:Suppl 1:S91-S97
CrossRef | Web of Science | Medline2
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. April 1994.
3
Oxtoby MJ. Vertically acquired HIV infection in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. 2nd ed. Baltimore: Williams & Wilkins, 1994:3-20.
4
Mofenson L . Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:252-2655
Mofenson LM, Wolinsky SM. Current insights regarding vertical transmission. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. 2nd ed. Baltimore: Williams & Wilkins, 1994:179-203.
6
de Rossi A ,Ometto L ,Mammano F , et al. Time course of antigenaemia and seroconversion in infants with vertically acquired HIV-1 infection. AIDS 1993;7:1528-1529
CrossRef | Web of Science | Medline7
Goedert JJ ,Duliege AM ,Amos CI ,Felton S ,Biggar RJ . High risk of HIV-1 infection for first-born twins: the International Registry of HIV-exposed Twins. Lancet 1991;338:1471-1475
Web of Science | Medline8
Bryson YJ ,Luzuriaga K ,Sullivan JL ,Wara DW . Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992;327:1246-1247
Full Text | Web of Science | Medline9
Krivine A ,Firtion G ,Cao L ,Francoual C ,Henrion R ,Lebon P . HIV replication during the first few weeks of life. Lancet 1992;339:1187-1189
CrossRef | Web of Science | Medline10
Rouzioux C, Burgard M, Blanche S, Costagliola D, HIV Infection in Newborns French Collaborative Study 11
Report of a consensus workshop, Siena, Italy, January 17-18, 1992: early diagnosis of HIV infection in infantsJ Acquir Immune Defic Syndr 1992;5:1169-1178
Web of Science | Medline12
Shih C-C ,Kaneshima H ,Rabin L , et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991;163:625-627
CrossRef | Web of Science | Medline13
Ruprecht RM ,O'Brien LG ,Rossoni LD ,Nusinoff-Lehrman S . Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine. Nature 1986;323:467-469
CrossRef | Web of Science | Medline14
Sharpe AH ,Jaenisch R ,Ruprecht RM . Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapy. Science 1987;236:1671-1674
CrossRef | Web of Science | Medline15
Sharpe AH ,Hunter JJ ,Ruprecht RM ,Jaenisch R . Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapy. Proc Natl Acad U S A 1988;85:9792-9796[Erratum, Proc Natl Acad Sci U S A 1989;86:2045.]
CrossRef | Web of Science | Medline16
Van Rompay KK ,Marthas ML ,Ramos RA , et al. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother 1992;36:2381-2386
Web of Science | Medline17
Ha JC ,Nosbisch C ,Conrad SH , et al. Fetal toxicity of zidovudine (azidothymidine) in Macaca nemestrina: preliminary observations. J Acquir Immune Defic Syndr 1994;7:154-157
Web of Science | Medline18
Sperling RS ,Roboz J ,Dische R ,Silides D , Holzman, I,Jew E . Zidovudine pharmacokinetics during pregnancy. Am J Perinatol 1992;9:247-249
CrossRef | Web of Science | Medline19
Watts DH ,Brown ZA ,Tartaglione T , et al. Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis 1991;163:226-232
CrossRef | Web of Science | Medline20
O'Sullivan MJ ,Boyer PJ ,Scott GB , et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Am J Obstet Gynecol 1993;168:1510-1516
Web of Science | Medline21
Sperling RS ,Stratton P ,O'Sullivan MJ , et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med 1992;326:857-861
Full Text | Web of Science | Medline22
Hollinger FB ,Bremer JW ,Myers LE ,Gold JWM ,McQuay L . Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-1794
Web of Science | Medline23
Calvelli T ,Denny TN ,Paxton H ,Gelman R ,Kagan J . Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-715
CrossRef | Medline24
Rouzioux C ,Puel J ,Agut H , et al. Comparative assessment of quantitative HIV viraemia assays. AIDS 1992;6:373-377
CrossRef | Web of Science | Medline25
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science26
Cox DR. The analysis of binary data. London: Methuen, 1970.
27
O'Brien PC ,Fleming TR . A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556
CrossRef | Web of Science | Medline28
Kim K ,Tsiatis AA . Study duration for clinical trials with survival response and early stopping rule. Biometrics 1990;46:81-92
CrossRef | Web of Science | Medline29
Greenwood M. A report on the natural duration of cancer. Reports on public health and medical subjects no. 33. London: Her Majesty's Stationery Office, 1926:1-26.
30
Ho DD ,Moudgil T ,Alam M . Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-1625
Full Text | Web of Science | Medline31
Volberding PA ,Lagakos SW ,Koch MA , et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941-949
Full Text | Web of Science | Medline32
Boucher FD ,Modlin JF ,Weller S , et al. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993;122:137-144
CrossRef | Web of Science | Medline33
Toltzis P ,Mourton T ,Magnuson T . Effect of zidovudine on preimplantation murine embryos. Antimicrob Agents Chemother 1993;37:1610-1613
Web of Science | Medline34
Sieh E ,Coluzzi ML ,Cusella De Angelis MG , et al. The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study. AIDS Res Hum Retroviruses 1992;8:639-649
CrossRef | Web of Science | Medline35
Comprehensive information for investigators: retrovir (1993). Research Triangle Park, N.C.: Burroughs Wellcome Co., 1993.
36
Coombs RW ,Collier AC ,Allain J-P , et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-1631
Full Text | Web of Science | Medline37
Pons JC ,Taburet AM ,Singlas E ,Delfraissy JF ,Papiernik E . Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study of direct fetal blood sampling under ultrasound. Eur J Obstet Gynecol Reprod Biol 1991;40:229-231
CrossRef | Web of Science | Medline38
Blanche S ,Mayaux M-J ,Rouzioux C , et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-312
Full Text | Web of Science | Medline
- Citing Articles (1123)
Citing Articles
1
Keila Correia Alcântara, Janaína Bacelar Accioli Lins, Maly Albuquerque, Letícia Mara Aires, Ludimila Paula Vaz Cardoso, Ana Lúcia Minuzzi, Mariane Martins Araújo Stefani. (2012) HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures. Journal of Clinical Virology
CrossRef2
K. Badillo, L. Prieto, M. Toledano, S. Guillen, A. Álvarez, I. García Bermejo, J.T. Ramos Amador. (2012) Características de niños con infección por virus de la inmunodeficiencia humana-1 que reciben tratamiento antirretroviral de gran actividad: estudio de corte transversal. Anales de Pediatría
CrossRef3
M. Bolten, A. Gingelmaier, W. Janni. (2012) Betreuung HIV-positiver Schwangerer. Der Gynäkologe
CrossRef4
Ruwan C. Wimalasundera. 2012. Antenatal Screening. , 183-199.
CrossRef5
2012. References. , 311-327.
CrossRef6
Mark R. Schleiss, Janna C. Patterson. 2012. Viral Infections of the Fetus and Newborn and Human Immunodeficiency Virus Infection during Pregnancy. , 468-512.
CrossRef7
Daniel E. Gordon, Lusine R. Ghazaryan, Julia Maslak, Bridget J. Anderson, Kathleen S. Brousseau, Alvaro F. Carrascal, Lou C. Smith. (2012) Projections of diagnosed HIV infection in children and adolescents in New York State*. Paediatric and Perinatal Epidemiologyno-no
CrossRef8
Esther F Gijsbers, Hanneke Schuitemaker, Neeltje A Kootstra. (2012) HIV-1 transmission and viral adaptation to the host. Future Virology 7:1, 63-71
CrossRef9
Andrew D. Forsyth, Ronald O. Valdiserri. (2012) Reaping the prevention benefits of highly active antiretroviral treatment. Current Opinion in HIV and AIDS1
CrossRef10
Jun Yong Choi, June Myung Kim. (2012) Updates on the prevention and treatment of AIDS. Journal of the Korean Medical Association 55:2, 146
CrossRef11
C. Gedeon, F. Garcia Bournissen, G. Koren. 2011. Development of Therapeutic Agents: The Maternal-Fetal Perspective. .
CrossRef12
Yongmin Liu, Phuonggiang Nguyen, Tara Z. Baris, Miriam C. Poirier. (2011) Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Cardiovascular Toxicology
CrossRef13
Federico Andrés De Maio, Carlos Rocco, Paula Aulicino, Rosa Bologna, Andrea Mangano, Luisa Sen. (2011) APOBEC3 mediated editing in HIV-1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability. AIDS Research and Human Retroviruses111206115946004
CrossRef14
Federico Andrés De Maio, Carlos Rocco, Paula Aulicino, Rosa Bologna, Andrea Mangano, Luisa Sen. (2011) APOBEC3 mediated editing in HIV-1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability. AIDS Research and Human Retroviruses111206115946004
CrossRef15
Cintia M. Crudeli, Paula C. Aulicino, Carlos A. Rocco, Rosa Bologna, Andrea Mangano, Luisa Sen. (2011) Relevance of Early Detection of HIV Type 1 SI/CXCR4-Using Viruses in Vertically Infected Children. AIDS Research and Human Retroviruses111202130412005
CrossRef16
C. Jasseron, L. Mandelbrot, C. Dollfus, N. Trocmé, R. Tubiana, J. P. Teglas, A. Faye, C. Rouzioux, S. Blanche, J. Warszawski. (2011) Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission. AIDS and Behavior
CrossRef17
Connie Celum, Jared M. Baeten. (2011) Tenofovir-based pre-exposure prophylaxis for HIV prevention. Current Opinion in Infectious Diseases1
CrossRef18
Nicole C. Schmidt, José Roman-Pouriet, Aracelis D. Fernandez, Consuelo M. Beck-Sagué, José Leonardo-Guerrero, Stephen W. Nicholas. (2011) Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic. International Journal of Gynecology & Obstetrics
CrossRef19
Pere Soler-Palacín, Andrea Martín-Nalda, Xavier Martínez-Gómez, Susana Melendo, Encarnació Riudor, Jose Antonio Arranz, Maria Espiau, Concepció Figueras. (2011) Hyperlactatemia and in Utero Exposure to Antiretrovirals: Is the Control Group the Clue?. AIDS Research and Human Retroviruses111116070158006
CrossRef20
Chi P. Dola, Rubina Khan, Nathaniel DeNicola, Mahin Amirgholami, Tara Benjamin, Azad Bhuiyan, Sherri Longo. (2011) Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy. Journal of Perinatal Medicine---
CrossRef21
Cynthia A. Gómez. (2011) Preventing HIV in U.S. Women and Girls: A Call for Social Action. Women's Health Issues 21:6, S287-S294
CrossRef22
Taís N. Mazzola, Marcos T.N. da Silva, Beatriz M. Abramczuk, Yara M.F. Moreno, Simone C.B.S. Lima, Tatiane Q. Zorzeto, Andréa S.Z. Passeto, Maria M.S. Vilela. (2011) Impaired Bacillus Calmette–Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS 25:17, 2079-2087
CrossRef23
S. Daou, A. Calmy. (2011) Le traitement prophylactique de l’infection par le virus de l’immunodéficience humaine (VIH). La Revue de Médecine Interne 32:11, 658-662
CrossRef24
Karalyn McDonald. (2011) ‘The old-fashioned way’: conception and sex in serodiscordant relationships after ART. Culture, Health & Sexuality 13:10, 1119-1133
CrossRef25
V. V. Wong. (2011) Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml?. Journal of Obstetrics & Gynaecology 31:8, 740-742
CrossRef26
Amanda Cotter, William R. Short. 2011. HIV. , 236-244.
CrossRef27
Koen K.A. Van Rompay. (2011) The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies. AIDS Research and Human Retroviruses111019063259004
CrossRef28
Harkaitz Azkune, Maialen Ibarguren, Xabier Camino, José Antonio Iribarren. (2011) Prevención de la transmisión del VIH (vertical, ocupacional y no ocupacional). Enfermedades Infecciosas y Microbiología Clínica 29:8, 615-625
CrossRef29
David M Haas. (2011) From no to yes: the history and ethics of including pregnant women in clinical trials. Clinical Investigation 1:10, 1349-1351
CrossRef30
Amy S. Sturt, Meira S. Halpern, Barbara Sullivan, Yvonne A. Maldonado. (2011) Timing of Antiretroviral Therapy Initiation and its Impact on Disease Progression in Perinatal Human Immunodeficiency Virus-1 Infection. The Pediatric Infectious Disease Journal1
CrossRef31
Katherine M. Knapp, Susan B. Brogly, Daniel G. Muenz, Hans M.L. Spiegel, Daniel H. Conway, Gwendolyn B. Scott, Jeffrey T. Talbot, David E. Shapiro, Jennifer S. Read. (2011) Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals. The Pediatric Infectious Disease Journal1
CrossRef32
Erik De Clercq. (2011) Pre-exposure chemoprophylaxis of HIV infection: Quo vadis?. Biochemical Pharmacology
CrossRef33
Cindy W. Christian. (2011) Timing of the Medical Examination. Journal of Child Sexual Abuse 20:5, 505-520
CrossRef34
Leolin Katsidzira, James G. Hakim. (2011) HIV prevention in southern Africa: why we must reassess our strategies?. Tropical Medicine & International Health 16:9, 1120-1130
CrossRef35
Marisa Pascale Quintino, Mary Uchiyama Nakamura, Manuel de Jesus Simões, Edward Araujo Júnior, Ricardo Martins de Oliveira Filho, Maria Regina Torloni, Silvia Espiridião, Luiz Kulay Júnior. (2011) Chronic use of indinavir in albino rat pregnancy (Rattus norvegicus albinus, Rodentia, Mammalia): Biological assay. Journal of Obstetrics and Gynaecology Research 37:9, 1212-1215
CrossRef36
Michael H. Chung, Kevin P. McKenzie, Barbra A. Richardson, Grace C. John-Stewart, Robert W. Coombs, Hugo De Vuyst, Julia W. Njoroge, Evans Nyongesa-Malava, Samah R. Sakr, Nelly R. Mugo. (2011) Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3. AIDS 25:15, 1915-1919
CrossRef37
Mirjam Belderbos, Jan LL Kimpen, Louis Bont. (2011) Prenatal prevention of respiratory syncytial virus bronchiolitis. Expert Review of Anti-infective Therapy 9:9, 703-706
CrossRef38
Udo Schüklenk, Sean Philpott. (2011) AIDS – the time for changes in law and policy is now. International Journal of Law in Context 7:03, 305-317
CrossRef39
David Brewster. (2011) Science and ethics of human immunodeficiency virus/acquired immunodeficiency syndrome controversies in Africa. Journal of Paediatrics and Child Health 47:9, 646-655
CrossRef40
S. Swindells, C. Flexner, C. V. Fletcher, J. M. Jacobson. (2011) The Critical Need for Alternative Antiretroviral Formulations, and Obstacles to Their Development. Journal of Infectious Diseases 204:5, 669-674
CrossRef41
M. Bolten, A. Gingelmaier, K. Weizsäcker, A. Reitter, W. Janni. (2011) Spontangeburten bei HIV-Infektion. Der Gynäkologe 44:9, 745-749
CrossRef42
Linden, Judith A., . (2011) Care of the Adult Patient after Sexual Assault. New England Journal of Medicine 365:9, 834-841
Full Text43
Jaime A. Yáñez, Dion R. Brocks, Laird M. Forrest, Neal M. Davies. 2011. Pharmacokinetic Behaviors of Orally Administered Drugs. , 183-219.
CrossRef44
Federico A. De Maio, Carlos A. Rocco, Paula C. Aulicino, Rosa Bologna, Andrea Mangano, Luisa Sen. (2011) Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms. Infection, Genetics and Evolution 11:6, 1256-1262
CrossRef45
Methodius G. Tuuli, Thinh H. Duong, Nicole P. Yost, Jane Ellis, Charlotte V. Burke, Patrice L. Basanta-Henry, Michael Lindsay. (2011) Postpartum contraceptive preferences of HIV-infected women in the era of highly active antiretroviral therapy (HAART) and scheduled cesarean deliveries. Contraception 84:2, 150-154
CrossRef46
Gita Ramjee. (2011) Antiretroviral-based microbicides and oral pre-exposure prophylaxis for HIV prevention. Future Virology 6:8, 997-1014
CrossRef47
Shema Tariq, Claire L Townsend, Mario Cortina-Borja, Trinh Duong, Jonathan Elford, Claire Thorne, Pat A Tookey. (2011) Use of Zidovudine-Sparing HAART in Pregnant HIV-Infected Women in Europe: 2000–2009. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:4, 326-333
CrossRef48
A. Gingelmaier. (2011) HIV-Infektion in der Schwangerschaft. Der Gynäkologe 44:8, 610-614
CrossRef49
HT Haile-Selassie, CL Townsend, PA Tookey. (2011) Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001-2008. HIV Medicine 12:7, 422-427
CrossRef50
Shirin Heidari, Lynne Mofenson, Mark F Cotton, Richard Marlink, Pedro Cahn, Elly Katabira. (2011) Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:4, 290-296
CrossRef51
Sten H Vermund. (2011) Modeling interventions to assess HIV epidemic impact in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes1
CrossRef52
Leslie S. Wilson, Lori Hensic, Carly J. Paoli, Rituparna Basu, Maria Christenson, Judith T. Moskowitz, Diane Wara. (2011) The effect of prophylaxis on pediatric HIV costs. AIDS Care1-11
CrossRef53
Nandi Siegfried, Lize van der Merwe, Peter Brocklehurst, Tin Tin Sint, Nandi Siegfried. 2011. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. .
CrossRef54
Louise Kuhn, Ida Susser, Zena Stein. (2011) Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?. The Lancet 378:9787, 285-287
CrossRef55
Eduard J Beck. (2011) Modeling the cost–effectiveness of health programs: HIV testing and early treatment in the USA. Future Microbiology 6:7, 725-729
CrossRef56
(2011) 30 Years of Pediatric HIV/AIDS Treatment: A Time of Breakthroughs, Innovation. Pediatric Annals 40:7, 340-341
CrossRef57
Echezona E. Ezeanolue, Paul G. Stumpf, Evelen Soliman, George Fernandez, Ineada Jack. (2011) Contraception choices in a cohort of HIV+ women in the era of highly active antiretroviral therapy. Contraception 84:1, 94-97
CrossRef58
Lars Navér, Jan Albert, Erik Belfrage, Leo Flamholc, Magnus Gisslén, Katarina Gyllensten, Filip Josephson, Olof Karlström, Susanne Lindgren, Karin Pettersson, Veronica Svedhem, Anders Sönnerborg, Katarina Westling, Aylin Yilmaz. (2011) Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010. Scandinavian Journal of Infectious Diseases 43:6-7, 411-423
CrossRef59
Donata R. Green, Britta L. Anderson, Michael F. Burke, Judith Griffith, Jay Schulkin. (2011) Obstetric Providers’ Knowledge, Awareness, and Use of CDC’s HIV Testing Recommendations and One Test. Two Lives.™. Maternal and Child Health Journal
CrossRef60
Nelly Briand, Laurent Mandelbrot, Stéphane Blanche, Roland Tubiana, Albert Faye, Catherine Dollfus, Jérôme Le Chenadec, Valérie Benhammou, Christine Rouzioux, Josiane Warszawski. (2011) Previous Antiretroviral Therapy for Prevention of Mother-to-Child Transmission of HIV Does not Hamper the Initial Response to PI-Based Multitherapy During Subsequent Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:2, 126-135
CrossRef61
Theodoros Kelesidis, Raphael J. Landovitz. (2011) Preexposure Prophylaxis for HIV Prevention. Current HIV/AIDS Reports 8:2, 94-103
CrossRef62
Russell B Van Dyke, Kunjal Patel, George K Siberry, Sandra K Burchett, Stephen A Spector, Miriam C Chernoff, Jennifer S Read, Lynne M Mofenson, George R Seage. (2011) Antiretroviral Treatment of US Children With Perinatally Acquired HIV Infection: Temporal Changes in Therapy Between 1991 and 2009 and Predictors of Immunologic and Virologic Outcomes. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:2, 165-173
CrossRef63
Fernando Lozano, Pere Domingo. (2011) Tratamiento antirretroviral de la infección por el VIH. Enfermedades Infecciosas y Microbiología Clínica 29:6, 455-465
CrossRef64
Silvia Degli Esposti, Dhvani Shah. (2011) Hepatitis B in Pregnancy: Challenges and Treatment. Gastroenterology Clinics of North America 40:2, 355-372
CrossRef65
Osarumwense David Osifo, Emmanuel Ajakaye Egwaikhide. (2011) Acquired Rectovaginal Fistula in Babies of Unknown and Asymptomatic Retroviral Positive Mothers. Journal of Pediatric and Adolescent Gynecology 24:3, e79-e82
CrossRef66
Karalyn McDonald, Maggie Kirkman. (2011) HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission. AIDS Care 23:5, 578-584
CrossRef67
Russell B. Van Dyke. (2011) Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: The role of drugs of abuse. Life Sciences 88:21-22, 922-925
CrossRef68
Taha E. Taha. (2011) Mother-to-child transmission of HIV-1 in sub-Saharan Africa: Past, present and future challenges. Life Sciences 88:21-22, 917-921
CrossRef69
Wendy Ferguson, Michele Goode, Amanda Walsh, Patrick Gavin, Karina Butler. (2011) Evaluation of 4 Weeksʼ Neonatal Antiretroviral Prophylaxis as a Component of a Prevention of Mother-to-child Transmission Program in a Resource-rich Setting. The Pediatric Infectious Disease Journal 30:5, 408-412
CrossRef70
Vishnudutt Purohit, Rao S. Rapaka, Paul Schnur, David Shurtleff. (2011) Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART). Life Sciences 88:21-22, 909-916
CrossRef71
Scott Dryden-Peterson, Roger L Shapiro, Michael D Hughes, Kathleen Powis, Anthony Ogwu, Claire Moffat, Sikhulile Moyo, Joseph Makhema, Max Essex, Shahin Lockman. (2011) Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:5, 428-436
CrossRef72
M. Arshad, S. S. El-Kamary, R. Jhaveri. (2011) Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment?. Journal of Viral Hepatitis 18:4, 229-236
CrossRef73
C Rudin, A Spaenhauer, O Keiser, M Rickenbach, C Kind, K Aebi-Popp, MWG Brinkhof, . (2011) Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data. HIV Medicine 12:4, 228-235
CrossRef74
Elijah Paintsil. (2011) Resistance, resistance, go away: persistence of nevirapine-resistant HIV mutations in HIV-infected infants. AIDS 25:7, 997-999
CrossRef75
Valentina Cambiano, Andrew N Phillips. (2011) Modelling the impact of treatment with individual antiretrovirals. Current Opinion in HIV and AIDS 6:2, 124-130
CrossRef76
Qiangen Wu, Frederick A. Beland, Ching-Wei Chang, Jia-Long Fang. (2011) XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells. Toxicology and Applied Pharmacology 251:2, 155-162
CrossRef77
Vijaya Karthekeyani, Glory Alexander, Eileen Solomon, Sarita Rao, P. S. S. Sunder Rao. (2011) Prevention of mother to child transmission of HIV: Our experience in South India. The Journal of Obstetrics and Gynecology of India 61:1, 62-66
CrossRef78
Valentina Cambiano, Alison J Rodger, Andrew N Phillips. (2011) ‘Test-and-treat’: the end of the HIV epidemic?. Current Opinion in Infectious Diseases 24:1, 19-26
CrossRef79
Chokechai Rongkavilit, Basim I. Asmar. (2011) Advances in Prevention of Mother-to-Child HIV Transmission: The International Perspectives. The Indian Journal of Pediatrics 78:2, 192-204
CrossRef80
SO Mepham, RM Bland, M-L Newell. (2011) Prevention of mother-to-child transmission of HIV in resource-rich and -poor settings. BJOG: An International Journal of Obstetrics & Gynaecology 118:2, 202-218
CrossRef81
Zikulah Namukwaya, Peter Mudiope, Adeodata Kekitiinwa, Philippa Musoke, Joyce Matovu, Sarah Kayma, William Salmond, Edward Bitarakwate, Michael Mubiru, Albert Maganda, Moses Galla, Josaphat Byamugisha, Mary Glenn Fowler. (2011) The Impact of Maternal Highly Active Antiretroviral Therapy and Short-Course Combination Antiretrovirals for Prevention of Mother-to-Child Transmission on Early Infant Infection Rates at the Mulago National Referral Hospital in Kampala, Uganda, January 2007 to May 2009. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:1, 69-75
CrossRef82
Elijah Paintsil. (2011) Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics. AIDS Research and Treatment 2011, 1-9
CrossRef83
Minseob Koh, Jongmin Park, Heeseon An, Seung Bum Park. (2011) Ratiometric analysis of zidovudine (ZDV) incorporation by reverse transcriptases or polymerases via bio-orthogonal click chemistry. Chemical Communications 47:27, 7614
CrossRef84
Tracie L. Miller, Laura L. Cushman. 2011. Gastrointestinal Complications of Secondary Immunodeficiency Syndromes. , 447-461.
CrossRef85
Adriana Weinberg, Jeri Forster-Harwood, Jill Davies, Elizabeth J. McFarland, Jennifer Pappas, Kay Kinzie, Emily Barr, Suzanne Paul, Carol Salbenblatt, Elizabeth Soda, Anna Vazquez, Myron J. Levin. (2011) Safety and Tolerability of Antiretrovirals during Pregnancy. Infectious Diseases in Obstetrics & Gynecology 2011, 1-6
CrossRef86
Juan Ambrosioni, Alexandra Calmy, Bernard Hirschel. (2011) HIV treatment for prevention. Journal of the International AIDS Society 14:1, 28
CrossRef87
Karalyn McDonald, Lisa H Amir, Mary-Ann Davey. (2011) Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals. BMC Public Health 11:Suppl 5, S5
CrossRef88
Gary L. Darmstadt, Anita K.M. Zaidi, Barbara J. Stoll. 2011. Neonatal Infections. , 24-51.
CrossRef89
Avinash K. Shetty, Yvonne A. Maldonado. 2011. Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant. , 622-660.
CrossRef90
Yvonne A. Maldonado, Victor Nizet, Jerome O. Klein, Jack S. Remington, Christopher B. Wilson. 2011. Current Concepts of Infections of the Fetus and Newborn Infant. , 2-23.
CrossRef91
Sidra Ishaque, Mohammad Yakoob, Aamer Imdad, Robert L Goldenberg, Thomas P Eisele, Zulfiqar A Bhutta. (2011) Effectiveness of interventions to screen and manage infections during pregnancy on reducing stillbirths: a review. BMC Public Health 11:Suppl 3, S3
CrossRef92
Russell W. Steele. (2011) LATE PREGNANCY SCREENING FOR HUMAN IMMUNODEFICIENCY VIRUS. The Pediatric Infectious Disease Journal 30:1, 72-74
CrossRef93
Adriane M Delicio, Helaine Milanez, Eliana Amaral, Sirlei S Morais, Giuliane J Lajos, Joao Luiz C Pinto e Silva, Jose Guilherme Cecatti. (2011) Mother-to-child transmission of Human Immunodeficiency Virus in a ten years period.. Reproductive Health 8:1, 35
CrossRef94
Grant, Robert M., Lama, Javier R., Anderson, Peter L., McMahan, Vanessa, Liu, Albert Y., Vargas, LorenaGoicochea, Pedro, Casapía, Martín, Guanira-Carranza, Juan Vicente, Ramirez-Cardich, Maria E., Montoya-Herrera, Orlando, Fernández, Telmo, Veloso, Valdilea G., Buchbinder, Susan P., Chariyalertsak, Suwat, Schechter, Mauro, Bekker, Linda-Gail, Mayer, Kenneth H., Kallás, Esper Georges, Amico, K. Rivet, Mulligan, Kathleen, Bushman, Lane R., Hance, Robert J., Ganoza, Carmela, Defechereux, Patricia, Postle, Brian, Wang, Furong, McConnell, J. Jeff, Zheng, Jia-Hua, Lee, Jeanny, Rooney, James F., Jaffe, Howard S., Martinez, Ana I., Burns, David N., Glidden, David V., . (2010) Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. New England Journal of Medicine 363:27, 2587-2599
Full Text95
Lisa-Gaye E. Robinson, Aracelis D. Fernandez. (2010) Clinical Care of the Exposed Infants of HIV–Infected Mothers. Clinics in Perinatology 37:4, 863-872
CrossRef96
Louise Kuhn, Grace Aldrovandi. (2010) Survival and Health Benefits of Breastfeeding Versus Artificial Feeding in Infants of HIV-Infected Women: Developing Versus Developed World. Clinics in Perinatology 37:4, 843-862
CrossRef97
Marc Bulterys, Sascha Ellington, Athena P. Kourtis. (2010) HIV-1 and Breastfeeding: Biology of Transmission and Advances in Prevention. Clinics in Perinatology 37:4, 807-824
CrossRef98
Mary Glenn Fowler, Alicia R. Gable, Margaret A. Lampe, Monica Etima, Maxensia Owor. (2010) Perinatal HIV and Its Prevention: Progress Toward an HIV-free Generation. Clinics in Perinatology 37:4, 699-719
CrossRef99
Lucky Jain. (2010) Foreword. Clinics in Perinatology 37:4, xv-xvii
CrossRef100
Philip L. Bulterys, Sudeb C. Dalai, David A. Katzenstein. (2010) Viral Sequence Analysis from HIV-Infected Mothers and Infants: Molecular Evolution, Diversity, and Risk Factors for Mother-To-Child Transmission. Clinics in Perinatology 37:4, 739-750
CrossRef101
Julie Mirpuri, Lucky Jain. (2010) Issues of Prematurity and HIV Infection. Clinics in Perinatology 37:4, 887-905
CrossRef102
K. Grovit-Ferbas, M. E. Harris-White. (2010) Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunologic Research 48:1-3, 40-58
CrossRef103
Vishnudutt Purohit, Rao S. Rapaka, David Shurtleff. (2010) Mother-to-Child Transmission (MTCT) of HIV and Drugs of Abuse in Post-Highly Active Antiretroviral Therapy (HAART) Era. Journal of Neuroimmune Pharmacology 5:4, 507-515
CrossRef104
Andres F. Camacho-Gonzalez, Allison C. Ross, Rana Chakraborty. (2010) The Clinical Care of the HIV-1–Infected Infant. Clinics in Perinatology 37:4, 873-885
CrossRef105
Kenneth H Mayer, Kartik K Venkatesh. (2010) Chemoprophylaxis for HIV Prevention: New Opportunities and New Questions. JAIDS Journal of Acquired Immune Deficiency Syndromes 55, S122-S127
CrossRef106
R. L. Divi, T. L. Einem, S. L. Leonard Fletcher, M. E. Shockley, M. M. Kuo, M. C. St Claire, A. Cook, K. Nagashima, S. W. Harbaugh, J. W. Harbaugh, M. C. Poirier. (2010) Progressive Mitochondrial Compromise in Brains and Livers of Primates Exposed In Utero to Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Toxicological Sciences 118:1, 191-201
CrossRef107
Bjarne Robberstad, Bjørg Evjen-Olsen. (2010) Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania-a Prospective Cost-Effectiveness Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:3, 397-403
CrossRef108
F Tissot, V Erard, T Dang, M Cavassini. (2010) Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis. HIV Medicine 11:9, 584-592
CrossRef109
Kenneth H. Mayer, Kartik K. Venkatesh. (2010) Antiretroviral Therapy as HIV Prevention: Status and Prospects. American Journal of Public Health 100:10, 1867-1876
CrossRef110
Nelly Briand, Sophie Le Coeur, Gonzague Jourdain, Somboon Hotrawarikarn, Surat Sirinontakan, Temsiri Hinjiranandana, Suparat Kanjanavanit, Patrinee Traisathit, Kenneth McIntosh, Marc Lallemant. (2010) Hematological Safety of Perinatal Exposure to Zidovudine in Uninfected Infants Born to HIV Type 1-Infected Women in Thailand. AIDS Research and Human Retroviruses 26:10, 1163-1166
CrossRef111
Anna Coutsoudis, Leith Kwaan, Mairi Thomson. (2010) Prevention of vertical transmission of HIV-1 in resource-limited settings. Expert Review of Anti-infective Therapy 8:10, 1163-1175
CrossRef112
Kaizad R. Damania, Parikshit D. Tank, Mamatha M. Lala. (2010) Recent trends in mother to child transmission of HIV in pregnancy. The Journal of Obstetrics and Gynecology of India 60:5, 395-402
CrossRef113
K. M. Booth. (2010) A Magic Bullet for the "African" Mother? Neo-Imperial Reproductive Futurism and the Pharmaceutical "Solution" to the HIV/AIDS Crisis. Social Politics: International Studies in Gender, State & Society 17:3, 349-378
CrossRef114
Ann C. Schramm, Sarah Deardorff Carter, Laurie D. Ayala, Patricia M. Garcia. (2010) Partnering for Success: Collaborations for Linking HIV-Positive Pregnant Women to Care. Journal of Obstetric, Gynecologic, & Neonatal Nursing 39, S121-S122
CrossRef115
, C. Giaquinto, M. Penazzato, R. Rosso, S. Bernardi, O. Rampon, P. Nasta, A. Ammassari, A. Antinori, R. Badolato, G. Castelli Gattinara, A. d’Arminio Monforte, M. De Martino, A. De Rossi, P. Di Gregorio, S. Esposito, F. Fatuzzo, S. Fiore, A. Franco, C. Gabiano, L. Galli, O. Genovese, V. Giacomet, A. Giannattasio, C. Gotta, A. Guarino, A. Martino, F. Mazzotta, N. Principi, M. B. Regazzi, P. Rossi, R. Russo, M. Saitta, F. Salvini, S. Trotta, A. Viganò, G. Zuccotti, G. Carosi. (2010) Italian consensus statement on paediatric HIV infection. Infection 38:4, 301-319
CrossRef116
Corinne Buchanan, Tram T. Tran. (2010) Management of Chronic Hepatitis B in Pregnancy. Clinics in Liver Disease 14:3, 495-504
CrossRef117
Sarit A Golub, William Kowalczyk, Corina L Weinberger, Jeffrey T Parsons. (2010) Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 54:5, 548-555
CrossRef118
Alagendran. (2010) Evaluation of Salivary Electrolytes during Normal Menstrual Cycle with Special Reference to Ovulation. American Journal of Applied Sciences 7:8, 1066-1072
CrossRef119
Susan D Hillis, Elena Kuklina, Natalia Akatova, Dmitry M Kissin, Elena N Vinogradova, Aza G Rakhmanova, Elena Stepanova, Denise J Jamieson, Joanna Robinson, Charles Vitek, William C Miller. (2010) Antiretroviral Prophylaxis to Prevent Perinatal HIV Transmission in St. Petersburg, Russia: Too Little, Too Late. JAIDS Journal of Acquired Immune Deficiency Syndromes 54:3, 304-310
CrossRef120
Zhongjie Shi, Yuebo Yang, Lin Ma, Xiaomao Li, Ann Schreiber. (2010) Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus. Obstetrics & Gynecology 116:1, 147-159
CrossRef121
Alice M. Stek. 2010. HIV in Pregnancy. , 150-155.
CrossRef122
Howard Minkoff. 2010. Human Immunodeficiency Virus Infection in Pregnancy. , 313-327.
CrossRef123
Ruth E. Tuomala, Judith S. Currier, Susan Cu-Uvin, Roshan Fernando. 2010. Human Immunodeficiency Virus Infection in Pregnancy. , 464-476.
CrossRef124
Panel de expertos de Gesida, Plan Nacional sobre el Sida. (2010) Documento de consenso del Grupo de Estudio de Sida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2010). Enfermedades Infecciosas y Microbiología Clínica 28:6, 362.e1-362.e91
CrossRef125
Parveen Reshi, Iqbal M. Lone. (2010) Human immunodeficiency virus and pregnancy. Archives of Gynecology and Obstetrics 281:5, 781-792
CrossRef126
Rachel L. Chin. (2010) Postexposure Prophylaxis for HIV. Emergency Medicine Clinics of North America 28:2, 421-429
CrossRef127
Ezekiel Kalipeni, Leo C. Zulu. (2010) HIV and AIDS in Africa: a geographic analysis at multiple spatial scales. GeoJournal
CrossRef128
Stephen R. Kandall. (2010) Women and Drug Addiction: A Historical Perspective. Journal of Addictive Diseases 29:2, 117-126
CrossRef129
R. Bland, H. Coovadia, A. Coutsoudis, N. Rollins, M. Newell. (2010) Cohort Profile: Mamanengane or the Africa Centre Vertical Transmission Study. International Journal of Epidemiology 39:2, 351-360
CrossRef130
Amy S Sturt, Emily Kainne Dokubo, Tin Tin Sint, Amy S Sturt. 2010. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. .
CrossRef131
Serena Koenig, LC Ivers, S Pace, R Destine, F Leandre, R Grandpierre, J Mukherjee, PE Farmer, JW Pape. (2010) Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake. HIV Therapy 4:2, 145-160
CrossRef132
Carolina P Bellusci, Carlos A Rocco, Paula C Aulicino, Debora Mecikovsky, Rosa Bologna, Luisa Sen, Andrea Mangano. (2010) MDR1 3435T and 1236T alleles delay disease progression to pediatric AIDS but have no effect on HIV-1 vertical transmission. AIDS 24:6, 833-840
CrossRef133
Ludimila Paula Vaz Cardoso, Gisner Alves Souza Pereira, Ângela Alves Viegas, Luiza Emylce Pelá Rosado Schmaltz, Mariane Martins de Araújo Stefani. (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil. Journal of Medical Virology 82:3, 351-357
CrossRef134
Sunanda Gaur, Patricia Whitley-Williams, Charlene Flash, Emanuel Jimenez, Anna Petrova. (2010) Disparity in Hospital Utilization of Rapid HIV-1 Testing for Women in Labor with Undocumented HIV Status. Maternal and Child Health Journal 14:2, 268-273
CrossRef135
Christopher V. Almario, Eric J. Moskowitz, Jeanette Koran, Bettina Berman, Valerie P. Pracilio, Albert Crawford, Jason K. Baxter. (2010) Examining the effectiveness of an opt-in approach to prenatal human immunodeficiency virus screening. American Journal of Obstetrics and Gynecology 202:2, 159.e1-159.e6
CrossRef136
Rohan Hazra, George K. Siberry, Lynne M. Mofenson. (2010) Growing Up with HIV: Children, Adolescents, and Young Adults with Perinatally Acquired HIV Infection*. Annual Review of Medicine 61:1, 169-185
CrossRef137
Martina Penazzato, Daniele Donà, Pia-Sophie Wool, Osvalda Rampon, Carlo Giaquinto. (2010) Update on antiretroviral therapy in paediatrics. Antiviral Research 85:1, 266-275
CrossRef138
Yeon-Soon Ahn. (2010) Infectious Diseases among Healthcare Workers. Journal of the Korean Medical Association 53:6, 454
CrossRef139
Samuel Broder. (2010) The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Research 85:1, 1-18
CrossRef140
Koen K.A. Van Rompay. (2010) Evaluation of antiretrovirals in animal models of HIV infection. Antiviral Research 85:1, 159-175
CrossRef141
Hoosen Coovadia, Ruth M. Bland, Tony Walls. (2009) Two commentaries on ‘Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children’. Evidence-Based Child Health: A Cochrane Review Journal 4:4, 1449-1451
CrossRef142
Rebeca Lahoz, Antoni Noguera, Núria Rovira, Albert Català, Emília Sánchez, Rafael Jiménez, Clàudia Fortuny. (2009) Antiretroviral-Related Hematologic Short-term Toxicity in Healthy Infants. The Pediatric Infectious Disease Journal1
CrossRef143
Ana Pilar Nso Roca, C. García-Bermejo, B. Larru, R. Madero, M. A. Muñoz Fernández, M. I. José. (2009) Pathology in children of HIV women. The Indian Journal of Pediatrics 76:11, 1125-1130
CrossRef144
R. Hazra, S. K Stoszek, L. Freimanis Hance, J. Pinto, H. Marques, M. Peixoto, J. Alarcon, M. Mussi-Pinhata, L. Serchuck, . (2009) Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. International Journal of Epidemiology 38:5, 1207-1214
CrossRef145
Yanqing Yi, Xikui Wang. (2009) Response Adaptive Designs with a Variance-penalized Criterion. Biometrical Journal 51:5, 763-773
CrossRef146
Raquel dos Santos Pinheiro, Talita Tenório França, Camila Maria Beder Ribeiro, Jair Carneiro Leão, Ivete Pomarico Ribeiro de Souza, Gloria Fernanda Castro. (2009) Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. Journal of Oral Pathology & Medicine 38:8, 613-622
CrossRef147
Mark J. Mulligan. (2009) Advances in human clinical trials of vaccines to prevent HIV/AIDS and other HIV prevention interventions. Current Infectious Disease Reports 11:5, 399-406
CrossRef148
Arthur J Ammann. (2009) Optimal Versus Suboptimal Treatment for HIV-Infected Pregnant Women and HIV-Exposed Infants in Clinical Research Studies. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:5, 509-512
CrossRef149
Joseph R. Fitchett. (2009) Ethical considerations of clinical trials in the developing world. Transactions of the Royal Society of Tropical Medicine and Hygiene 103:8, 756-760
CrossRef150
Tram T. Tran. (2009) Hepatitis B and pregnancy. Current Hepatitis Reports 8:3, 91-95
CrossRef151
Dolly Sharma, Rana Chakraborty. (2009) Managing HIV infection in infants, children and adolescents with HAART. HIV Therapy 3:4, 391-404
CrossRef152
Arthur J Ammann. (2009) Advances in HIV care and treatment in resource-poor countries. HIV Therapy 3:4, 329-338
CrossRef153
M. Bouillon-Pichault, V. Jullien, E. Azria, E. Pannier, G. Firtion, A. Krivine, A. Compagnucci, O. Taulera, L. Finkielsztejn, S. Chhun, G. Pons, O. Launay, J.-M. Treluyer. (2009) Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment. Journal of Antimicrobial Chemotherapy 63:6, 1223-1232
CrossRef154
FRANCO GUIDOZZI, VIVIAN BLACK. (2009) The Obstetric Face and Challenge of HIV/AIDS. Clinical Obstetrics and Gynecology 52:2, 270-284
CrossRef155
Keila C. Alcântara, Gisner A.S. Pereira, Maly Albuquerque, Mariane M.A. Stefani. (2009) Seroreversion in children born to HIV-positive and AIDS mothers from Central West Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 103:6, 620-626
CrossRef156
David Pao, Deenan Pillay, Martin Fisher. (2009) Potential impact of early antiretroviral therapy on transmission. Current Opinion in HIV and AIDS 4:3, 215-221
CrossRef157
Christy A Beneri, Sharon Nachman. (2009) To treat or not to treat? No longer a question. Future Microbiology 4:4, 391-395
CrossRef158
Abraham M Siika, Winston M Nyandiko, Ann Mwangi, Michael Waxman, John E Sidle, Sylvester N Kimaiyo, Kara Wools-Kaloustian. (2009) The Structure and Outcomes of a HIV Postexposure Prophylaxis Program in a High HIV Prevalence Setup in Western Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:1, 47-53
CrossRef159
Olive N Nakakeeto, Lilani Kumaranayake. (2009) The global strategy to eliminate HIV infection in infants and young children: a seven-country assessment of costs and feasibility. AIDS 23:8, 987-995
CrossRef160
Patrinee Traisathit, Jean Yves Mary, Sophie Le Cœur, Sudanee Thantanarat, Sivaporn Jungpichanvanich, Witaya Pornkitprasarn, Vorapin Gomutbutra, Wanmanee Matanasarawut, Wiroj Wannapira, Marc Lallemant. (2009) Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV. Journal of Obstetrics and Gynaecology Research 35:2, 225-233
CrossRef161
, G. Carosi, P. Nasta, S. Fiore, A. Matteelli, R. Cauda, E. Ferrazzi, E. Tamburrini, V. Savasi, T. Bini, M. Ravizza, A. Bucceri, F. Vichi, R. Murri, F. Mazzotta, A. d’Arminio Monforte. (2009) Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop. Infection 37:2, 168-178
CrossRef162
Bridget Haire. (2009) Back to Basics in Clinical Research Ethics. The American Journal of Bioethics 9:3, 48-49
CrossRef163
Hendramoorthy Maheswaran, Ruth M Bland. (2009) Preventing mother-to-child transmission of HIV in resource-limited settings. Future Virology 4:2, 165-175
CrossRef164
Elijah Paintsil, Warren A Andiman. (2009) Update on successes and challenges regarding mother-to-child transmission of HIV. Current Opinion in Pediatrics 21:1, 94-101
CrossRef165
W. Leelawiwat, N.L. Young, T. Chaowanachan, C.Y. Ou, M. Culnane, N. Vanprapa, N. Waranawat, P. Wasinrapee, P.A. Mock, J. Tappero, J.M. McNicholl. (2009) Dried blood spots for the diagnosis and quantitation of HIV-1: Stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. Journal of Virological Methods 155:2, 109-117
CrossRef166
Louise Kuhn, Cordula Reitz, Elaine J Abrams. (2009) Breastfeeding and AIDS in the developing world. Current Opinion in Pediatrics 21:1, 83-93
CrossRef167
(2009) HIV and AIDS in the Workplace. Journal of Occupational and Environmental Medicine 51:2, 243-250
CrossRef168
Atul Kantilal Patel, Ketan K Patel, Rakesh Sharma, Rajiv R Ranjan, Riddhi K Shukla, Janak A Patel. (2009) Prevention of Mother-to-Child HIV Transmission Using 3-Drug Combination Antiretroviral Treatment: Observational Cohort in Clinical Practice Setting in India. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:2, 231-233
CrossRef169
Abdulrahman A. Alrajhi. (2009) Premarital HIV screening in Saudi Arabia, is antenatal next?. Journal of Infection and Public Health 2:1, 4-6
CrossRef170
Salim S Abdool Karim, Cheryl Baxter. (2009) Antiretroviral prophylaxis for the prevention of HIV infection: future implementation challenges. HIV Therapy 3:1, 3-6
CrossRef171
Tessa Goetghebuer, Edwige Haelterman, Isabelle Marvillet, Patricia Barlow, Marc Hainaut, Assaad Salameh, Roberta Ciardelli, Michele Gerard, Jack Levy. (2009) Vertical transmission of HIV in Belgium: a 1986–2002 retrospective analysis. European Journal of Pediatrics 168:1, 79-85
CrossRef172
Helen Cavasin, Thao Dola, Olga Uribe, Manoj Biswas, Mai Do, Azad Bhuiyan, MarkAlain Dery, Chi Dola. (2009) Postoperative Infectious Morbidities of Cesarean Delivery in Human Immunodeficiency Virus-Infected Women. Infectious Diseases in Obstetrics & Gynecology 2009, 1-6
CrossRef173
Samuel C. Hughes. (2008) HIV and Pregnancy: Twenty-five Years into the Epidemic. International Anesthesiology Clinics 45:1, 29-49
CrossRef174
Dean V. Coonrod, Brian W. Jack, Phillip G. Stubblefield, Lisa M. Hollier, Kim A. Boggess, Robert Cefalo, Shanna N. Cox, Anne L. Dunlop, Kam D. Hunter, Mona R. Prasad, Michael C. Lu, Jeanne A. Conry, Ronald S. Gibbs, Vijaya K. Hogan. (2008) The clinical content of preconception care: infectious diseases in preconception care. American Journal of Obstetrics and Gynecology 199:6, S296-S309
CrossRef175
Pride Chigwedere, George R Seage, Sofia Gruskin, Tun-Hou Lee, M Essex. (2008) Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:4, 410-415
CrossRef176
Guangwu Wang, Nazanin Izadpanah, Christina M.R. Kitchen, Helene B. Bernstein. (2008) Fetal Allostimulation of Maternal Cells: A Potential Mechanism for Perinatal HIV Transmission following Obstetrical Hemorrhage. AIDS Research and Human Retroviruses 24:12, 1545-1554
CrossRef177
Bradley Stephen DE VRIES, Yvonne E. COSSART, Henry MURRAY, Michael John PEEK. (2008) Transplacental haemorrhage may explain the intrapartum transmission of HIV. A pilot study uses flow cytometry to quantify maternal red blood cells in infants born vaginally or by caesarean section. Australian and New Zealand Journal of Obstetrics and Gynaecology 48:6, 575-579
CrossRef178
Jordi Carratalà, José Alcamí, Elisa Cordero, José M. Miró, José Manuel Ramos. (2008) Investigación en enfermedades infecciosas. Enfermedades Infecciosas y Microbiología Clínica 26, 40-50
CrossRef179
Nuria Vives, Jesús Almeda, Claudia A. Contreras, Felipe García, Magda Campins, Jordi Casabona. (2008) Demanda y prescripción de la profilaxis postexposición no ocupacional al VIH en España (2001-2005). Enfermedades Infecciosas y Microbiología Clínica 26:9, 546-551
CrossRef180
(2008) Guidelines for reducing the risk of viral transmission during fertility treatment. Fertility and Sterility 90:5, S156-S162
CrossRef181
Amy Nunn, Francisco I. Bastos. (2008) Financing the Welfare Needs of Children Affected by HIV/AIDS: The Case of Brazil. IDS Bulletin 39:5, 108-116
CrossRef182
Andrea L Ciaranello, George R Seage, Kenneth A Freedberg, Milton C Weinstein, Shahin Lockman, Rochelle P Walensky. (2008) Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS 22:17, 2359-2369
CrossRef183
Nittaya Phanuphak, Praphan Phanuphak. (2008) Proposed guidelines for the prevention of mother-to-child transmission of HIV in middle-income countries: the Thai Red Cross PMTCT guidelines. Future HIV Therapy 2:6, 551-565
CrossRef184
Olivia Keiser, Angèle Gayet-Ageron, Christoph Rudin, Martin WG Brinkhof, Erika Gremlich, Dorothea Wunder, Gero Drack, Bernard Hirschel, Begoña Martinez de Tejada. (2008) Antiretroviral treatment during pregnancy. AIDS 22:17, 2323-2330
CrossRef185
Philippe Msellati, Philippe Van de Perre. (2008) Maternal HIV infection and infant feeding: support is the key. AIDS 22:17, 2391-2392
CrossRef186
Marineide Gonçalves Melo, Breno Riegel Santos, Rita De Cassia Lira, Ivana S. Varella, Maria Lourdes Turella, Tauí Melo Rocha, Karin Nielsen-Saines. (2008) Sexual Transmission of HIV-1 Among Serodiscordant Couples in Porto Alegre, Southern Brazil. Sexually Transmitted Diseases 35:11, 912-915
CrossRef187
Jennifer S. Read, Michael J. Cannon, Lawrence R. Stanberry, Susan Schuval. (2008) Prevention of Mother-to-Child Transmission of Viral Infections. Current Problems in Pediatric and Adolescent Health Care 38:9, 274-297
CrossRef188
José Alcamí. (2008) Introducción. Una breve historia del sida. Enfermedades Infecciosas y Microbiología Clínica 26, 1-4
CrossRef189
Naser L Rezk, Nicole White, Arlene S Bridges, Mohamed F Abdel-Megeed, Tarek M Mohamed, Said S Moselhy, Angela D M Kashuba. (2008) Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications. Therapeutic Drug Monitoring 30:5, 611-619
CrossRef190
Valérie Benhammou, Josiane Warszawski, Stéphanie Bellec, François Doz, Nicolas André, Brigitte Lacour, Martine Levine, Françoise Bavoux, Roland Tubiana, Laurent Mandelbrot, Jacqueline Clavel, Stéphane Blanche. (2008) Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS 22:16, 2165-2177
CrossRef191
A. Mangano, C. Rocco, S. M. Marino, D. Mecikovsky, F. Genre, P. Aulicino, R. Bologna, L. Sen. (2008) Detrimental Effects of Mannose‐Binding Lectin (MBL2) Promoter Genotype XA/XA on HIV‐1 Vertical Transmission and AIDS Progression. The Journal of Infectious Diseases 198:5, 694-700
CrossRef192
JILL CLARK, MARGARET A. LAMPE, DENISE J. JAMIESON. (2008) Testing Women for Human Immunodeficiency Virus Infection: Who, When, and How?. Clinical Obstetrics and Gynecology 51:3, 507-517
CrossRef193
Kamal Desai, Stephanie L Sansom, Marta L Ackers, Scott R Stewart, H Irene Hall, Dale J Hu, Rachel Sanders, Carol R Scotton, Sada Soorapanth, Marie-Claude Boily, Geoffrey P Garnett, Peter D McElroy. (2008) Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 22:14, 1829-1839
CrossRef194
Katherine A. Belden, Kathleen E. Squires. (2008) HIV infection in women: Do sex and gender matter?. Current Infectious Disease Reports 10:5, 423-431
CrossRef195
Woong Hwan Bae, Carolyn Wester, Laura M Smeaton, Roger L Shapiro, Shahin Lockman, Kenneth Onyait, Ibou Thior, Max Essex. (2008) Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS 22:13, 1633-1640
CrossRef196
Nancy S Padian, Anne Buvé, Jennifer Balkus, David Serwadda, Ward Cates. (2008) Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. The Lancet 372:9638, 585-599
CrossRef197
Anna Suy, Sandra Hernandez, Claire Thorne, Montserrat Lonca, Marta Lopez, Oriol Coll. (2008) Current guidelines on management of HIV-infected pregnant women: Impact on mode of delivery. European Journal of Obstetrics & Gynecology and Reproductive Biology 139:2, 127-132
CrossRef198
CL Townsend, M Cortina-Borja, CS Peckham, PA Tookey. (2008) Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG: An International Journal of Obstetrics & Gynaecology 115:9, 1078-1086
CrossRef199
Mayris P. Webber, Penelope Demas, Nancy Blaney, Mardge H. Cohen, Rosalind Carter, Margaret Lampe, Denise Jamieson, Robert Maupin, Steven Nesheim, Marc Bulterys. (2008) Correlates of Prenatal HIV Testing in Women with Undocumented Status at Delivery. Maternal and Child Health Journal 12:4, 427-434
CrossRef200
Lisa Rahangdale, Deborah Cohan. (2008) Rapid Human Immunodeficiency Virus Testing on Labor and Delivery. Obstetrics & Gynecology 112:1, 159-163
CrossRef201
Erika Ono, Amélia M. N. dos Santos, Daisy M. Machado, Regina C. de M. Succi, Abes M. Amed, Reinaldo Salomão, Esper G. Kallás, M. Isabel de Moraes-Pinto. (2008) Immunologic features of HIV-1-infected women on HAART at delivery. Cytometry Part B: Clinical Cytometry 74B:4, 236-243
CrossRef202
Carine Jasseron, Laurent Mandelbrot, Roland Tubiana, Jean-Paul Teglas, Albert Faye, Catherine Dollfus, Jerome Le Chenadec, Christine Rouzioux, Stephane Blanche, Josiane Warszawski. (2008) Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?. AIDS 22:12, 1503-1511
CrossRef203
Elijah Paintsil, Musie Ghebremichael, Sostena Romano, Warren A. Andiman. (2008) Absolute CD4+ T-Lymphocyte Count as a Surrogate Marker of Pediatric Human Immunodeficiency Virus Disease Progression. The Pediatric Infectious Disease Journal 27:7, 629-635
CrossRef204
Charles Kilewo, Katarina Karlsson, Augustine Massawe, Eligius Lyamuya, Andrew Swai, Fred Mhalu, Gunnel Biberfeld. (2008) Prevention of Mother-to-Child Transmission of HIV-1 Through Breast-Feeding by Treating Infants Prophylactically With Lamivudine in Dar es Salaam, Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:3, 315-323
CrossRef205
David E. Shapiro. 2008. Mother to Child Human Immunodeficiency Virus Transmission Trials. .
CrossRef206
A. Luengo-Tabernero, V. Zornoza-García, A. Fernández-Corona, A. Ferrero-Viñas, C. González-García. (2008) Asistencia a la gestante con VIH-sida en el período 1996-2006 en el Hospital de León. Clínica e Investigación en Ginecología y Obstetricia 35:3, 72-77
CrossRef207
Pride Chigwedere, George R. Seage, Tun-Hou Lee, M. Essex. (2008) Efficacy of Antiretroviral Drugs in Reducing Mother-to-Child Transmission of HIV in Africa: A Meta-Analysis of Published Clinical Trials. AIDS Research and Human Retroviruses 24:6, 827-837
CrossRef208
Luis E. Soto-Ramirez, Roberto Rodriguez-Diaz, Adriana S. Durán, Marcelo H. Losso, Horacio Salomón, Manuel Gómez-Carrillo, Sandra Pampuro, D. Robert Harris, Geraldo Duarte, Ricardo S. De Souza, Jennifer S. Read. (2008) Antiretroviral Resistance among HIV Type 1-Infected Women First Exposed to Antiretrovirals during Pregnancy: Plasma versus PBMCs. AIDS Research and Human Retroviruses 24:6, 797-804
CrossRef209
Dolly Sharma, Paul Spearman. (2008) The Impact of Cesarean Delivery on Transmission of Infectious Agents to the Neonate. Clinics in Perinatology 35:2, 407-420
CrossRef210
Job CJ Calis, Michaël Boele van Hensbroek, Rob J de Haan, Peter Moons, Bernard J Brabin, Imelda Bates. (2008) HIV-associated anemia in children: a systematic review from a global perspective. AIDS 22:10, 1099-1112
CrossRef211
Brookie M Best, Edmund V Capparelli. (2008) Implications of gender and pregnancy for antiretroviral drug dosing. Current Opinion in HIV and AIDS 3:3, 277-282
CrossRef212
Sabada Dube, Marie-Claude Boily, Owen Mugurungi, Agnes Mahomva, Frank Chikhata, Simon Gregson. (2008) Estimating Vertically Acquired HIV Infections and the Impact of the Prevention of Mother-to-Child Transmission Program in Zimbabwe. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:1, 72-81
CrossRef213
SOFIA GRUSKIN, SHAHIRA AHMED, LAURA FERGUSON. (2008) PROVIDER-INITIATED HIV TESTING AND COUNSELING IN HEALTH FACILITIES – WHAT DOES THIS MEAN FOR THE HEALTH AND HUMAN RIGHTS OF PREGNANT WOMEN?. Developing World Bioethics 8:1, 23-32
CrossRef214
Mehri S McKellar, Steven FJ Callens, Robert Colebunders. (2008) Pediatric HIV infection: the state of antiretroviral therapy. Expert Review of Anti-infective Therapy 6:2, 167-180
CrossRef215
Kenneth H Mayer, Matthew J Mimiaga, Daniel Cohen, Chris Grasso, Ronn Bill, Rodney VanDerwarker, Alvan Fisher. (2008) Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health Center. JAIDS Journal of Acquired Immune Deficiency Syndromes 47:4, 494-499
CrossRef216
James McIntyre, Marc Lallemant. (2008) The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure?. Current Opinion in HIV and AIDS 3:2, 139-145
CrossRef217
Rachel Hignett, Roshan Fernando. (2008) Anesthesia for the Pregnant HIV Patient. Anesthesiology Clinics 26:1, 127-143
CrossRef218
Tahaniyat Lalani, Charles Hicks. (2008) Does antiretroviral therapy prevent HIV transmission to sexual partners?. Current Infectious Disease Reports 10:2, 140-145
CrossRef219
Ofelia A. Olivero. (2008) Relevance of experimental models for investigation of genotoxicity induced by antiretroviral therapy during human pregnancy. Mutation Research/Reviews in Mutation Research 658:3, 184-190
CrossRef220
Y. Jia, J. Sun, L. Fan, D. Song, S. Tian, Y. Yang, M. Jia, L. Lu, X. Sun, S. Zhang, A. Kulczycki, S. H Vermund. (2008) Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. International Journal of Epidemiology 37:6, 1287-1296
CrossRef221
Ryan M. Troyer, Matthew S. Lalonde, Erika Fraundorf, Korey R. Demers, Fred Kyeyune, Peter Mugyenyi, Aslam Syed, Christopher C. Whalen, Francis Bajunirwe, Eric J. Arts. (2008) A Radiolabeled Oligonucleotide Ligation Assay Demonstrates the High Frequency of Nevirapine Resistance Mutations in HIV Type 1 Quasispecies of NVP-Treated and Untreated Mother–Infant Pairs from Uganda. AIDS Research and Human Retroviruses 24:2, 235-250
CrossRef222
Tram T. Tran, Emmet B. Keeffe. (2008) Management of the pregnant hepatitis B patient. Current Hepatitis Reports 7:1, 12-17
CrossRef223
Josiane Warszawski, Roland Tubiana, Jerome Le Chenadec, Stephane Blanche, Jean-Paul Teglas, Catherine Dollfus, Albert Faye, Marianne Burgard, Christine Rouzioux, Laurent Mandelbrot. (2008) Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 22:2, 289-299
CrossRef224
Judy Levison. (2008) The Ostrich Syndrome. Obstetrics & Gynecology 111:1, 183-186
CrossRef225
Donna B. Barnes. 2008. “I’m Still Here”: a 10 year follow-up of women's experiences living with HIV. , 123-138.
CrossRef226
I Grosch-Woerner, K Puch, RF Maier, T Niehues, G Notheis, D Patel, S Casteleyn, C Feiterna-Sperling, S Groeger, D Zaknun, . (2008) Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women. HIV Medicine 9:1, 6-13
CrossRef227
Inge Derdelinckx, Charles Boucher. 2008. Surveillance of Antiretroviral Drug Resistance in Resource-poor Settings. , 703-710.
CrossRef228
E. Rutta, R. Gongo, A. Mwansasu, D. Mutasingwa, V. Rwegasira, S. Kishumbu, J. Tabayi, T. Masini, H. Ramadhani. (2008) Prevention of mother-to-child transmission of HIV in a refugee camp setting in Tanzania. Global Public Health 3:1, 62-76
CrossRef229
Helene D. Gayle. 2008. HIV Prevention. , 91-100.
CrossRef230
Lynne M. Mofenson. 2008. Prevention of Mother-to-Child Transmission of HIV-1. , 497-512.
CrossRef231
Barbara J. Blake, Gloria A. Jones Taylor, Paula Reid, Margaret Kosowski. (2008) Experiences of women in obtaining human immunodeficiency virus testing and healthcare services. Journal of the American Academy of Nurse Practitioners 20:1, 40-46
CrossRef232
Tracy Creek, Amilcar Tanuri, Monica Smith, Khumo Seipone, Molly Smit, Keitumetse Legwaila, Catherine Motswere, Maruping Maruping, Tapologo Nkoane, Ralph Ntumy, Ebi Bile, Madisa Mine, Lydia Lu, Goitebetswe Tebele, Loeto Mazhani, Margarett K. Davis, Thierry H. Roels, Peter H. Kilmarx, Nathan Shaffer. (2008) Early Diagnosis of Human Immunodeficiency Virus in Infants Using Polymerase Chain Reaction on Dried Blood Spots in Botswanaʼs National Program for Prevention of Mother-to-Child Transmission. The Pediatric Infectious Disease Journal 27:1, 22-26
CrossRef233
Adelisa L. Panlilio, Denise M. Cardo. 2008. Post-exposure Prevention. , 711-724.
CrossRef234
J. Kates, J. Levi. (2007) Insurance Coverage and Access to HIV Testing and Treatment: Considerations for Individuals at Risk for Infection and for Those with Undiagnosed Infection. Clinical Infectious Diseases 45:Supplement 4, S255-S260
CrossRef235
Reidar K. Lie. 2007. Ethical Issues in International Research. .
CrossRef236
N. Hiransuthikul, P. Hiransuthikul, Y. Kanasuk. (2007) Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand. Journal of Hospital Infection 67:4, 344-349
CrossRef237
Fabiana M. Kakehasi, Unaí Tupinambás, Silvia Cleto, Agdemir Aleixo, Elisa Lin, Victor H. Melo, Regina A.L.P. Aguiar, Jorge A. Pinto. (2007) Persistence of Genotypic Resistance to Nelfinavir among Women Exposed to Prophylactic Antiretroviral Therapy during Pregnancy. AIDS Research and Human Retroviruses 23:12, 1515-1520
CrossRef238
Warner C. Greene. (2007) A history of AIDS: Looking back to see ahead. European Journal of Immunology 37:S1, S94-S102
CrossRef239
Katherine Luzuriaga. (2007) Mother-to-child transmission of HIV: A global perspective. Current Infectious Disease Reports 9:6, 511-517
CrossRef240
Michelle S McConnell, Paul Bakaki, Chineta Eure, Michael Mubiru, Danstan Bagenda, Robert Downing, Flavia Matovu, Michael C Thigpen, Alan E Greenberg, Mary Glenn Fowler. (2007) Effectiveness of Repeat Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV-1 in Repeat Pregnancies in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:3, 291-296
CrossRef241
Jean B Nachega, Edward J Mills. (2007) Antiretroviral therapy adherence in resource-limited and resource-rich settings: current status of knowledge and research priorities. Therapy 4:6, 775-786
CrossRef242
Dara A. Lehman, Carey Farquhar. (2007) Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Reviews in Medical Virology 17:6, 381-403
CrossRef243
M Mirochnick, JH Rodman, BL Robbins, A Fridland, J Gandía, J Hitti, A Bardeguez, MH Rathore, A Gonzalez Garcia, M Cababasay, P Samson, L Mofenson, YJ Bryson, A Dorenbaum. (2007) Pharmacokinetics of oral zidovudine administered during labour: a preliminary study. HIV Medicine 8:7, 451-456
CrossRef244
Xavier Rojano i Luque, Jesús Almeda Ortega, Emília Sánchez Ruiz, Claudia Fortuny i Guasch, Josep Maria Bertrán i Sanguès, Antonio Mur Sierra, Carlos Rodrigo Gonzalo de Liria, Jordi Casabona i Barbarà. (2007) Evolución de la transmisión vertical del VIH en Cataluña durante el período 1987-2003. Medicina Clínica 129:13, 487-493
CrossRef245
Lisa K. Hicks, Andreas Laupacis, Arthur S. Slutsky. (2007) A primer on data safety monitoring boards: mission, methods, and controversies. Intensive Care Medicine 33:10, 1815-1818
CrossRef246
Stephanie L. Sansom, Norma S. Harris, Ramses Sadek, Margaret A. Lampe, Nan M. Ruffo, Mary Glenn Fowler. (2007) Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001. American Journal of Obstetrics and Gynecology 197:3, S90-S95
CrossRef247
Michelle S. McConnell, Jeffrey S.A. Stringer, Athena P. Kourtis, Paul J. Weidle, Susan H. Eshleman. (2007) Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?. American Journal of Obstetrics and Gynecology 197:3, S56-S63
CrossRef248
Halima Dao, Lynne M. Mofenson, Rene Ekpini, Charles F. Gilks, Matthew Barnhart, Omotayo Bolu, Nathan Shaffer. (2007) International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. American Journal of Obstetrics and Gynecology 197:3, S42-S55
CrossRef249
Lynda A. Tyer-Viola. (2007) Obstetric Nurses’ Attitudes and Nursing Care Intentions Regarding Care of HIV-Positive Pregnant Women. Journal of Obstetric, Gynecologic, & Neonatal Nursing 36:5, 398-409
CrossRef250
Mary Glenn Fowler, Margaret A. Lampe, Denise J. Jamieson, Athena P. Kourtis, Martha F. Rogers. (2007) Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. American Journal of Obstetrics and Gynecology 197:3, S3-S9
CrossRef251
Denise J. Jamieson, Jill Clark, Athena P. Kourtis, Allan W. Taylor, Margaret A. Lampe, Mary Glenn Fowler, Lynne M. Mofenson. (2007) Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. American Journal of Obstetrics and Gynecology 197:3, S26-S32
CrossRef252
Enrico Girardi, Caroline A Sabin, Antonella d??Arminio Monforte. (2007) Late Diagnosis of HIV Infection: Epidemiological Features, Consequences and Strategies to Encourage Earlier Testing. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:Suppl 1, S3-S8
CrossRef253
Norma S. Harris, Mary Glenn Fowler, Stephanie L. Sansom, Nan Ruffo, Margaret A. Lampe. (2007) Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001. American Journal of Obstetrics and Gynecology 197:3, S33-S41
CrossRef254
Zhongfa Liu, Patty Fan-Havard, Zhiliang Xie, Chen Ren, Kenneth K. Chan. (2007) A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2-hydroxynevirapine and nevirapine 4-carboxylic acid, and pharmacokinetics in baboons. Rapid Communications in Mass Spectrometry 21:16, 2734-2742
CrossRef255
Rachel Smith, Nicola M Zetola, Jeffrey D Klausner. (2007) Beyond the end of exceptionalism: integrating HIV testing into routine medical care and HIV prevention. Expert Review of Anti-infective Therapy 5:4, 581-589
CrossRef256
CHARLES B. SMITH, MARGARET P. BATTIN, LESLIE P. FRANCIS, JAY A. JACOBSON. (2007) SHOULD RAPID TESTS FOR HIV INFECTION NOW BE MANDATORY DURING PREGNANCY? GLOBAL DIFFERENCES IN SCARCITY AND A DILEMMA OF TECHNOLOGICAL ADVANCE. Developing World Bioethics 7:2, 86-103
CrossRef257
D. Heather Watts. (2007) Teratogenicity risk of antiretroviral therapy in pregnancy. Current HIV/AIDS Reports 4:3, 135-140
CrossRef258
Ann E. Bryant Borders, Rebecca L. Eary, Yolanda Olszewski, Anne Statton, Arden Handler, Mardge H. Cohen, Patricia M. Garcia. (2007) Ready or Not—Intrapartum Prevention of Perinatal HIV Transmission in Illinois. Maternal and Child Health Journal 11:5, 485-493
CrossRef259
Katherine M Coyne, Rachael Jones, David Hawkins. (2007) Treating pregnant women with highly active antiretroviral therapy. Future HIV Therapy 1:2, 215-222
CrossRef260
Mark H. Yudin, Catherine Moravac, Rajiv R. Shah. (2007) Influence of an “Opt-Out” Test Strategy and Patient Factors on Human Immunodeficiency Virus Screening in Pregnancy. Obstetrics & Gynecology 110:1, 81-86
CrossRef261
J. Simpore, V. Pietra, S. Pignatelli, D. Karou, W.M.C. Nadembega, D. Ilboudo, F. Ceccherini-Silberstein, W.N. Ghilat-Avoid-Belem, M.C. Bellocchi, N. Saleri, M.J. Sanou, C.M. Ouedraogo, J.B. Nikiema, V. Colizzi, C.P. Perno, F. Castelli, S. Musumeci. (2007) Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. Journal of Medical Virology 79:7, 873-879
CrossRef262
Ouzama Nicholson, David E. Michalik, Sameer Patel, Philip LaRussa, Natalie Neu. (2007) ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN A BREAST-FED INFANT IN NEW YORK CITY. The Pediatric Infectious Disease Journal 26:7, 653-655
CrossRef263
Udo Schuklenk, Anita Kleinsmidt. (2007) Rethinking Mandatory HIV Testing During Pregnancy in Areas With High HIV Prevalence Rates: Ethical and Policy Issues. American Journal of Public Health 97:7, 1179-1183
CrossRef264
Paula M. Castaño. (2007) Use of intrauterine devices and systems by HIV-infected women. Contraception 75:6, S51-S54
CrossRef265
Gita Sinha, Tou J Choi, Uma Nayak, Amita Gupta, Sandeep Nair, Nikhil Gupte, Pandurang M Bulakh, Jayagowri Sastry, Sanjay D Deshmukh, Medha M Khandekar, Vandana Kulkarni, Ramesh A Bhosale, Kapila E Bharucha, Mrudula A Phadke, Anandini S Kshirsagar, Robert C Bollinger. (2007) Clinically Significant Anemia in HIV-Infected Pregnant Women in India Is Not a Major Barrier to Zidovudine Use for Prevention of Maternal-to-Child Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:2, 210-217
CrossRef266
Claire Thorne, Marie-Louise Newell. (2007) HIV. Seminars in Fetal and Neonatal Medicine 12:3, 174-181
CrossRef267
A. Luque, S. Hulse, D. Wang, U. Shahzad, E. Tanzman, S. Antenozzi, B. Smith. (2007) Assessment of Adverse Events Associated With Antiretroviral Regimens for Postexposure Prophylaxis for Occupational and Nonoccupational Exposures to Prevent Transmission of Human Immunodeficiency Virus • . Infection Control and Hospital Epidemiology 28:6, 695-701
CrossRef268
N. Suksomboon, N. Poolsup, S. Ket-aim. (2007) Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. Journal of Clinical Pharmacy and Therapeutics 32:3, 293-311
CrossRef269
Clea C. Sarnquist, Shayna D. Cunningham, Barbara Sullivan, Yvonne Maldonado. (2007) The Effectiveness of State and National Policy on the Implementation of Perinatal HIV Prevention Interventions. American Journal of Public Health 97:6, 1041-1046
CrossRef270
Claudia Palladino Sili Scavalli, Laurent Mandelbrot, Alain Berrebi, Agnès Batallan, Ludovic Cravello, Emmanuelle Pannier, Karima Hamrene, Nicole Ciraru-Vigneron, Albert Faye, Josiane Warszawski. (2007) Twin pregnancy as a risk factor for mother-to-child transmission of HIV-1: trends over 20 years. AIDS 21:8, 993-1002
CrossRef271
E. H. C. J. Buster, A. A. van der Eijk, R. A. de Man, H. L. A. Janssen, S. W. Schalm. (2007) Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety. Journal of Viral Hepatitis 14:5, 350-354
CrossRef272
Rebecca L. Eary, Ann E. Bryant Borders, Arden Handler, Mardge H. Cohen, Patricia M. Garcia. (2007) AZT Availability in Illinois Birthing Hospitals: Is the Perinatal HIV Prevention Safety Net in Place?. Maternal and Child Health Journal 11:4, 313-318
CrossRef273
Cornelia Feiterna-Sperling, Katharina Weizsaecker, Christoph B??hrer, Simone Casteleyn, Andrea Loui, Thomas Schmitz, Volker Wahn, Michael Obladen. (2007) Hematologic Effects of Maternal Antiretroviral Therapy and Transmission Prophylaxis in HIV-1-Exposed Uninfected Newborn Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:1, 43-51
CrossRef274
Marc Lallemant, Gonzague Jourdain. (2007) Nevirapine prophylaxis for the prevention of perinatal HIV and the impact of resistance mutations on subsequent therapy. Future HIV Therapy 1:1, 23-27
CrossRef275
Susan B Brogly, Nathalie Ylitalo, Lynne M Mofenson, James Oleske, Russell Van Dyke, Marilyn J Crain, Mark J Abzug, Michael Brady, Patrick Jean-Philippe, Michael D Hughes, George R Seage. (2007) In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS 21:8, 929-938
CrossRef276
Prasanna Jagannathan, Raphael Landovitz, Michelle E Roland. (2007) Postexposure prophylaxis after sexual exposure to HIV. Future HIV Therapy 1:1, 35-47
CrossRef277
Elise Arrivé, François Dabis. (2007) Development of resistance after administration of single-dose nevirapine to prevent mother-to-child transmission of HIV. Future HIV Therapy 1:1, 91-101
CrossRef278
Tahaniyat Lalani, Charles Hicks. (2007) Does antiretroviral therapy prevent HIV transmission to sexual partners?. Current HIV/AIDS Reports 4:2, 80-85
CrossRef279
Claire L Townsend, Mario Cortina-Borja, Catherine S Peckham, Pat A Tookey. (2007) Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 21:8, 1019-1026
CrossRef280
Summer R. Lewis, Catherine A. White, Michael G. Bartlett. (2007) Simultaneous determination of abacavir and zidovudine from rat tissues using HPLC with ultraviolet detection. Journal of Chromatography B 850:1-2, 45-52
CrossRef281
Vasily N. Dobrovolsky, Joseph G. Shaddock, Roberta A. Mittelstaedt, Michelle E. Bishop, Sherry M. Lewis, Fei W. Lee, Anane Aidoo, Julian E.A. Leakey, June K. Dunnick, Robert H. Heflich. (2007) Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC. Environmental and Molecular Mutagenesis 48:3-4, 270-282
CrossRef282
Ofelia A. Olivero. (2007) Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environmental and Molecular Mutagenesis 48:3-4, 215-223
CrossRef283
Hue-Hua L. Hong, June Dunnick, Ronald Herbert, Theodora R. Devereux, Yongbaek Kim, Robert C. Sills. (2007) Genetic alterations in K-ras andp53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Environmental and Molecular Mutagenesis 48:3-4, 299-306
CrossRef284
Patricia A. Escobar, Ofelia A. Olivero, Nancy A. Wade, Elaine J. Abrams, Carol J. Nesel, Roberta B. Ness, Richard D. Day, Billy W. Day, Quanxin Meng, J. Patrick O'Neill, Dale M. Walker, Miriam C. Poirier, Vernon E. Walker, William L. Bigbee, . (2007) Genotoxicity assessed by the comet andGPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother–child pairs to AZT or AZT-3TC. Environmental and Molecular Mutagenesis 48:3-4, 330-343
CrossRef285
Linda S. Von Tungeln, Lee D. Williams, Daniel R. Doerge, Joseph G. Shaddock, Lynda J. McGarrity, Suzanne M. Morris, Roberta A. Mittelstaedt, Robert H. Heflich, Frederick A. Beland. (2007) Transplacental drug transfer and frequency ofTk andHprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine. Environmental and Molecular Mutagenesis 48:3-4, 258-269
CrossRef286
Salina M. Torres, Dale M. Walker, Meghan M. Carter, Dennis L. Cook, Consuelo L. McCash, Edmund M. Cordova, Ofelia A. Olivero, Miriam C. Poirier, Vernon E. Walker. (2007) Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environmental and Molecular Mutagenesis 48:3-4, 224-238
CrossRef287
Dale M. Walker, David E. Malarkey, Steven K. Seilkop, Frederick A. Ruecker, Kathleen A. Funk, Marilyn J. Wolfe, Christopher P. Treanor, Julie F. Foley, Fletcher F. Hahn, Jerry F. Hardisty, Vernon E. Walker. (2007) Transplacental carcinogenicity of 3′-azido-3′-deoxythymidine in B6C3F1 mice and F344 rats. Environmental and Molecular Mutagenesis 48:3-4, 283-298
CrossRef288
Elijah Paintsil, Warren A. Andiman. (2007) Care and Management of the Infant of the HIV-1-Infected Mother. Seminars in Perinatology 31:2, 112-123
CrossRef289
Jianyong Wang, Tao Chen, Masamitsu Honma, Ling Chen, Martha M. Moore. (2007) 3′-azido-3′-deoxythymidine induces deletions in L5178Y mouse lymphoma cells. Environmental and Molecular Mutagenesis 48:3-4, 248-257
CrossRef290
Valérie Benhammou, Marc Tardieu, Josiane Warszawski, Pierre Rustin, Stéphane Blanche, . (2007) Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues. Environmental and Molecular Mutagenesis 48:3-4, 173-178
CrossRef291
Quanxin Meng, Ofelia A. Olivero, Michael J. Fasco, Ronald Bellisario, Laurence Kaminsky, Ken A. Pass, Nancy A. Wade, Elaine J. Abrams, Carol J. Nesel, Roberta B. Ness, William L. Bigbee, J. Patrick O'Neill, Dale M. Walker, Miriam C. Poirier, Vernon E. Walker, . (2007) Plasma and cellular markers of 3′-azido-3′-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs. Environmental and Molecular Mutagenesis 48:3-4, 307-321
CrossRef292
Aglaêr A. Nóbrega, Fabíola A.S. Oliveira, Marli T.G. Galvão, Rosa S. Mota, Regina M. Barbosa, Inês Dourado, Carl Kendall, Ligia R.S. Kerr-Pontes. (2007) Desire for a Child Among Women Living with HIV/AIDS in Northeast Brazil. AIDS Patient Care and STDs 21:4, 261-267
CrossRef293
Vernon E. Walker, Miriam C. Poirier. (2007) Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors. Environmental and Molecular Mutagenesis 48:3-4, 159-165
CrossRef294
Erna Milunka Kojic, Susan Cu-Uvin. (2007) Special Care Issues of Women Living with HIV-AIDS. Infectious Disease Clinics of North America 21:1, 133-148
CrossRef295
Verina Wild. (2007) Plädoyer für einen Einschluss schwangerer Frauen in Arzneimittelstudien*. Ethik in der Medizin 19:1, 7-23
CrossRef296
Dimitris Rigopoulos, Stamatis Gregoriou, Vasilis Paparizos, Andreas Katsambas. (2007) AIDS in Pregnancy, Part II: Treatment in the Era of Highly Active Antiretroviral Therapy and Management of Obstetric, Anesthetic, and Pediatric Issues. SKINmed 6:2, 79-84
CrossRef297
Ibou Thior, Lesego Gabaitiri, Janet Grimes, Roger Shapiro, Shahin Lockman, Soyeon Kim, Poloko Kebaabetswe, Edward Garmey, Monty Montano, Trevor Peter, Su-Yuan Chang, Ric Marlink, Max Essex. (2007) Voluntary counseling and testing among post-partum women in Botswana. Patient Education and Counseling 65:3, 296-302
CrossRef298
Jordi Casabona i Barbarà. (2007) Prevención de la transmisión vertical del virus de la inmunodeficiencia humana: un reto programático. Medicina Clínica 128:9, 333-334
CrossRef299
Bluma G Brenner. (2007) Resistance and viral subtypes: how important are the differences and why do they occur?. Current Opinion in HIV and AIDS 2:2, 94-102
CrossRef300
Mireya Orío, José M. Peña, M. Teresa Rives, Mario Sanz, Isabel Bates, Rosario Madero, M. Isabel de José. (2007) Cambios en la transmisión vertical del virus de la inmunodeficiencia humana: comparación de los años 1994 y 2004. Medicina Clínica 128:9, 321-324
CrossRef301
M. Tournoud, R. Ecochard. (2007) Application of the promotion time cure model with time-changing exposure to the study of HIV/AIDS and other infectious diseases. Statistics in Medicine 26:5, 1008-1021
CrossRef302
Natalie Neu, Susan Heffernan-Vacca, Mari Millery, Mindy Stimell, Jocelyn Brown. (2007) Postexposure Prophylaxis for HIV in Children and Adolescents After Sexual Assault: A Prospective Observational Study in an Urban Medical Center. Sexually Transmitted Diseases 34:2, 65-68
CrossRef303
Takehisa Ikeda, Tong Wei Ch’ng, James M Oleske. (2007) Recommendations in pediatric antiretroviral therapy. Expert Opinion on Pharmacotherapy 8:2, 155-166
CrossRef304
Jimmy Volmink, Nandi Siegfried, Lize van der Merwe, Peter Brocklehurst, Jimmy Volmink. 2007. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. .
CrossRef305
U Natarajan, A Pym, C McDonald, P Velisetty, SG Edwards, P Hay, J Welch, A de Ruiter, GP Taylor, J Anderson. (2007) Safety of nevirapine in pregnancy. HIV Medicine 8:1, 64-69
CrossRef306
Claire Thorne, Marie-Louise Newell. (2007) Safety of Agents Used to Prevent Mother-to-Child Transmission of HIV. Drug Safety 30:3, 203-213
CrossRef307
Adriana S Duran, Marcelo H Losso, Horacio Salomón, D Robert Harris, Sandra Pampuro, Luis E Soto-Ramirez, Geraldo Duarte, Ricardo S de Souza, Jennifer S Read. (2007) Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. AIDS 21:2, 199-205
CrossRef308
Paul Thistle, Rachel F. Spitzer, Richard H. Glazier, Richard Pilon, Gordon Arbess, Andrew Simor, Eleanor Boyle, Inam Chitsike, Tsungai Chipato, Maureen Gottesman, Michael Silverman. (2007) A Randomized, Double‐Blind, Placebo‐Controlled Trial of Combined Nevirapine and Zidovudine Compared with Nevirapine Alone in the Prevention of Perinatal Transmission of HIV in Zimbabwe. Clinical Infectious Diseases 44:1, 111-119
CrossRef309
Mia-Tuang Koh. (2007) Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors. International Journal of Infectious Diseases 11:1, 85-86
CrossRef310
On Jeong, Jong-Hyun Kim. (2007) The outcome of perinatal prophylaxis for HBeAg positive mothers according to the maternal HBV-DNA levels at the delivery time. Korean Journal of Pediatrics 50:4, 348
CrossRef311
David R Berk, Meira S Falkovitz-Halpern, Barbara Sullivan, Juan Ruiz, Yvonne A Maldonado. (2007) Disease Progression Among HIV-Infected Children Who Receive Perinatal Zidovudine Prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes 44:1, 106-111
CrossRef312
Michele Jonsson Funk, Suzanne E Belinson, Jeanne M Pimenta, Megan Morsheimer, David C Gibbons. (2007) Mitochondrial Disorders among Infants Exposed to HIV and Antiretroviral Therapy. Drug Safety 30:10, 845-859
CrossRef313
Moon Won Kang. (2007) Prevention of HIV/AIDS. Journal of the Korean Medical Association 50:4, 330
CrossRef314
Aaron Santmyire, Marian Jamison. (2006) Educating African Pastors on Mother-to-Child Transmission of HIV/AIDS. Journal of Nursing Scholarship 38:4, 321-327
CrossRef315
Haritini Petropoulou, Alexander J. Stratigos, Andreas D. Katsambas. (2006) Human immunodeficiency virus infection and pregnancy. Clinics in Dermatology 24:6, 536-542
CrossRef316
Athena P Kourtis, Francis K Lee, Elaine J Abrams, Denise J Jamieson, Marc Bulterys. (2006) Mother-to-child transmission of HIV-1: timing and implications for prevention. The Lancet Infectious Diseases 6:11, 726-732
CrossRef317
Mark R. Schleiss. (2006) Editorial Commentary: The Role of the Placenta in the Pathogenesis of Congenital Cytomegalovirus Infection: Is the Benefit of Cytomegalovirus Immune Globulin for the Newborn Mediated through Improved Placental Health and Function?. Clinical Infectious Diseases 43:8, 1001-1003
CrossRef318
Rhonda Y. Kropp, Clea C. Sarnquist, Elizabeth T. Montgomery, Juan D. Ruiz, Yvonne A. Maldonado. (2006) A Comparison of Perinatal HIV Prevention Opportunities for Hispanic and Non-Hispanic Women in California. AIDS Education and Prevention 18:5, 430-443
CrossRef319
Sia E. Msuya, Elizabeth Mbizvo, Jacqueline Uriyo, Babill Stray-Pedersen, Noel E. Sam, Akhtar Hussain. (2006) Predictors of Failure to Return for HIV Test Results Among Pregnant Women in Moshi, Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes 43:1, 85-90
CrossRef320
Regina Lúcia Braga Barreto, José Maria Soares, Ricardo Santos Simões, Gustavo Arantes Rosa Maciel, Manuel de Jesus Simões, Luiz Kulay. (2006) Effects of chronic stavudine exposure on liver, pancreas and kidneys of pregnant rats and their fetuses: Morphological and biochemical aspects. European Journal of Obstetrics & Gynecology and Reproductive Biology 128:1-2, 50-53
CrossRef321
Margaret A. Lampe. (2006) Human Immunodeficiency Virus-1 and Preconception Care. Maternal and Child Health Journal 10:S1, 195-197
CrossRef322
Patrícia El Beitune, Geraldo Duarte. (2006) Antiretroviral agents during pregnancy: Consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. European Journal of Obstetrics & Gynecology and Reproductive Biology 128:1-2, 59-63
CrossRef323
Koen K.A. Van Rompay, Brian P. Kearney, Jonathan J. Sexton, Roxana Col??n, Jonathan R. Lawson, Emily J. Blackwood, William A. Lee, Norbert Bischofberger, Marta L. Marthas. (2006) Evaluation of Oral Tenofovir Disoproxil Fumarate and Topical Tenofovir GS-7340 to Protect Infant Macaques Against Repeated Oral Challenges With Virulent Simian Immunodeficiency Virus. JAIDS Journal of Acquired Immune Deficiency Syndromes 43:1, 6-14
CrossRef324
S. Pornprasert, A. Faye, J.Y. Mary, G. Dolcini, P. Leechanachai, G. Chaouat, N. Ngo, F. Barré-Sinoussi, E. Menu. (2006) Down Modulation of TNF-α mRNA Placental Expression by AZT Used for the Prevention of HIV-1 Mother-to-Child Transmission. Placenta 27:9-10, 989-995
CrossRef325
Lisa M. Frenkel, Jennifer McKernan, Phil V. Dinh, Deborah Goldman, Jane Hitti, D. Heather Watts, Ellen R. Cooper, Joan Dragavon, Robert W. Coombs. (2006) Short Communication: HIV Type 1 Zidovudine (ZDV) Resistance in Blood and Uterine Cervical Secretions of Pregnant Women. AIDS Research and Human Retroviruses 22:9, 870-873
CrossRef326
Mari McQuitty, William McFarland, Timothy A. Kellogg, Edward White, Mitchell H. Katz. (2006) Home Collection Versus Publicly Funded HIV Testing in San Francisco: Who Tests Where?. Journal of Acquired Immune Deficiency Syndromes 21:5, 417
CrossRef327
Lars Navér, Susanne Lindgren, Erik Belfrage, Katarina Gyllensten, Knut Lidman, Magnus Gisslén, Anneka Ehrnst, Malin Arneborn, Ann-Britt Bohlin. (2006) Children Born to HIV-1-Infected Women in Sweden in 1982-2003. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:4, 484-489
CrossRef328
Diana B. Schramm, Louise Kuhn, Glenda E. Gray, Caroline T. Tiemessen. (2006) In Vivo Effects of HIV-1 Exposure in the Presence and Absence of Single-Dose Nevirapine on Cellular Plasma Activation Markers of Infants Born to HIV-1-Seropositive Mothers. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:5, 545-553
CrossRef329
Magid Herida, Christine Larsen, Florence Lot, Anne Laporte, Jean-Claude Desenclos, Françoise F Hamers. (2006) Cost-effectiveness of HIV post-exposure prophylaxis in France. AIDS 20:13, 1753-1761
CrossRef330
Katherine Luzuriaga, Marie-Louise Newell, Francois Dabis, Jean-Louis Excler, John L Sullivan. (2006) Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities. The Lancet 368:9534, 511-521
CrossRef331
Stéphane Blanche, Marc Tardieu, Valérie Benhammou, Josiane Warszawski, Pierre Rustin. (2006) Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 20:13, 1685-1690
CrossRef332
Greta R Bauer, Robert C Colgrove, Philip S LaRussa, Jane Pitt, Seth L Welles. (2006) Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infants. AIDS 20:13, 1707-1712
CrossRef333
Stephen A Spector, Akihiko Saitoh. (2006) Mitochondrial dysfunction: prevention of HIV-1 mother-to-infant transmission outweighs fear. AIDS 20:13, 1777-1778
CrossRef334
Maud Tournoud, Ren?? Ecochard. (2006) Age at Which HIV Infection Can Be Detected in Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:3, 362-367
CrossRef335
Jill Clark, Stephanie Sansom, B. Joyce Simpson, Frances Walker, Cheryl Wheeler, Kelly Yazdani, Amy Zapata. (2006) Promising Strategies for Preventing Perinatal HIV Transmission: Model Programs from Three States. Maternal and Child Health Journal 10:4, 367-373
CrossRef336
Nancy J. Cibulka. (2006) Mother-to-Child Transmission of HIV in the United States. AJN, American Journal of Nursing 106:7, 56-63
CrossRef337
C McDonald, H Curtis, A de Ruiter, MA Johnson, J Welch, . (2006) National review of maternity care for women with HIV infection. HIV Medicine 7:5, 275-280
CrossRef338
Debbie Indyk, Sarit A. Golub. (2006) The Shifting Locus of Risk-Reduction. Social Work in Health Care 42:3-4, 112-132
CrossRef339
Olav Lapaire, Olivier Irion, Annemarie Koch-Holch, Wolfgang Holzgreve, Christoph Rudin, Irène Hoesli, . (2006) Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: a case-controlled multicenter study. Archives of Gynecology and Obstetrics 274:3, 165-169
CrossRef340
Rafik Samuel, Robert Bettiker, Byungse Suh. (2006) Antiretroviral therapy 2006: Pharmacology, applications, and special situations. Archives of Pharmacal Research 29:6, 431-458
CrossRef341
Glenda Gray, Avye Violari, James McIntyre, Boris Jivkov, Steven Schnittman, Laurie Reynolds, Jean-Marie Ledeine. (2006) Antiviral Activity of Nucleoside Analogues During Short-Course Monotherapy or Dual Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:2, 169-176
CrossRef342
M Montano, M Rarick, P Sebastiani, P Brinkmann, M Russell, A Navis, C Wester, I Thior, M Essex. (2006) Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana. Genes and Immunity 7:4, 298-309
CrossRef343
T. Nicole Clark, Catherine A. White, Michael G. Bartlett. (2006) Determination of didanosine in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography–tandem mass spectrometry. Biomedical Chromatography 20:6-7, 605-611
CrossRef344
Jeny Wegbreit, Stefano Bertozzi, Lisa M DeMaria, Nancy S Padian. (2006) Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS 20:9, 1217-1235
CrossRef345
Isabel Solís Villamarzo, Eloy Muñoz Gálligo, José Tomás Ramos Amador, María Isabel González Tomé, Xavier Rojano Luque, Jesús Almeda Ortega. (2006) Características maternas en una cohorte de gestantes con infección por el VIH-1. Medicina Clínica 127:4, 121-125
CrossRef346
Jennifer H. Tang, Jeanne S. Sheffield, Julie Grimes, Barbara McElwee, Scott W. Roberts, Vanessa Laibl, Donald D. McIntire, George D. Wendel. (2006) Effect of Protease Inhibitor Therapy on Glucose Intolerance in Pregnancy. Obstetrics & Gynecology 107:5, 1115-1119
CrossRef347
Michael M. Lederman, Robin E. Offord, Oliver Hartley. (2006) Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nature Reviews Immunology 6:5, 371-382
CrossRef348
Nils Venhoff, Ulrich A Walker. (2006) Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opinion on Drug Safety 5:3, 373-381
CrossRef349
Nelly Briand, Sophie Le Coeur, Patrinee Traisathit, Varit Karnchanamayul, Rawiwan Hansudewechakul, Chaiwat Ngampiyasakul, Sorakit Bhakeecheep, Jeerapahan Ithisukanan, Suchat Hongsiriwon, Kenneth McIntosh, Marc Lallemant. (2006) Growth of Human Immunodeficiency Virus-Uninfected Children Exposed to Perinatal Zidovudine for the Prevention of Mother-to-Child Human Immunodeficiency Virus Transmission. The Pediatric Infectious Disease Journal 25:4, 325-332
CrossRef350
Lorraine Sherr, Zoe Fox, Michelle Lipton, Patricia Whyte, Patricia Jones, Ursula Harrison, CAMDEN AND ISLINGTON STEERING GROUP. (2006) Sustaining HIV testing in pregnancy – Evaluation of routine offer of HIV testing in three London hospitals over 2 years. AIDS Care 18:3, 183-188
CrossRef351
Robert J. Biggar, Taha E. Taha, Donald R. Hoover, Francis Yellin, Newton Kumwenda, Robin Broadhead. (2006) Higher In Utero and Perinatal HIV Infection Risk in Girls Than Boys. JAIDS Journal of Acquired Immune Deficiency Syndromes 41:4, 509-513
CrossRef352
Stephanie L. Sansom, John E. Anderson, Paul G. Farnham, Kenneth Dominguez, Sada Soorapanth, Jill Clark, Thom Sukalac, Mary Jo Earp, Beverly Bohannon, Mary Glenn Fowler. (2006) Updated Estimates of Healthcare Utilization and Costs Among Perinatally HIV-Infected Children. JAIDS Journal of Acquired Immune Deficiency Syndromes 41:4, 521-526
CrossRef353
Giuseppe Murdaca, Sergio Costantini, Roberto Villa, Maurizio Setti, Francesco Puppo, Francesco Indiveri. (2006) A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Internal and Emergency Medicine 1:1, 86-88
CrossRef354
Carolyn K. Burr, Deborah S. Storm, Elaine Gross. (2006) A Faculty Trainer Model: Increasing Knowledge and Changing Practice to Improve Perinatal HIV Prevention and Care. AIDS Patient Care and STDs 20:3, 183-192
CrossRef355
Pietro L Vernazza, Lital Hollander, Augusto E Semprini, Deborah J Anderson, Ann Duerr. (2006) HIV-discordant couples and parenthood: how are we dealing with the risk of transmission?. AIDS 20:4, 635-636
CrossRef356
Denis Evseenko, James W Paxton, Jeffrey A Keelan. (2006) Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opinion on Drug Metabolism & Toxicology 2:1, 51-69
CrossRef357
Kirsty England, Claire Thorne, Marie-Louise Newell. (2006) Vertically acquired paediatric coinfection with HIV and hepatitis C virus. The Lancet Infectious Diseases 6:2, 83-90
CrossRef358
Carlo Giaquinto, Osvalda Rampon, Anita De Rossi. (2006) Antiretroviral Therapy for Prevention of Mother-to-Child HIV Transmission. Clinical Drug Investigation 26:11, 611-627
CrossRef359
Yvonne A. Maldonado. 2006. Acquired Immunodeficiency Syndrome in the Infant. , 667-692.
CrossRef360
2006. Zidovudine. , 3713-3717.
CrossRef361
Anna Suy, Esteban Martínez, Oriol Coll, Montserrat Lonca, Montserrat Palacio, Elisa de Lazzari, María Larrousse, Ana Milinkovic, Sandra Hernández, José L Blanco, Josep Mallolas, Agathe León, Juan A Vanrell, José M Gatell. (2006) Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 20:1, 59-66
CrossRef362
2006. .
CrossRef363
D Heather Watts. (2006) Treating HIV During Pregnancy. Drug Safety 29:6, 467-490
CrossRef364
Karine Lacombe, Anne Daguenel-Nguyen, Véronique Lebeau, Laurent Fonquernie, Pierre-Marie Girard, Marie-Caroline Meyohas. (2006) Determinants of adherence to non-occupational post HIV exposure prophylaxis. AIDS 20:2, 291-294
CrossRef365
Barbara J. Stoll. 2006. Neonatal Infections: A Global Perspective. , 27-57.
CrossRef366
Jerome O. Klein, Carol J. Baker, Jack S. Remington, Christopher B. Wilson. 2006. Current Concepts of Infections of the Fetus and Newborn Infant. , 3-25.
CrossRef367
Davey M Smith. (2006) The controversies of nevirapine for preventing mother-to-child HIV transmission. AIDS 20:2, 281-283
CrossRef368
Luisa Galli, Donella Puliti, Elena Chiappini, Clara Gabiano, Pier-Angelo Tovo, Patrizio Pezzotti, Maurizio de Martino. (2005) Lower Mother-to-Child HIV-1 Transmission in Boys Is Independent of Type of Delivery and Antiretroviral Prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:4, 479-485
CrossRef369
James McIntyre. (2005) Prevention of mother-to-child transmission of HIV: treatment options. Expert Review of Anti-infective Therapy 3:6, 971-980
CrossRef370
Thomas D'aquin Toni, Bernard Masquelier, Estibaliz Lazaro, Mireille Dore-Mbami, Franck-Olivier Ba-Gomis, Yacine Téa-Diop, Kouadio Kouakou, Joseph Diby, Evelyne Sia, Sylvie Soppi, Samuel Essien, Marie- Hélène Schrive, Patricia Pinson, Henri Chenal, Hervé J. Fleury. (2005) Characterization of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Côte d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission. AIDS Research and Human Retroviruses 21:12, 1031-1034
CrossRef371
L. Kuhn, P. Kasonde, M. Sinkala, C. Kankasa, K. Semrau, N. Scott, W.-Y. Tsai, S. H. Vermund, G. M. Aldrovandi, D. M. Thea. (2005) Does Severity of HIV Disease in HIV-Infected Mothers Affect Mortality and Morbidity among Their Uninfected Infants?. Clinical Infectious Diseases 41:11, 1654-1661
CrossRef372
Lertlakana Bhoopat, Surapan Khunamornpong, Piyaporn Lerdsrimongkol, Punnee Sirivatanapa, Soisaang Sethavanich, Aram Limtrakul, Vorapin Gomutbuthra, Suparut Kajanavanich, Paul S Thorner, Tanin Bhoopat. (2005) Effectiveness of Short-Term and Long-Term Zidovudine Prophylaxis on Detection of HIV-1 Subtype E in Human Placenta and Vertical Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:5, 545-550
CrossRef373
Nitin K. Shah. (2005) Management of Pediatric HIV Infection. Apollo Medicine 2:4, 349-356
CrossRef374
Stephen A. Myers, Sandra Torrente, Daniel Hinthorn, Perry L. Clark. (2005) Life-Threatening Maternal and Fetal Macrocytic Anemia From Antiretroviral Therapy. Obstetrics & Gynecology 106:5, Part 2, 1189-1191
CrossRef375
Madeleine Bunders, Vincent Bekker, Henriette Scherpbier, Kees Boer, Mieke Godfried, Taco Kuijpers. (2005) Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatrica 94:11, 1571-1577
CrossRef376
Claire Thorne, Marie-Louise Newell. (2005) Managing mother-to-child transmission of HIV infection in developed-country settings. Women's Health 1:3, 385-399
CrossRef377
Siripon Kanshana, Thananda Naiwatanakul, R. J. Simonds, Pornsinee Amornwichet, Achara Teeraratkul, Mary Culnane, Nartlada Chantharojwong, Khanchit Limpakarnjanarat. (2005) Monitoring and evaluating the national program to prevent mother-to-child HIV transmission in Thailand. New Directions for Evaluation 2004:103, 117-128
CrossRef378
&NA;. (2005) Does Exposure to Antiretroviral Therapy Affect Growth in the First 18 Months of Life in Uninfected Children Born to HIV-Infected Women?. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:3, 364-370
CrossRef379
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Riley, Laura E., Yawetz, Sigal, . (2005) Case 32-2005. New England Journal of Medicine 353:16, 1725-1732
Full Text380
Luiza Harunari Matida, Mariliza Henrique da Silva, Ângela Tayra, Regina Celia de Menezes Succi, Maria Clara Gianna, Alexandre Gonçalves, Heráclito Barbosa de Carvalho, Norman Hearst. (2005) Prevention of mother-to-child transmission of HIV in São Paulo State, Brazil: an update. AIDS 19:Suppl 4, S37-S41
CrossRef381
Shing-Shun Siu, John Hok-Keung Yeung, Man-Wah Pang, Pui Yu Chiu, Tze Kin Lau. (2005) Placental Transfer of Zidovudine in First Trimester of Pregnancy. Obstetrics & Gynecology 106:4, 824-827
CrossRef382
Mary Weglarz, Mary Boland. (2005) Family-Centered Nursing Care of the Perinatally Infected Mother and Child Living with HIV Infection. Journal for Specialists in Pediatric Nursing 10:4, 161-170
CrossRef383
Sonia GROVER, Claire PETTERSON. (2005) Uptake of HIV screening in an antenatal clinic. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45:5, 365-367
CrossRef384
Paivi Lehtovirta, Kirsi Skogberg, Eeva Salo, Pirkko Ammala, Matti Ristola, Jukka Suni, Jorma Paavonen, Oskari Heikinheimo. (2005) Pregnancy outcome among HIV-infected women in the Helsinki metropolitan area. Acta Obstetricia et Gynecologica Scandinavica 84:10, 945-950
CrossRef385
Benjamin Lee, Chi-Jen Lee, Christopher Wu, Lucia Lee. 2005. Antiviral Drugs. , 391-399.
CrossRef386
Anne B Morris, Ana Rua Dobles, Susan Cu-Uvin, Carmen Zorrilla, Jean Anderson, Joseph I Harwell, Jean Keller, Jane Garb. (2005) Protease Inhibitor Use in 233 Pregnancies. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:1, 30-33
CrossRef387
Gian Maria Pacifici. (2005) Pharmacokinetics of antivirals in neonate. Early Human Development 81:9, 773-780
CrossRef388
James McIntyre. (2005) REVIEW: Preventing mother-to-child transmission of HIV: successes and challenges. BJOG: An International Journal of Obstetrics & Gynaecology 112:9, 1196-1203
CrossRef389
Luc Desfrere, Isabelle de Oliveira, François Goffinet, Mayass el Ayoubi, Ghislaine Firtion, Françoise Bavoux, Pierre-Henri Jarreau, Guy Moriette. (2005) Increased incidence of necrotizing enterocolitis in premature infants born to HIV-positive mothers. AIDS 19:14, 1487-1493
CrossRef390
Matthew F. Chersich, Glenda E. Gray. (2005) Progress and emerging challenges in preventing mother-to-child transmission. Current Infectious Disease Reports 7:5, 393-400
CrossRef391
Naomi Rutenberg, Carolyn Baek. (2005) Field Experiences Integrating Family Planning into Programs to Prevent Mother-to-Child Transmission of HIV. Studies in Family Planning 36:3, 235-245
CrossRef392
Jes??s Castilla, Jorge del Romero, Victoria Hernando, Beatriz Marincovich, Soledad Garc??a, Carmen Rodr??guez. (2005) Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:1, 96-101
CrossRef393
Frank Romanelli. (2005) The Pharmacotherapy of the Modern Day Epidemic Infection with Human Immunodeficiency Virus (HIV). American Journal of Pharmaceutical Education 69:4, 72
CrossRef394
Nora M. Doyle, Judy E. Levison, Michael O. Gardner. (2005) Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: A cost-effectiveness analysis. American Journal of Obstetrics and Gynecology 193:3, 1280-1285
CrossRef395
Judette M. Louis, Mudathiru A. Buhari, Sean C. Blackwell, Jerrie Refuerzo, Dianne Allen, Bernard Gonik, Theodore B. Jones. (2005) Characteristics associated with suboptimal viral suppression at delivery in human immunodeficiency virus-1–infected pregnant women. American Journal of Obstetrics and Gynecology 193:3, 1266-1269
CrossRef396
E Girardi, F N Lauria, G Ippolito. (2005) HIV/AIDS in 2004: the epidemiologist's point of view. Cell Death and Differentiation 12, 837-844
CrossRef397
Gian Maria Pacifici. (2005) Transfer of antivirals across the human placenta. Early Human Development 81:8, 647-654
CrossRef398
A. E. Miranda, R. A. Soares, B. C. Prado, R. B. Monteiro, N. C. Figueiredo. (2005) Mother to child transmission of HIV in Vitória, Brazil: Factors associated with lack of HIV prevention. AIDS Care 17:6, 721-728
CrossRef399
A. Krosigk, H. Jäger. (2005) Aspekte der HIV-Therapie in der Schwangerschaft. Der Gynäkologe 38:8, 694-700
CrossRef400
A. Mehta, C. Rodrigues, S. Ghag, P. Bavi, S. Shenai, F. Dastur. (2005) Needlestick injuries in a tertiary care centre in Mumbai, India. Journal of Hospital Infection 60:4, 368-373
CrossRef401
Robert D. Schremmer, Douglas Swanson, Kathe Kraly. (2005) Human Immunodeficiency Virus Postexposure Prophylaxis in Child and Adolescent Victims of Sexual Assault. Pediatric Emergency Care 21:8, 502-506
CrossRef402
A. Gingelmaier, K. Friese. (2005) Betreuung HIV-positiver Frauen in der Schwangerschaft und unter der Geburt. Der Gynäkologe 38:8, 688-693
CrossRef403
Glenda E Gray, Michael Urban, Matthew F Chersich, Carolyn Bolton, Ronelle van Niekerk, Avy Violari, Wendy Stevens, James A McIntyre. (2005) A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 19:12, 1289-1297
CrossRef404
Kristine Hopkins, Regina Maria Barbosa, Daniela Riva Knauth, Joseph E. Potter. (2005) The impact of health care providers on female sterilization among HIV-positive women in Brazil. Social Science & Medicine 61:3, 541-554
CrossRef405
D. Hawkins, M. Blott, P. Clayden, A. de Ruiter, G. Foster, C. Gilling-Smith, B. Gosrani, H. Lyall, D. Mercey, M-L. Newell, S. O'Shea, R. Smith, J. Sunderland, C. Wood, G. Taylor, . (2005) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Medicine 6:S2, 107-148
CrossRef406
David Moreno-Pérez, Alfredo García Saiz, Francico Jesús García Martín, Antonio Jurado Ortiz. (2005) Infección perinatal por el VIH-1 en un niño sin formación de anticuerpos anti-VIH-1. Medicina Clínica 125:6, 237-238
CrossRef407
(2005) Increasing likelihood of further live births in HIV-infected women in recent years. BJOG: An International Journal of Obstetrics and Gynaecology 112:7, 881-888
CrossRef408
Susan M. Melnick, Jeremy Weedon, Diana L. Dow-Edwards. (2005) Perinatal AZT exposure alters the acoustic and tactile startle response to 8-OH-DPAT and apomorphine in adult rats. Neurotoxicology and Teratology 27:4, 599-608
CrossRef409
G TAYLOR. (2005) Prevention of perinatal transmission. Medicine 33:6, 26-27
CrossRef410
D. Stephen Coad, Anastasia Ivanova. (2005) The use of the triangular test with response-adaptive treatment allocation. Statistics in Medicine 24:10, 1483-1493
CrossRef411
Nuria V Martin, J Almeda, Jordi Casabona, Nuria V Martin. 2005. Effectiveness and safety of HIV post-exposure prophylaxis after sexual, injecting-drug-use or other non-occupational exposure.. .
CrossRef412
J. Moodley, D. Moodley. (2005) Management of human immunodeficiency virus infection in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 19:2, 169-183
CrossRef413
Edmund Capparelli, Natella Rakhmanina, Mark Mirochnick. (2005) Pharmacotherapy of perinatal HIV. Seminars in Fetal and Neonatal Medicine 10:2, 161-175
CrossRef414
Amaboo Dhai, Ray Noble. (2005) Ethical issues in HIV. Best Practice & Research Clinical Obstetrics & Gynaecology 19:2, 255-267
CrossRef415
Claire Thorne, Marie-Louise Newell. (2005) The safety of antiretroviral drugs in pregnancy. Expert Opinion on Drug Safety 4:2, 323-335
CrossRef416
Anthony C. Atkinson, Atanu Biswas. (2005) Bayesian Adaptive Biased-Coin Designs for Clinical Trials with Normal Responses. Biometrics 61:1, 118-125
CrossRef417
Vasily N. Dobrovolsky, Lynda J. McGarrity, Linda S. VonTungeln, Roberta A. Mittelstaedt, Suzanne M. Morris, Frederick A. Beland, Robert H. Heflich. (2005) Micronucleated erythrocyte frequency in control and azidothymidine-treated Tk+/+, Tk+/− and Tk−/− mice. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 570:2, 227-235
CrossRef418
M. Mseleku, T.H. Smith, F. Guidozzi. (2005) HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screening. BJOG: An International Journal of Obstetrics and Gynaecology 112:3, 370-371
CrossRef419
E RICHARD STIEHM, RICHARD B. JOHNSTON. (2005) A History of Pediatric Immunology. Pediatric Research 57:3, 458-467
CrossRef420
Yazen Alnouti, Summer R. Lewis, Catherine A. White, Michael G. Bartlett. (2005) Simultaneous determination of zidovudine and lamivudine from rat tissues by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 19:4, 503-508
CrossRef421
Charles L.M. Olweny, Margaret Borok, Ivy Gudza, Jennifer Clinch, Mary Cheang, Clem F. Kiire, Lorraine Levy, David Otim-Oyet, Joseph Nyamasve, Harvey Schipper. (2005) Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: Results of a randomized quality of life focused clinical trial. International Journal of Cancer 113:4, 632-639
CrossRef422
Lisa Bond, Jennifer Lauby, Heather Batson. (2005) HIV testing and the role of individual- and structural-level barriers and facilitators. AIDS Care 17:2, 125-140
CrossRef423
K. Lee, W. T. Cheung, V. S. C. Kwong, W. Y. Wan, S. S. Lee. (2005) Access to appropriate information on HIV is important in maximizing the acceptance of the antenatal HIV antibody test. AIDS Care 17:2, 141-152
CrossRef424
L. Katherine, L. S. John. (2005) Prevention of Mother-to-Child Transmission of HIV Infection. Clinical Infectious Diseases 40:3, 466-467
CrossRef425
Rhonda Y. Kropp, Elizabeth T. Montgomery, David W. Hill, Juan D. Ruiz, Yvonne A. Maldonado. (2005) Unique Challenges to Preventing Perinatal HIV Transmission Among Hispanic Women in California: Results of A Needs Assessment. AIDS Education and Prevention 17:1, 22-40
CrossRef426
Zoltan Lukacs, Alexandra Dietrich, Rainer Ganschow, Alfried Kohlschütter, Rudolf Kruithof. (2005) Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots –a feasibility study using a multi-analyte immunoassay. Clinical Chemistry and Laboratory Medicine 43:2, 141-145
CrossRef427
Caroline Foster, Hermione Lyall. (2005) Current Guidelines for the management of UK Infants born to HIV-1 infected mothers. Early Human Development 81:1, 103-110
CrossRef428
Mary E. Paul, Caroline J. Chantry, Jennifer S. Read, Margaret M. Frederick, Ming Lu, Jane Pitt, Delmyra B. Turpin, Ellen R. Cooper, Edward L. Handelsman. (2005) Morbidity and Mortality During The First Two Years of Life Among Uninfected Children Born to Human Immunodeficiency Virus Type 1-Infected Women. The Pediatric Infectious Disease Journal 24:1, 46-56
CrossRef429
Catherine L. Cherry, Luxshimi Lal, Steven L. Wesselingh. (2005) Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management. Sexual Health 2:1, 1
CrossRef430
Aldina Venerosi, Angelina Valanzano, Maria Puopolo, Gemma Calamandrei. (2005) Neurobehavioral effects of prenatal exposure to AZT: a preliminary investigation with the D1 receptor agonist SKF 38393 in mice. Neurotoxicology and Teratology 27:1, 169-173
CrossRef431
&NA;. (2005) Antiretroviral therapy is recommended for all pregnant women with HIV infection after the first trimester. Drugs & Therapy Perspectives 21:1, 15-18
CrossRef432
John S Lambert. (2005) HIV Vaccines in Infants and Children. Pediatric Drugs 7:5, 267-276
CrossRef433
Karen P. Beckerman. 2005. Identification, Evaluation, and Care of the Human Immunodeficiency Virus–Exposed Neonate. , 475-494.
CrossRef434
Guy Harling, Robin Wood, Eduard J Beck. (2005) Efficiency of Interventions in HIV Infection, 1994???2004. Disease Management & Health Outcomes 13:6, 371-394
CrossRef435
Mitchell H. Katz, Julie Louise Gerberding. (2004) Management of occupational and nonoccupational postexposure HIV prophylaxis. Current HIV/AIDS Reports 1:4, 159-165
CrossRef436
Yuchi C. Chang, Stephen K. Tyring. (2004) Therapy of HIV infection. Dermatologic Therapy 17:6, 449-464
CrossRef437
Robert Gaiser. (2004) Human Immunodeficiency Virus. Survey of Anesthesiology 48:6, 292-293
CrossRef438
Wivine Burny, Corinne Liesnard, Catherine Donner, Arnaud Marchant. (2004) Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection. Expert Review of Anti-infective Therapy 2:6, 881-894
CrossRef439
Heather B. Jaspan, James E. Robinson, Angela Martin Amedee, Russell B. Van Dyke, Robert F. Garry. (2004) Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies. Journal of Clinical Virology 31:3, 190-197
CrossRef440
Helene B. Bernstein, Audrey L. Kinter, Robert Jackson, Anthony S. Fauci. (2004) Neonatal Natural Killer Cells Produce Chemokines and Suppress HIV Replication in Vitro. AIDS Research and Human Retroviruses 20:11, 1189-1195
CrossRef441
Marie-Louise Newell, Claire Thorne. (2004) Antiretroviral therapy and mother-to-child transmission of HIV-1. Expert Review of Anti-infective Therapy 2:5, 717-732
CrossRef442
Emily F Westheimer, Willy Urassa, Gernard Msamanga, Ana Baylin, Ruilan Wei, Said Aboud, Sylvia Kaaya, Wafaie W Fawzi. (2004) Acceptance of HIV Testing Among Pregnant Women in Dar-es-Salaam, Tanzania. JAIDS Journal of Acquired Immune Deficiency Syndromes 37:1, 1197-1205
CrossRef443
J. F. J. B. Nellen, I. Schillevoort, F. W. N. M. Wit, A. S. Bergshoeff, M. H. Godfried, K. Boer, J. M. A. Lange, D. M. Burger, J. M. Prins. (2004) Nelfinavir Plasma Concentrations Are Low during Pregnancy. Clinical Infectious Diseases 39:5, 736-740
CrossRef444
Miriam C Poirier, Ofelia A Olivero, Dale M Walker, Vernon E Walker. (2004) Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicology and Applied Pharmacology 199:2, 151-161
CrossRef445
Beth A. Plunkett, William A. Grobman. (2004) Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: A cost-effectiveness analysis. American Journal of Obstetrics and Gynecology 191:3, 998-1003
CrossRef446
(2004) Human immunodeficiency virus and infertility treatment. Fertility and Sterility 82, 228-231
CrossRef447
Michael D Sweat, Kevin R O'Reilly, George P Schmid, Julie Denison, Isabelle de Zoysa. (2004) Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 18:12, 1661-1671
CrossRef448
Ana Ceballos, Guadalupe Andreani, Silvia E. Gonzalez Ayala, Yamila Romer, Isabel Rimoldi, María Rosa Agosti, Liliana Martinez Peralta. (2004) Epidemiological and Molecular Evidence of Two Events of Father-to-Child HIV Type 1 Horizontal Transmission. AIDS Research and Human Retroviruses 20:8, 789-793
CrossRef449
Boris Renjifo, Peter Gilbert, Beth Chaplin, Gernard Msamanga, Davis Mwakagile, Wafaie Fawzi, Max Essex. (2004) Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 18:12, 1629-1636
CrossRef450
Nancy A. Wade, Mary A. Zielinski, Maia Butsashvili, Louise-Anne McNutt, Barbara L. Warren, Roberta Glaros, Babu Cheku, Wendy Pulver, Kenneth Pass, Kathleen Fox, Antonia C. Novello, Guthrie S. Birkhead. (2004) Decline in Perinatal HIV Transmission in New York State (1997???2000). JAIDS Journal of Acquired Immune Deficiency Syndromes 36:5, 1075-1082
CrossRef451
Lallemant, Marc, Jourdain, Gonzague, Le Coeur, Sophie, Mary, Jean Yves, Ngo-Giang-Huong, Nicole, Koetsawang, Suporn, Kanshana, Siripon, McIntosh, Kenneth, Thaineua, Vallop, . (2004) Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand. New England Journal of Medicine 351:3, 217-228
Full Text452
Rebecca A. Clark, Jeanne Dumestre. (2004) Women and Human Immunodeficiency Virus: Unique Management Issues. The American Journal of the Medical Sciences 328:1, 17-25
CrossRef453
Kiat Ruxrungtham, Tim Brown, Praphan Phanuphak. (2004) HIV/AIDS in Asia. The Lancet 364:9428, 69-82
CrossRef454
Coleen K. Cunningham, Rajalakshmi Balasubramanian, Isaac Delke, Robert Maupin, Lynne Mofenson, Alex Dorenbaum, John L. Sullivan, Adolfo Gonzalez-Garcia, Edwin Thorpe, Mobeen Rathore, Richard D. Gelber. (2004) The Impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316. JAIDS Journal of Acquired Immune Deficiency Syndromes 36:3, 800-807
CrossRef455
L Sherr, N Barry. (2004) Fatherhood and HIV-positive heterosexual men. HIV Medicine 5:4, 258-263
CrossRef456
Milind Khare, Mike Sharland, Isaac Manyonda, Phil Rice, J.Martin Bland, Paul Griffiths. (2004) Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative pregnant women. Journal of Virological Methods 119:1, 31-35
CrossRef457
Regis Kreitchmann, Sandra Costa Fuchs, Theodoro Suffert, Gisele Preussler. (2004) Perinatal HIV-1 transmission among low income women participants in the HIV/AIDS Control Program in Southern Brazil: a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 111:6, 579-584
CrossRef458
Michael Neely, Andrea Kovacs. (2004) Management of antiretroviral therapy in neonates, children, and adolescents. Current HIV/AIDS Reports 1:2, 97-104
CrossRef459
Charles Weijer, Paul B Miller. (2004) When are research risks reasonable in relation to anticipated benefits?. Nature Medicine 10:6, 570-573
CrossRef460
Augusto E Semprini, Simona Fiore. (2004) HIV and reproduction. Current Opinion in Obstetrics and Gynecology 16:3, 257-262
CrossRef461
Michelle L. GILES, Anne M. MIJCH, Suzanne M. GARLAND, Sonia R. GROVER, Margaret E. HELLARD. (2004) HIV and pregnancy in Australia. The Australian and New Zealand Journal of Obstetrics and Gynaecology 44:3, 197-204
CrossRef462
Regina Lucia Braga Barreto, Manuel de Jesus Simoes, Abes Mahmed Amed, Jose Maria Soares Junior, Ricardo Martins Oliveira-Filho. (2004) Stavudine effects on rat pregnancy outcome. Journal of Obstetrics and Gynaecology Research 30:3, 242-245
CrossRef463
Mark R Schleiss, Michael A McVoy. (2004) Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Review of Anti-infective Therapy 2:3, 389-403
CrossRef464
ELIZABETH G. DOHERTY, ERIC C. EICHENWALD. (2004) Cesarean Delivery: Emphasis on the Neonate. Clinical Obstetrics and Gynecology 47:2, 332-341
CrossRef465
David Wendler, Ezekiel J. Emanuel, Reidar K. Lie. (2004) The Standard of Care Debate: Can Research in Developing Countries Be Both Ethical and Responsive to Those Countries’ Health Needs?. American Journal of Public Health 94:6, 923-928
CrossRef466
Raji Balasubramanian, Stephen W. Lagakos. (2004) Analyzing Time-to-Event Data in a Clinical Trial When an Unknown Proportion of Subjects Has Experienced the Event at Entry. Biometrics 60:2, 335-343
CrossRef467
Rao L Divi, Vernon E Walker, Nancy A Wade, Kunio Nagashima, Steven K Seilkop, Mary Ellen Adams, Carol J Nesel, J Patrick O'Neill, Elaine J Abrams, Miriam C Poirier. (2004) Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS 18:7, 1013-1021
CrossRef468
Natella Y. Rakhmanina, John N. van den Anker, Steven J. Soldin. (2004) Safety and Pharmacokinetics of Antiretroviral Therapy During Pregnancy. Therapeutic Drug Monitoring 26:2, 110-115
CrossRef469
Pieter L. A. Fraaij, Natella Rakhmanina, David M. Burger, Ronald de Groot. (2004) Therapeutic Drug Monitoring in Children with HIV/AIDS. Therapeutic Drug Monitoring 26:2, 122-126
CrossRef470
Janet M. Blair, Debra L. Hanson, Jeffrey L. Jones, Mark S. Dworkin. (2004) Trends in Pregnancy Rates Among Women With Human Immunodeficiency Virus. Obstetrics & Gynecology 103:4, 663-668
CrossRef471
Dominique Rey, Catherine Marimoutou, Anne-Deborah Bouhnik, Rosemary Dray-Spira, France Lert, Yolande Obadia. (2004) Knowledge of HIV Postexposure Prophylaxis in a Population of HIV-Positive Outpatients: Results of a French National Survey. JAIDS Journal of Acquired Immune Deficiency Syndromes 35:4, 393-400
CrossRef472
Mauro Schechter, Regina F. do Lago, Aaron B. Mendelsohn, Ronaldo I. Moreira, Lawrence H. Moulton, Lee H. Harrison. (2004) Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 35:5, 519-525
CrossRef473
Panyu Panburana, Sayomporn Sirinavin, Winit Phuapradit, Asda Vibhagool, Wasun Chantratita. (2004) Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1. American Journal of Obstetrics and Gynecology 190:3, 803-808
CrossRef474
Maarten J Postma, Kwamena WC Sagoe, Fleur Dronkers, Herman G Sprenger, Lolkje de Jong – van den Berg, Eduard J Beck. (2004) Cost-effectiveness of antenatal HIV-testing: reviewing its pharmaceutical and methodological aspects. Expert Opinion on Pharmacotherapy 5:3, 521-528
CrossRef475
Philippe Gaillard, Mary-Glenn Fowler, Francois Dabis, Hoosen Coovadia, Charles van der Horst, Koen van Rompay, Andrea Ruff, Taha Taha, Tim Thomas, Isabelle de Vincenzi, Marie-Louise Newell. (2004) Use of Antiretroviral Drugs to Prevent HIV-1 Transmission Through Breast-feeding: From Animal Studies to Randomized Clinical Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes 35:2, 178-187
CrossRef476
Kristine L. Witt, Raymond R. Tice, Gary W. Wolfe, Jack B. Bishop. (2004) Genetic damage detected in CD-1 mouse pups exposed perinatally to 3?-azido-3?-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environmental and Molecular Mutagenesis 44:4, 321-328
CrossRef477
Mark Mirochnick, Edmund Capparelli. (2004) Pharmacokinetics of Antiretrovirals in Pregnant Women. Clinical Pharmacokinetics 43:15, 1071-1087
CrossRef478
Jack B. Bishop, Kristine L. Witt, Raymond R. Tice, Gary W. Wolfe. (2004) Genetic damage detected in CD-1 mouse pups exposed perinatally to 3?-azido-3?-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage. Environmental and Molecular Mutagenesis 43:1, 3-9
CrossRef479
Jennifer Handforth, Mike Sharland. (2004) Triple Nucleoside Reverse Transcriptase Inhibitor Therapy in??Children. Pediatric Drugs 6:3, 147-159
CrossRef480
Michael R Syme, James W Paxton, Jeffrey A Keelan. (2004) Drug Transfer and Metabolism by the Human Placenta. Clinical Pharmacokinetics 43:8, 487-514
CrossRef481
D.K. Benjamin, W.C. Miller, R.W. Ryder, D.J. Weber, E. Walter, R.E. McKinney. (2004) Growth Patterns Reflect Response to Antiretroviral Therapy in HIV-Positive Infants: Potential Utility in Resource-Poor Settings. AIDS Patient Care and STDs 18:1, 35-43
CrossRef482
Chokechai Rongkavilit, Basim I. Asmar. (2004) Advances in prevention of mother-to-child HIV transmission. The Indian Journal of Pediatrics 71:1, 69-79
CrossRef483
Travis C Porco, Jeffrey N Martin, Kimberly A Page-Shafer, Amber Cheng, Edwin Charlebois, Robert M Grant, Dennis H Osmond. (2004) Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18:1, 81-88
CrossRef484
Anne Katz. (2004) Neonatal HIV Infection. Neonatal Network: The Journal of Neonatal Nursing 23:1, 15-20
CrossRef485
Shannon R. Galvin, Myron S. Cohen. (2004) The role of sexually transmitted diseases in HIV transmission. Nature Reviews Microbiology 2:1, 33-42
CrossRef486
Denise J. Jamieson, Toussaint S. Sibailly, Ramses Sadek, Thierry H. Roels, Ehounou R. Ekpini, Edith Boni-Ouattara, John M. Karon, John Nkengasong, Alan E. Greenberg, Stefan Z. Wiktor. (2003) HIV-1 Viral Load and Other Risk Factors for Mother-to-Child Transmission of HIV-1 in a Breast-Feeding Population in Cote d'Ivoire. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:4, 430-436
CrossRef487
Eddy Perez-Then, Ricarda Pe??a, Maria Tavarez-Rojas, Cleotilde Pe??a, Salvador Qui??onez, Marta Buttler, Arthur Ammann, William Hern??ndez, Miguel Goyanes, Maria Jose Miguez, Gail Shor-Posner. (2003) Preventing Mother-to-Child HIV Transmission in a Developing Country. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:5, 506-511
CrossRef488
M. M. Tabi, S. Frimpong. (2003) HIV infection of women in African countries. International Nursing Review 50:4, 242-250
CrossRef489
Michael Neely, Andrea Kovacs. (2003) Management of antiretroviral therapy in neonates, children, and adolescents. Current Infectious Disease Reports 5:6, 521-530
CrossRef490
C. F. Ho, A. Y. Loke. (2003) Pregnant women's decisions on antenatal HIV screening in Hong Kong. AIDS Care 15:6, 821-827
CrossRef491
D MONEY. (2003) Antiviral and antiretroviral use in pregnancy. Obstetrics and Gynecology Clinics of North America 30:4, 731-749
CrossRef492
Greta R. Bauer, Seth L. Welles, Robert R. Colgrove, Jane Pitt. (2003) Zidovudine Resistance Phenotype and Risk of Perinatal HIV-1 Transmission in Zidovudine Monotherapy???Treated Mothers With Moderately Advanced Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:3, 312-319
CrossRef493
Marie Jeanne Mayaux, Jean Paul Teglas, Stephane Blanche. (2003) Characteristics of HIV-Infected Women Who Do Not Receive Preventive Antiretroviral Therapy in the French Perinatal Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:3, 338-343
CrossRef494
Daniel K Benjamin, Wiliam C Miller, Daniel K Benjamin, Robert W Ryder, David J Weber, Emmanuel Walter, Ross E McKinney. (2003) A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS 17:16, 2331-2336
CrossRef495
Mary Glenn Fowler, Lynne Mofenson, Michelle McConnell. (2003) The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know?. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:3, 308-311
CrossRef496
Jeffrey SA Stringer, Dwight J Rouse, Moses Sinkala, Elliot A Marseille, Sten H Vermund, Elizabeth M Stringer, Robert L Goldenberg. (2003) Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus. The Lancet 362:9398, 1850-1853
CrossRef497
(2003) Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. The Lancet 362:9396, 1605-1611
CrossRef498
Lisa M. Lee, Patricia L. Fleming. (2003) Estimated Number of Children Left Motherless by AIDS in the United States, 1978???1998. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:2, 231-236
CrossRef499
Robert S. Remis, Susan M. King, Lee Vernich, Carol Major, Elaine Whittingham. (2003) Epidemiologic Modeling to Evaluate Prevention of Mother???Infant HIV Transmission in Ontario. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:2, 221-230
CrossRef500
J??r??me Le Chenadec, Marie-Jeanne Mayaux, Chantal Guihenneuc-Jouyaux, St??phane Blanche. (2003) Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17:14, 2053-2061
CrossRef501
J Brooks Jackson, Philippa Musoke, Thomas Fleming, Laura A Guay, Danstan Bagenda, Melissa Allen, Clemensia Nakabiito, Joseph Sherman, Paul Bakaki, Maxensia Owor, Constance Ducar, Martina Deseyve, Anthony Mwatha, Lynda Emel, Corey Duefield, Mark Mirochnick, Mary Glenn Fowler, Lynne Mofenson, Paolo Miotti, Maria Gigliotti, Dorothy Bray, Francis Mmiro. (2003) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. The Lancet 362:9387, 859-868
CrossRef502
John L. Sullivan. (2003) Prevention of Mother-to-Child Transmission of HIV-What Next?. JAIDS Journal of Acquired Immune Deficiency Syndromes 34:Supplement 1, S67-S72
CrossRef503
Athena P Kourtis, Ann Duerr. (2003) Prevention of perinatal HIV transmission: a review of novel strategies. Expert Opinion on Investigational Drugs 12:9, 1535-1544
CrossRef504
ARIANE ALIMENTI, DAVID R. BURDGE, GINA S. OGILVIE, DEBORAH M. MONEY, JOHN C. FORBES. (2003) Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. The Pediatric Infectious Disease Journal 22:9, 782-788
CrossRef505
ROBERT R. GAISER. (2003) Changes in the Provision of Anesthesia for the Parturient Undergoing Cesarean Section. Clinical Obstetrics and Gynecology 46:3, 646-656
CrossRef506
Elyse Olshen, Cathryn L. Samples. (2003) Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents. Current Opinion in Pediatrics 15:4, 379-384
CrossRef507
B??atrice Barret, Marc Tardieu, Pierre Rustin, Catherine Lacroix, Brigitte Chabrol, Isabelle Desguerre, Catherine Dollfus, Marie-Jeanne Mayaux, St??phane Blanche. (2003) Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants. AIDS 17:12, 1769-1785
CrossRef508
Tracey E. Wilson, Linda Koenig, Jeannette Ickovics, Emmanuel Walter, Amy Suss, M. Isabel Fernandez. (2003) Contraception Use, Family Planning, and Unprotected Sex: Few Differences Among HIV-Infected and Uninfected Postpartum Women in Four US States. JAIDS Journal of Acquired Immune Deficiency Syndromes 33:5, 608-613
CrossRef509
Esa?? Cust??dio Jo??o, Maria Let??ciaS Cruz, Jacqueline A Menezes, Haroldo J Matos, Guilherme A Calvet, Marcos M d'Ippolito, Lu??sa T Salgado, Sonia S Silva, Gabriela R Bazin, Ricardo C Braga. (2003) Vertical transmission of HIV in Rio de Janeiro, Brazil. AIDS 17:12, 1853-1855
CrossRef510
Robert Gaiser. (2003) Low Complication Rate Associated With Cesarean Section Under Spinal Anesthesia for HIV-1 Infected Women on Antiretroviral Therapy. Survey of Anesthesiology 47:4, 215-216
CrossRef511
Ho Choi Fung, Loke Alice Yuen. (2003) HIV/AIDS knowledge and risk behaviour in Hong Kong Chinese pregnant women. Journal of Advanced Nursing 43:3, 238-245
CrossRef512
D. Heather Watts, John Lambert, E. Richard Stiehm, D. Robert Harris, James Bethel, Lynne Mofenson, William A. Meyer, Bonnie Mathieson, Mary Glen Fowler, George Nemo. (2003) Progression of HIV Disease Among Women Following Delivery. JAIDS Journal of Acquired Immune Deficiency Syndromes 33:5, 585-593
CrossRef513
Brian W.C. Forsyth. (2003) Psychological aspects of HIV infection in children. Child and Adolescent Psychiatric Clinics of North America 12:3, 423-437
CrossRef514
RICHARD M. SELIK, MARY LOU LINDEGREN. (2003) Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. The Pediatric Infectious Disease Journal 22:7, 635-642
CrossRef515
Eleonor Brandin, Lena Lindborg, Katarina Gyllensten, Christina Broström, Lars Hagberg, Magnus Gisslen, Björn Tuvesson, Anders Blaxhult, Jan Albert. (2003) pol Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy. AIDS Research and Human Retroviruses 19:7, 543-550
CrossRef516
M. Zonneveld, A. B. Nunen, H. G. M. Niesters, R. A. Man, S. W. Schalm, H. L. A. Janssen. (2003) Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. Journal of Viral Hepatitis 10:4, 294-297
CrossRef517
D Jeppesen, H Hasselbalch, AK Ersbøll, C Heilmann, NH Valerius. (2003) Thymic size in uninfected infants born to HIV-positive mothers and fed with pasteurized human milk. Acta Paediatrica 92:6, 679-683
CrossRef518
Roger L. Shapiro, Shahin Lockman, Ibou Thior, Lisa Stocking, Poloko Kebaabetswe, Carolyn Wester, Trevor Peter, Richard Marlink, Max Essex, S. Jody Heymann. (2003) Low Adherence to Recommended Infant Feeding Strategies Among HIV-Infected Women: Results from the Pilot Phase of a Randomized Trial to Prevent Mother-to-child Transmission in Botswana. AIDS Education and Prevention 15:3, 221-230
CrossRef519
Miriam C. Poirier, Rao L. Divi, Lena Al-Harthi, Ofelia A. Olivero, Vi Nguyen, Brettania Walker, Alan L. Landay, Vernon E. Walker, Manhattan Charurat, William A. Blattner. (2003) Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected Mothers. JAIDS Journal of Acquired Immune Deficiency Syndromes 33:2, 175-183
CrossRef520
Avinash K. Shetty, Yvonne Maldonado. (2003) Preventing mother-to-child transmission of human immunodeficiency virus type 1 in resource-poor countries. The Pediatric Infectious Disease Journal 22:6, 553-555
CrossRef521
Peter Duesberg, Claus Koehnlein, David Rasnick. (2003) The chemical bases of the various AIDS epidemics: Recreational drugs, anti-viral chemotherapy and malnutrition. Journal of Biosciences 28:4, 383-412
CrossRef522
Bradley W Kosel, Karen P Beckerman, Sandra Hayashi, Masato Homma, Francesca T Aweeka. (2003) Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS 17:8, 1195-1199
CrossRef523
ANNE M. ST. JOHN, ALOK KUMAR, CLYDE CAVE. (2003) Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados. The Pediatric Infectious Disease Journal 22:5, 422-425
CrossRef524
Riad Agbaria, Esther Manor, Jacob Barak, Jan Balzarini. (2003) Phosphorylation of 3´-Azidothymidine in Maternal and Fetal Peripheral Blood Mononuclear Cells During Gestation and at Term. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:5, 477-481
CrossRef525
(2003) Exposure to Antiretroviral Therapy in Utero or Early Life: the Health of Uninfected Children Born to HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:4, 380-387
CrossRef526
Donald P Kotler. (2003) Human immunodeficiency virus and pregnancy. Gastroenterology Clinics of North America 32:1, 437-448
CrossRef527
Dale Bramley, Nicholas Graves, Damian Walker. (2003) The cost effectiveness of universal antenatal screening for HIV in New Zealand. AIDS 17:5, 741-748
CrossRef528
Richard E. Rothman, Kerunne S. Ketlogetswe, Teresa Dolan, Peter C. Wyer, Gabor D. Kelen. (2003) Preventive Care in the Emergency Department: Should Emergency Departments Conduct Routine HIV Screening? A Systematic Review. Academic Emergency Medicine 10:3, 278-285
CrossRef529
Joan Duggan, Sadik Khuder, Neil Sinha, Joana Chakraborty. (2003) Survey of Physician Attitudes Toward HIV Testing in Pregnant Women in Ohio. AIDS Patient Care and STDs 17:3, 121-127
CrossRef530
Y. Sunila Reddy, Angela Kashuba, John Gerber, Veronica Miller. (2003) Roundtable Report: Importance of Antiretroviral Drug Concentrations in Sanctuary Sites and Viral Reservoirs. AIDS Research and Human Retroviruses 19:3, 167-176
CrossRef531
Monica M. Parker, Nancy Wade, Robert M. Lloyd,, Guthrie S. Birkhead, Brian K. Gallagher, Babu Cheku, Timothy Sullivan, Jill Taylor. (2003) Prevalence of Genotypic Drug Resistance Among a Cohort of HIV-Infected Newborns. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:3, 292-297
CrossRef532
Gerberding, Julie Louise, . (2003) Occupational Exposure to HIV in Health Care Settings. New England Journal of Medicine 348:9, 826-833
Full Text533
Arlene D. Bardeguez, David E. Shapiro, Lynne M. Mofenson, Robert Coombs, Lisa M. Frenkel, Mary Glenn Fowler, Sharon Huang, Rhoda S. Sperling, Bethann Cunningham, Jorge Gandia, Robert Maupin, Carmen D. Zorrilla, Theodore Jones, Mary Jo O'Sullivan. (2003) Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:2, 170-181
CrossRef534
Chitsanu Pancharoen, Usa Thisyakorn. (2003) Preventive strategies of perinatal HIV-1 transmission: an experience from Thailand. Expert Opinion on Pharmacotherapy 4:2, 179-182
CrossRef535
Sandra Arnold, Naushaba Degani, Susan King. (2003) Lack of Adverse Events Associated with Pre- and Postnatal Antiretroviral Therapy Exposure: A Retrospective Review of 43 Children Followed up at 4–7 Years of Age. AIDS Patient Care and STDs 17:2, 53-55
CrossRef536
Aldina Venerosi, Francesca Cirulli, Francesca Capone, Enrico Alleva. (2003) Prolonged perinatal AZT administration and early maternal separation: effects on social and emotional behaviour of periadolescent mice. Pharmacology Biochemistry and Behavior 74:3, 671-681
CrossRef537
Anthony Al‐Khan, Jose Colon, Vidya Palta, Arlene Bardeguez. (2003) Assisted Reproductive Technology for Men and Women Infected with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases 36:2, 195-200
CrossRef538
Atanu Biswas. (2003) Generalized Delayed Response in Randomized Play-the-Winner Rule. Communications in Statistics - Simulation and Computation 32:1, 259-274
CrossRef539
Despina G. Contopoulos-Ioannidis, Thomas R. O'Brien, James J. Goedert, Phillip S. Rosenberg, John P.A. Ioannidis. (2003) Effect of CCR5-Δ32 Heterozygosity on the Risk of Perinatal HIV-1 Infection: A Meta-Analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:1, 70-76
CrossRef540
Jorge Luján-Zilbermann, Wally Bitar, Katherine Knapp, Patricia Flynn. (2003) Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants. The Pediatric Infectious Disease Journal 22:1, 97-99
CrossRef541
Jamease Kowalczyk, Pauline Jolly, Etienne Karita, Joseph-Ardent Nibarere, Joseph Vyankandondera, Hamisu Salihu. (2002) Voluntary Counseling and Testing for HIV Among Pregnant Women Presenting in Labor in Kigali, Rwanda. JAIDS Journal of Acquired Immune Deficiency Syndromes 31:4, 408-415
CrossRef542
Carmen Muñoz-Almagro, Claudia Fortuny, Teresa Juncosa, Maria T. Garcia-Fructuoso, A. Gonzalez-Cuevas, C. Latorre. (2002) Absence of Detectable HIV-1 Provirus DNA After Early Highly Active Antiretroviral Therapy in Children Infected by Vertical Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 31:4, 450-452
CrossRef543
Stacy A. Nichols, Madhav P. Bhatta, Jennifer Lewis, Sten H. Vermund. (2002) Prenatal HIV Counseling, Testing, and Antiretroviral Prophylaxis by Obstetric and Family Medicine Providers in Alabama. The American Journal of the Medical Sciences 324:6, 305-309
CrossRef544
Pongsakdi Chaisilwattana, Kulkanya Chokephaibulkit, Amphan Chalermchockcharoenkit, Nirun Vanprapar, Korakot Sirimai, Sanay Chearskul, Ruengpung Sutthent, Nisarat Opartkiattikul. (2002) Short‐Course Therapy with Zidovudine Plus Lamivudine for Prevention of Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1 in Thailand. Clinical Infectious Diseases 35:11, 1405-1413
CrossRef545
Mitchell H. Katz, Julie Louise Gerberding. (2002) Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Infectious Disease Reports 4:6, 543-549
CrossRef546
Natasha Press, Mark W. Tyndall, Evan Wood, Robert S. Hogg, Julio S. G. Montaner. (2002) Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S112-S117
CrossRef547
Juan D Ruiz, Fred Molitor, Tim Bruckner, Donna Zukowski. (2002) Ethnic disparity in HIV prevalence and zidovudine treatment among childbearing women and pediatric AIDS cases in California. AIDS 16:18, 2469-2472
CrossRef548
Gemma Calamandrei, Angela Valanzano, Maria Puopolo, Luigi Aloe. (2002) Developmental exposure to the antiretroviral drug zidovudine increases brain levels of brain-derived neurotrophic factor in mice. Neuroscience Letters 333:2, 111-114
CrossRef549
Ana Ceballos, María de Los Angeles Pando, Diana Liberatore, Mirna Biglione, Patricia Coll Cárdenas, Marina Martínez, María Luisa Celadilla, María M. Avila, Liliana Martínez Peralta. (2002) Efficacy of Strategies to Reduce Mother-to-Child HIV-1 Transmission in Argentina, 1993–2000. JAIDS Journal of Acquired Immune Deficiency Syndromes 31:3, 348-353
CrossRef550
Brent M. Booker, Patrick F. Smith, Gene D. Morse. 2002. Universal Precautions and Post-exposure Prophylaxis for HIV. , 891-898.
CrossRef551
Anita L. Belman. (2002) HIV-1 infection and AIDS. Neurologic Clinics 20:4, 983-1011
CrossRef552
Susan M Melnick, Jeremy Weedon, Diana L Dow-Edwards. (2002) The effects of perinatal AZT exposure on the acoustic startle response in adult rats. Neurotoxicology and Teratology 24:6, 773-781
CrossRef553
Paul D. Griffiths. (2002) Tomorrow’s Challenges for Herpesvirus Management: Potential Applications of Valacyclovir. The Journal of Infectious Diseases 186:s1, S131-S137
CrossRef554
Baruch A. Brody. (2002) Ethical issues in clinical trials in developing countries. Statistics in Medicine 21:19, 2853-2858
CrossRef555
Antonia L Moore, Sara Madge, Margaret A Johnson. (2002) HIV and pregnancy. The Obstetrician & Gynaecologist 4:4, 197-200
CrossRef556
John A Harrington. (2002) The instrumental uses of autonomy: A review of AIDS law and policy in Europe. Social Science & Medicine 55:8, 1425-1434
CrossRef557
Kristin Anne Bendikson, Deborah Anderson, Mark D. Hornstein. (2002) Fertility options for HIV patients. Current Opinion in Obstetrics and Gynecology 14:5, 453-457
CrossRef558
JULIETA KOPKA, MARCELO BATALLA, ANDREA MANGANO, DEBORA MECIKOVSKY, ROSA BOLOGNA, AND, LUISA SEN. (2002) Relevance of Viral Phenotype in the Early AIDS Outcome of Pediatric HIV-1 Primary Infection. Pediatric Research 52:4, 475-480
CrossRef559
David Orentlicher. (2002) Universality and its Limits: When Research Ethics Can Reflect Local Circumstances. The Journal of Law, Medicine & Ethics 30:3, 403-410
CrossRef560
C Wilfert. (2002) Prevention of mother-to-child transmission of HIV: reflections on implementation of PMTCT in the developing world. Acta Paediatrica 91:8, 863-865
CrossRef561
E.G Hermione Lyall. (2002) Paediatric HIV in 2002—a treatable and preventable infection. Journal of Clinical Virology 25:2, 107-119
CrossRef562
Usha Sambamoorthi, Ayse Akincigil, Elizabeth McSpiritt, Stephen Crystal. (2002) Zidovudine Use During Pregnancy Among HIV-Infected Women on Medicaid. JAIDS Journal of Acquired Immune Deficiency Syndromes 30:4, 429-439
CrossRef563
MATTHEW R. GOLDEN. (2002) HIV Partner Notification: A Neglected Prevention Intervention. Sexually Transmitted Diseases 29:8, 472-475
CrossRef564
Anastasia Polycarpou, Christos Ntais, Bette T. Korber, Henry A. Elrich, Robert Winchester, Paul Krogstad, Steven Wolinsky, Timothy Rostron, Sarah L. Rowland-Jones, Arthur J. Ammann, John P.A. Ioannidis. (2002) Association between Maternal and Infant Class I and II HLA Alleles and of Their Concordance with the Risk of Perinatal HIV Type 1 Transmission. AIDS Research and Human Retroviruses 18:11, 741-746
CrossRef565
SUSAN A. FISCUS, ADAORA A. ADIMORA, MICHELE L. FUNK, VICTOR J. SCHOENBACH, DEBORAH TRISTRAM, WILMA LIM, ROSS MCKINNEY, DAVID RUPAR, CHARLES WOODS, CATHERINE WILFERT. (2002) Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina. The Pediatric Infectious Disease Journal 21:7, 664-668
CrossRef566
F Ramos-Gomez. (2002) Dental considerations for the paediatric AIDS/HIV patient. Oral Diseases 8:s2, 49-54
CrossRef567
Gemma Calamandrei, Ombretta Rufini, Angela Valanzano, Maria Puopolo. (2002) Long-term effects of developmental exposure to zidovudine on exploratory behavior and novelty discrimination in CD-1 mice. Neurotoxicology and Teratology 24:4, 529-540
CrossRef568
GM McCarthy, CS Ssali, H Bednarsh, J Jorge, K Wangrangsimakul, K Page-Shafer. (2002) Transmission of HIV in the dental clinic and elsewhere. Oral Diseases 8:s2, 126-135
CrossRef569
Leslie London. (2002) Ethical Oversight of Public Health Research: Can Rules and IRBs Make a Difference in Developing Countries?. American Journal of Public Health 92:7, 1079-1084
CrossRef570
Wood, Alastair J.J., , Watts, D. Heather, . (2002) Management of Human Immunodeficiency Virus Infection in Pregnancy. New England Journal of Medicine 346:24, 1879-1891
Full Text571
Tuomala, Ruth E., Shapiro, David E., Mofenson, Lynne M., Bryson, Yvonne, Culnane, Mary, Hughes, Michael D., O'Sullivan, M.J., Scott, Gwendolyn, Stek, Alice M., Wara, Diane, Bulterys, Marc, . (2002) Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. New England Journal of Medicine 346:24, 1863-1870
Full Text572
Monica Nolan, Mary Glenn Fowler, Lynne M. Mofenson. (2002) Antiretroviral Prophylaxis of Perinatal HIV-1 Transmission and the Potential Impact of Antiretroviral Resistance. JAIDS Journal of Acquired Immune Deficiency Syndromes 30:2, 216-229
CrossRef573
Louise Kuhn. (2002) Beyond informed choice: Infant feeding dilemmas for women in low‐resource communities of high HIV prevalence. Social Dynamics 28:1, 132-154
CrossRef574
Juan D. Ruiz, Fred Molitor, Erica Prussing, Laura Peck, Paola Grasso. (2002) Prenatal HIV Counseling and Testing in California: Women's Experiences and Providers' Practices. AIDS Education and Prevention 14:3, 190-195
CrossRef575
Mark Russi. (2002) HIV and AIDS in the Workplace. Journal of Occupational and Environmental Medicine 44:6, 495-502
CrossRef576
&NA;. (2002) Pregnancy and HIV infection: a European consensus on management. AIDS 16, S1-S18
CrossRef577
J.L. Wiesner, F.C.W. Sutherland, M.J. Smit, G.H. van Essen, H.K.L. Hundt, K.J. Swart, A.F. Hundt. (2002) Sensitive and rapid liquid chromatography–tandem mass spectrometry method for the determination of stavudine in human plasma. Journal of Chromatography B 773:2, 129-134
CrossRef578
Elise M. Beltrami, Chi‐Cheng Luo, Nicolas de la Torre, Denise M. Cardo. (2002) Transmission of Drug‐Resistant HIV After an Occupational Exposure Despite Postexposure Prophylaxis With a Combination Drug Regimen • . Infection Control and Hospital Epidemiology 23:6, 345-348
CrossRef579
Lynne M. Mofenson, Paula Munderi. (2002) Safety of Antiretroviral Prophylaxis of Perinatal Transmission for HIV-Infected Pregnant Women and Their Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes 30:2, 200-215
CrossRef580
Teresa Cameron. (2002) Mandatory HIV Testing of Newborns in New York State. Journal of Health & Social Policy 14:3, 59-78
CrossRef581
Mina Hosseinipour, Myron S. Cohen, Pietro L. Vernazza, Angela D. M. Kashuba. (2002) Can Antiretroviral Therapy Be Used to Prevent Sexual Transmission of Human Immunodeficiency Virus Type 1?. Clinical Infectious Diseases 34:10, 1391-1395
CrossRef582
Claudia A. Chiriboga. (2002) Human immunodeficiency virus (HIV) in children. Current Treatment Options in Neurology 4:3, 213-224
CrossRef583
Siripon Kanshana, R. J. Simonds. (2002) National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned. AIDS 16:7, 953-959
CrossRef584
Chitsanu Pancharoen, Usa Thisyakorn. (2002) Pediatric Acquired Immunodeficiency Syndrome in Asia: Mother‐to‐Child Transmission. Clinical Infectious Diseases 34:S2, S65-S69
CrossRef585
(2002) Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. The Lancet 359:9313, 1178-1186
CrossRef586
Ofelia A. Olivero, Juan J. Fernandez, Brendan B. Antiochos, Jessica L. Wagner, Marisa E. St. Claire, Miriam C. Poirier. (2002) Transplacental Genotoxicity of Combined Antiretroviral Nucleoside Analogue Therapy in Erythrocebus patas Monkeys. JAIDS Journal of Acquired Immune Deficiency Syndromes 29:4, 323-329
CrossRef587
Ellen R. Cooper, Manhattan Charurat, Lynne Mofenson, I. Celine Hanson, Jane Pitt, Clemente Diaz, Karen Hayani, Edward Handelsman, Vincent Smeriglio, Rodney Hoff, William Blattner. (2002) Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 29:5, 484-494
CrossRef588
Catia Marzolini, Christoph Rudin, Laurent A. Decosterd, Amalio Telenti, Alain Schreyer, Jérôme Biollaz, Thierry Buclin. (2002) Transplacental passage of protease inhibitors at delivery. AIDS 16:6, 889-893
CrossRef589
Taha E. Taha, Newton Kumwenda, Amanda Gibbons, Donald Hoover, Valentino Lema, Susan Fiscus, Joshua Mukiibi, George Liomba, Robin Broadhead. (2002) Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants. AIDS 16:6, 851-858
CrossRef590
C. Casper, L. Navér, P. Clevestig, E. Belfrage, T. Leitner, J. Albert, S. Lindgren, C. Ottenblad, A.-B. Bohlin, E.M. Fenyö, A. Ehrnst. (2002) Coreceptor Change Appears after Immune Deficiency Is Established in Children Infected with Different HIV-1 Subtypes. AIDS Research and Human Retroviruses 18:5, 343-352
CrossRef591
WENDY F. HANSEN, JEROME YANKOWITZ. (2002) Pharmacologic Therapy for Medical Disorders During Pregnancy. Clinical Obstetrics and Gynecology 45:1, 136-152
CrossRef592
J. Blake Scott. (2002) The public policy debate over newborn HIV testing: A case study of the knowledge enthymeme. Rhetoric Society Quarterly 32:2, 57-83
CrossRef593
Mitchell H. Katz, Sandra K. Schwarcz, Timothy A. Kellogg, Jeffrey D. Klausner, James W. Dilley, Steven Gibson, William McFarland. (2002) Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco. American Journal of Public Health 92:3, 388-394
CrossRef594
Maki Arai, Donald D Earl, Janet K Yamamoto. (2002) Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?. Veterinary Immunology and Immunopathology 85:3-4, 189-204
CrossRef595
Warren A. Andiman. (2002) Transmission of HIV-1 from mother to infant. Current Opinion in Pediatrics 14:1, 78-85
CrossRef596
(2002) Human immunodeficiency virus and infertility treatment. Fertility and Sterility 77:2, 218-222
CrossRef597
Anne Laporte, Nathalie Jourdan, Elisabeth Bouvet, Franck Lamontagne, Josiane Pillonel, Jean-Claude Desenclos. (2002) Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians’ experiences and attitudes. AIDS 16:3, 397-405
CrossRef598
Peter Brocklehurst, Peter Brocklehurst. 2002. Interventions for reducing the risk of mother-to-child transmission of HIV infection. .
CrossRef599
Louise Kuhn, Stephen Meddows‐Taylor, Glenda Gray, Caroline Tiemessen. (2002) Human Immunodeficiency Virus (HIV)–Specific Cellular Immune Responses in Newborns Exposed to HIV In Utero. Clinical Infectious Diseases 34:2, 267-276
CrossRef600
Noreen Jack. (2002) HIV/AIDS in Caribbean Children and Adolescents. Journal of HIV/AIDS Prevention & Education for Adolescents & Children 4:2-3, 23-40
CrossRef601
Louise Kuhn, Ingrid Peterson. (2002) Options for Prevention of HIV Transmission from Mother to Child, with a Focus on Developing Countries. Pediatric Drugs 4:3, 191-203
CrossRef602
Athena P. Kourtis. (2002) Prevention of Perinatal HIV Transmission. Drugs 62:15, 2213-2220
CrossRef603
Massimo Resti, Chiara Azzari, Flavia Bortolotti. (2002) Hepatitis C Virus Infection in Children Coinfected with HIV. Pediatric Drugs 4:9, 571-580
CrossRef604
Joseph J Amon. (2002) Preventing HIV infections in children and adolescents in sub-Saharan Africa through integrated care and support activities: a review of the literature. African Journal of AIDS Research 1:2, 143-149
CrossRef605
Christina Stefanaki, Alexander J Stratigos, John D Stratigos. (2002) Skin manifestations of HIV-1 infection in children. Clinics in Dermatology 20:1, 74-86
CrossRef606
Margaret Kingston, Elizabeth Carlin. (2002) Treatment of Sexually Transmitted Infections with Single-Dose Therapy. Drugs 62:6, 871-878
CrossRef607
Patrick J. Gavin, Ram Yogev. (2002) The Role of Protease Inhibitor Therapy in Children with HIV Infection. Pediatric Drugs 4:9, 581-607
CrossRef608
L. Romano, V. Giulietta, A. Vivarelli, L. Galli, Z. Maurizio. (2002) Detection of a Drug-Resistant Human Immunodeficiency Virus Variant in a Newly Infected Heterosexual Couple. Clinical Infectious Diseases 34:1, 116-117
CrossRef609
Gideon Koren, Gil Klinger, Arne Ohlsson. (2002) Fetal Pharmacotherapy. Drugs 62:5, 757-773
CrossRef610
&NA;. (2002) Postexposure prophylaxis for occupational exposure to HIV has its risks. Drugs & Therapy Perspectives 18:1, 17-20
CrossRef611
Daniel Avi Lemberg, Pamela Palasanthiran, Michele Goode, John B. Ziegler. (2002) Tolerabilities of Antiretrovirals in Paediatric HIV Infection. Drug Safety 25:14, 973-991
CrossRef612
Susan Bersoff‐Matcha, William Miller, Linda M. Mundy. (2001) Reply. Clinical Infectious Diseases 33:12, 2097-2098
CrossRef613
Ronald P. Strauss, Sohini Sengupta, Sandra Crouse Quinn, Jean Goeppinger, Cora Spaulding, Susan M. Kegeles, Greg Millett. (2001) The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process. American Journal of Public Health 91:12, 1938-1943
CrossRef614
Larry Corey. (2001) My Life In Medicine: Translational Research Involving HSV and HIV. Infectious Diseases in Clinical Practice 10:9, 463-466
CrossRef615
Charles Kilewo, Augustine Massawe, Eligius Lyamuya, Innocent Semali, Festus Kalokola, Ernest Urassa, Maryrose Giattas, Florence Temu, Katarina Karlsson, Fred Mhalu, Gunnel Biberfeld. (2001) HIV Counseling and Testing of Pregnant Women in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 28:5, 458-462
CrossRef616
Raji Balasubramanian, Stephen W. Lagakos. (2001) Estimation of the Timing of Perinatal Transmission of HIV. Biometrics 57:4, 1048-1058
CrossRef617
Yamit Busidan, Xiandong Shi, Diana L. Dow-Edwards. (2001) AZT distribution in the fetal and postnatal rat central nervous system. Journal of Pharmaceutical Sciences 90:12, 1964-1971
CrossRef618
Emilio Fumero, Daniel Podzamczer. (2001) The role of nevirapine in the treatment of HIV-1 disease. Expert Opinion on Pharmacotherapy 2:12, 2065-2078
CrossRef619
Sullivan, John L., Luzuriaga, Katherine, . (2001) The Changing Face of Pediatric HIV-1 Infection. New England Journal of Medicine 345:21, 1568-1569
Full Text620
S. Yerly, S. Vora, P. Rizzardi, J.-P. Chave, P. L. Vernazza, M. Flepp, A. Telenti, M. Battegay, A.-L. Veuthey, J.-P. Bru, M. Rickenbach, B. Hirschel, L. Perrin. (2001) Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 15:17, 2287-2292
CrossRef621
Jing Zhang, Emanuela Balestrieri, Sandro Grelli, Claudia Matteucci, Veronica Pagnini, Cartesio D'Agostini, Antonio Mastino, Beatrice Macchi. (2001) Efficacy of 3′-azido 3′deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells. Virus Research 78:1-2, 67-78
CrossRef622
Milton L. Wainberg, Marshall Forstein, Alan Berkman, Francine Cournos. (2001) Essential medical facts for mental health practitioners. New Directions for Mental Health Services 2000:87, 3-15
CrossRef623
GIUSEPPE IPPOLITO, VINCENZO GALATI, DIEGO SERRAINO, ENRICO GIRARDI. (2001) The Changing Picture of the HIV/AIDS Epidemic. Annals of the New York Academy of Sciences 946:1, 1-12
CrossRef624
Sheryl L. Henderson, Michael K. Lindsay, Joel E. Higgins, W. Scott Clark, Marc Bulterys, Steven R. Nesheim. (2001) Experience with routine voluntary perinatal human immunodeficiency virus testing in an inner city hospital. The Pediatric Infectious Disease Journal 20:11, 1090-1092
CrossRef625
Raffaele D'Amelio, Emmanuelle Tuerlings, Olga Perito, Roberto Biselli, Sergio Natalicchio, Stuart Kingma. (2001) A Global Review of Legislation on HIV/AIDS: The Issue of HIV Testing. JAIDS Journal of Acquired Immune Deficiency Syndromes 28:2, 173-179
CrossRef626
Richard M. Rutstein. (2001) Prevention of perinatal HIV infection. Current Opinion in Pediatrics 13:5, 408-416
CrossRef627
R. Pool, S. Nyanzi, J. A. G. Whitworth. (2001) Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care 13:5, 605-615
CrossRef628
EGH Lyall, M Blott, A de Ruiter, D Hawkins, D Mercy, Z Mitchla, M-L Newell, S O'Shea, JR Smith, J Sunderland, R Webb, GP Taylor. (2001) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. British HIV Association. HIV Medicine 2:4, 314-334
CrossRef629
Wendy Holmes, Tamara Kwarteng. (2001) Parent to child transmission of HIV: policy considerations in the Asia-Pacific region. Journal of Clinical Virology 22:3, 315-324
CrossRef630
Linda Levin, Lisa Henry-Reid, Debra A Murphy, Ligia Peralta, Moussa Sarr, Yong Ma, Audrey Smith Rogers. (2001) Incident pregnancy rates in HIV infected and HIV uninfected at-risk adolescents. Journal of Adolescent Health 29:3, 101-108
CrossRef631
Sherry L. Orloff, Marc Bulterys, Peter Vink, Steven Nesheim, Elaine J. Abrams, Ellie Schoenbaum, Paul Palumbo, Richard W. Steketee, R. J. Simonds. (2001) Maternal Characteristics Associated With Antenatal, Intrapartum, and Neonatal Zidovudine Use in Four U.S. Cities, 1994–1998. JAIDS Journal of Acquired Immune Deficiency Syndromes 28:1, 65-72
CrossRef632
Anna-Bettina Haidich, John P.A Ioannidis. (2001) Patterns of patient enrollment in randomized controlled trials. Journal of Clinical Epidemiology 54:9, 877-883
CrossRef633
M. Moussa, P. Roques, N. Fievet, E. Menu, J. G. Maldonado-Estrada, J. Brunerie, R. Frydman, X. Fritel, F. Herve, G. Chaouat. (2001) Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women. Clinical and Experimental Immunology 125:3, 455-464
CrossRef634
HIDEKI KOI, JIAN ZHANG, SAMUEL PARRY. (2001) The Mechanisms of Placental Viral Infection. Annals of the New York Academy of Sciences 943:1, 148-156
CrossRef635
LOUISE KUHN, ANNA COUTSOUDIS, DERSEREE MOODLEY, NOLWANDLE MNGQUNDANISO, DARIA TRABATTONI, GENE M. SHEARER, MARIO CLERICI, AND, HOOSEN M. COOVADIA. (2001) Interferon-Gamma and Interleukin-10 Production Among HIV-1???Infected and Uninfected Infants of HIV-1???Infected Mothers. Pediatric Research 50:3, 412-416
CrossRef636
George Kamkamidze, Timothy Sullivan, Tina Charbonneau. (2001) Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants. Journal of Clinical Virology 22:1, 143-148
CrossRef637
Paul Farmer, Fernet Léandre, Joia S Mukherjee, Marie Sidonise Claude, Patrice Nevil, Mary C Smith-Fawzi, Serena P Koenig, Arachu Castro, Mercedes C Becerra, Jeffrey Sachs, Amir Attaran, Jim Yong Kim. (2001) Community-based approaches to HIV treatment in resource-poor settings. The Lancet 358:9279, 404-409
CrossRef638
Wendy Mitchell. (2001) Neurological and developmental effects of HIV and AIDS in children and adolescents. Mental Retardation and Developmental Disabilities Research Reviews 7:3, 211-216
CrossRef639
Shapiro, Harold T., Meslin, Eric M., . (2001) Ethical Issues in the Design and Conduct of Clinical Trials in Developing Countries. New England Journal of Medicine 345:2, 139-142
Full Text640
Chokechai Rongkavilit, Basim I. Asmar. (2001) Antiretroviral drugs in pediatrics. The Indian Journal of Pediatrics 68:7, 641-647
CrossRef641
(2001) The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. American Journal of Public Health 91:7, 1019-1024
CrossRef642
Jaime Deville, Yvonne Bryson. (2001) Perinatal transmission of HIV: Recognition and treatment interventions. Current Infectious Disease Reports 3:4, 388-396
CrossRef643
A J Smith, S O Cameron, J Bagg, D Kennedy. (2001) Occupational health: Management of needlestick injuries in general dental practice. British Dental Journal 190:12, 645-650
CrossRef644
Gottlieb, Michael S., . (2001) AIDS — Past and Future. New England Journal of Medicine 344:23, 1788-1791
Full Text645
ROXANA B. FERREIRO, KENT A. SEPKOWITZ. (2001) Management of Needlestick Injuries. Clinical Obstetrics and Gynecology 44:2, 276-288
CrossRef646
MARGARET KHOURY, ANDREA KOVACS. (2001) Pediatric HIV Infection. Clinical Obstetrics and Gynecology 44:2, 243-275
CrossRef647
Laura A Guay. (2001) From research to implementation: challenges in the prevention of mother to child HIV transmission in the developing world. Trends in Molecular Medicine 7:6, 277-279
CrossRef648
JOANN M. SCHULTE, SUSAN BURKHAM, DOUGLAS HAMAKER, MICHAEL E. ST. LOUIS, JOHN M. PAFFEL, DON HUTCHESON, M. BLAKE CALDWELL, KENNETH L. DOMINGUEZ, WILLIAM C. LEVINE. (2001) Syphilis Among HIV-Infected Mothers and Their Infants in Texas From 1988 to 1994. Sex Transm Dis 28:6, 315-320
CrossRef649
John H. Rodman. (2001) Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infants. Seminars in Perinatology 25:3, 170-176
CrossRef650
TRACEY E. WILSON. (2001) Sexual and Reproductive Behavior of Women With HIV Infection. Clinical Obstetrics and Gynecology 44:2, 289-299
CrossRef651
SONIA I. ARBONA, SHARON K. MELVILLE, I. CELINE HANSON, JANET E. SQUIRES, MARILYN DOYLE, TERENCE I. DORAN, JANAK A. PATEL, GILBERTO A. HANDAL, SARMISTHA B. HAUGER, DONALD K. MURPHEY, KENNETH DOMINGUEZ. (2001) Mother-to-child transmission of the human immunodeficiency virus in Texas. The Pediatric Infectious Disease Journal 20:6, 602-606
CrossRef652
Wafaie Fawzi, Gernard Msamanga, Boris Renjifo, Donna Spiegelman, Ernest Urassa, Lobat Hashemi, Gretchen Antelman, Max Essex, David Hunter. (2001) Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 15:9, 1157-1165
CrossRef653
L. Sherr, A. Bergenstrom, E. Bell, E. McCann, C. N Hudson. (2001) Ante-natal HIV testing: An observational study of HIV test discussion in maternity care. Counselling Psychology Quarterly 14:2, 129-138
CrossRef654
Bernard Masquelier, Marie-Laure Chaix, Marianne Burgard, Jérome Lechenadec, Anne Doussin, François Simon, Jacqueline Cottalorda, Jacques Izopet, Catherine Tamalet, Danielle Douard, Hervé Fleury, Marie-Jeanne Mayaux, Stéphane Blanche, Christine Rouzioux. (2001) Zidovudine Genotypic Resistance in HIV-1–Infected Newborns in the French Perinatal Cohort. Journal of Acquired Immune Deficiency Syndromes 27:2, 99-104
CrossRef655
D. HEATHER WATTS. (2001) Maternal Therapy for HIV in Pregnancy. Clinical Obstetrics and Gynecology 44:2, 182-197
CrossRef656
Bernard Masquelier, Marie-Laure Chaix, Marianne Burgard, Jérome Lechenadec, Anne Doussin, François Simon, Jacqueline Cottalorda, Jacques Izopet, Catherine Tamalet, Danielle Douard, Hervé Fleury, Marie-Jeanne Mayaux, Stéphane Blanche, Christine Rouzioux. (2001) Zidovudine Genotypic Resistance in HIV-1–Infected Newborns in the French Perinatal Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 27:2, 99-104
CrossRef657
Karolynn Siegel, Helen-Maria Lekas, Eric W. Schrimshaw, Jennifer K. Johnson. (2001) Factors Associated With HIV-Infected Women's Use or Intention to Use AZT During Pregnancy. AIDS Education and Prevention 13:3, 189-206
CrossRef658
HOWARD MINKOFF. (2001) Prevention of Mother-to-Child Transmission of HIV. Clinical Obstetrics and Gynecology 44:2, 210-225
CrossRef659
Carlo Giaquinto, Antonia De Romeo, Vania Giacomet, Osvalda Rampon, Ezia Ruga, Alberto Burlina, Anita De Rossi, Miriam Sturkenboom, Ruggiero D'Elia. (2001) Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. AIDS 15:8, 1074-1075
CrossRef660
ELAINE J. ABRAMS, JEREMY WEEDON, JEANNE BERTOLLI, KATIE BORNSCHLEGEL, JOSEPH CERVIA, HERMAN MENDEZ, GENEVIEVE LAMBERT, TEJINDER SINGH, PAULINE THOMAS. (2001) Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. The Pediatric Infectious Disease Journal511-517
CrossRef661
(2001) Where is the M in MTCT? The broader issues in mother-to-child transmission of HIV. American Journal of Public Health 91:5, 703-704
CrossRef662
Ruth Nduati, Barbra A Richardson, Grace John, Dorothy Mbori-Ngacha, Anthony Mwatha, Jeckoniah Ndinya-Achola, Job Bwayo, Francis E Onyango, Joan Kreiss. (2001) Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. The Lancet 357:9269, 1651-1655
CrossRef663
&NA;. (2001) Nevirapine: an option for preventing as well as treating paediatric HIV infection. Drugs & Therapy Perspectives 17:10, 1-5
CrossRef664
Beth R. Santmyire. (2001) Vertical Transmission of HIV From Mother to Child in Sub-Saharan Africa:. Obstetric and Gynecologic Survey 56:5, 306-312
CrossRef665
(2001) Keeping the M in MTCT: women, mothers, and HIV prevention. American Journal of Public Health 91:5, 701-703
CrossRef666
(2001) Barriers to universal prenatal HIV testing in 4 US locations in 1997. American Journal of Public Health 91:5, 727-733
CrossRef667
M. Bulterys. (2001) Preventing Vertical HIV Transmission in the Year 2000: Progress and Prospects—A Review. Placenta 22, S5-S12
CrossRef668
M. Carneiro, A. Sanchéz, P. Maneiro, W. Angelosante, C. Pérez, M. Valleé. (2001) Vertical HIV-1 Transmission: Prophylaxis and Paediatric Follow-Up. Placenta 22, S13-S18
CrossRef669
Anuvat Roongpisuthipong, Wimol Siriwasin, R. J. Simonds, Varaporn Sangtaweesin, Nirun Vanprapar, Chantapong Wasi, Sunee Singhanati, Philip Mock, Nancy Young, Bharat Parekh, Timothy D. Mastro, Nathan Shaffer. (2001) HIV Seroconversion During Pregnancy and Risk for Mother-to-Infant Transmission. Journal of Acquired Immune Deficiency Syndromes 26:4, 348-351
CrossRef670
(2001) HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 15:6, 761-770
CrossRef671
Joan Diegel, Bridget Murtaug, Randall Ruppel, Joseph A. Carcillo. (2001) Lessons the ???developing??? and ???developed??? nations are learning about pediatric AIDS. Pediatric Critical Care Medicine 2:2, 181-183
CrossRef672
Anuvat Roongpisuthipong, Wimol Siriwasin, R. J. Simonds, Varaporn Sangtaweesin, Nirun Vanprapar, Chantapong Wasi, Sunee Singhanati, Philip Mock, Nancy Young, Bharat Parekh, Timothy D. Mastro, Nathan Shaffer. (2001) HIV Seroconversion During Pregnancy and Risk for Mother-to-Infant Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 26:4, 348-351
CrossRef673
Gary Reiss, Megan O'Brien, Jeff Kopicko, Rebecca A. Clark. (2001) Lack of Association Between Pregnancy and Selected Gastrointestinal Adverse Events Among Women Prescribed Nelfinavir. Journal of Acquired Immune Deficiency Syndromes 26:5, 513-514
CrossRef674
Gary Reiss, Megan O'Brien, Jeff Kopicko, Rebecca A. Clark. (2001) Lack of Association Between Pregnancy and Selected Gastrointestinal Adverse Events Among Women Prescribed Nelfinavir. JAIDS Journal of Acquired Immune Deficiency Syndromes 26:5, 513-514
CrossRef675
Richard L. Sowell, Kenneth D. Phillips, Brenda F. Seals, Terry R. Misener, Charles Rush. (2001) HIV-Infected Women's Experiences and Beliefs Related to AZT Therapy During Pregnancy. AIDS Patient Care and STDs 15:4, 201-209
CrossRef676
Sg Edwards, N Larbalestier, P Hay, A de Ruiter, J Welch, Gp Taylor, P Easterbrook. (2001) Experience of nevirapine use in a London cohort of HIV-infected pregnant women. HIV Medicine 2:2, 89-91
CrossRef677
V. Bongertz, C. I. Costa, V. G. Veloso, B. Grinsztejn, E. C. João Filho, G. Calvet, J. H. Pilotto, M. L. Guimarães, M. G. Morgado. (2001) Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity. Scandinavian Journal of Immunology 53:3, 302-309
CrossRef678
C. K. Cunningham, D. W. Wara, M. Kang, T. Fenton, E. Hawkins, J. McNamara, L. Mofenson, A. M. Duliege, D. Francis, E. J. McFarland, W. Borkowsky, . (2001) Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected Women. Clinical Infectious Diseases 32:5, 801-807
CrossRef679
Mary E. Temple, Katalin I. Koranyi, Milap C. Nahata. (2001) The Safety and Antiviral Effect of Protease Inhibitors in Children. Pharmacotherapy 21:3, 287-294
CrossRef680
Gustavo H. Kijak, Marı́a M. Avila, Horacio Salomón. (2001) Mother-to-child transmission of drug-resistant HIV. Drug Resistance Updates 4:1, 29-37
CrossRef681
Peter Wutzler, Rudolf Thust. (2001) Genetic risks of antiviral nucleoside analogues – a survey. Antiviral Research 49:2, 55-74
CrossRef682
Stephen A. Spector. (2001) Mother-to-infant transmission of HIV-1: the placenta fights back. Journal of Clinical Investigation 107:3, 267-269
CrossRef683
Philippe Gaillard, Fabian Mwanyumba, Chris Verhofstede, Patricia Claeys, Varsha Chohan, Els Goetghebeur, Kishorchandra Mandaliya, Jeckoniah Ndinya-Achola, Marleen Temmerman. (2001) Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS 15:3, 389-396
CrossRef684
Ernesto O. Parra, Terence I. Doran, Linda M. Ivy, Jose Manuel Ramirez Aranda, Cristela Hernandez. (2001) Concerns of Pregnant Women about Being Tested for HIV: A Study in a Predominately Mexican-American Population. AIDS Patient Care and STDs 15:2, 83-93
CrossRef685
Michele Trotta, Massimo Meli, Roberta Ginelli, Serena Sbaragli, Francesco Leoncini. (2001) Antiretroviral therapy in pregnant women of florence. International Journal of Infectious Diseases 5:4, 230-231
CrossRef686
Laura M. Lee, David K. Henderson. (2001) Tolerability of Postexposure Antiretroviral Prophylaxis for Occupational Exposures to HIV. Drug Safety 24:8, 587-597
CrossRef687
Takuma HAYASHI. (2001) U.S. Warns on Some Use of Anti-AIDS Drug.. YAKUGAKU ZASSHI 121:9, 679-682
CrossRef688
(2001) Further views by the Erice working group on mother-to-child transmission of HIV type 1. Acta Paediatrica 90:1, 102-103
CrossRef689
Edgar J. Schoen, Carole Limata, Steven B. Black. (2001) UNSUCCESSFUL VOLUNTARY PRENATAL TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION. The Pediatric Infectious Disease Journal 20:1, 79-81
CrossRef690
Richard Marlink, Helen Kao, Evelyn Hsieh. (2001) Clinical Care Issues for Women Living with HIV and AIDS in the United States. AIDS Research and Human Retroviruses 17:1, 1-33
CrossRef691
Dianne M. Rausch, Ellen S. Stover. (2001) Neuroscience research in AIDS. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25:1, 231-257
CrossRef692
Graham P. Taylor, Naomi Low-Beer. (2001) Antiretroviral Therapy in Pregnancy. Drug Safety 24:9, 683-702
CrossRef693
Susan Maddocks, Dominic Dwyer. (2001) The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection. Paediatric Drugs 3:9, 681-702
CrossRef694
Paul J. Bock, David M. Markovitz. (2001) Infection with HIV-2. AIDS 15, S35-S45
CrossRef695
Bernard Lo, Leslie Wolf, Sohini Sengupta. (2000) Ethical Issues in Early Detection of HIV Infection To Reduce Vertical Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 25, S136-S143
CrossRef696
Bernard Lo, Leslie Wolf, Sohini Sengupta. (2000) Ethical Issues in Early Detection of HIV Infection To Reduce Vertical Transmission. Journal of Acquired Immune Deficiency SyndromesS136-S143
CrossRef697
Michael E. Blocker, Myron S. Cohen. (2000) BIOLOGIC APPROACHES TO THE PREVENTION OF SEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS. Infectious Disease Clinics of North America 14:4, 983-999
CrossRef698
Gregory S. Zaric, Ahmed M. Bayoumi, Margaret L. Brandeau, Douglas K. Owens. (2000) The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes 25:5, 403-416
CrossRef699
Susan A. Wang, Adelisa L. Panlilio, Peggy A. Doi, Alice D. White, Michael Stek, Alfred Saah, . (2000) Experience of Healthcare Workers Taking Postexposure Prophylaxis After Occupational HIV Exposures: Findings of the HIV Postexposure Prophylaxis Registry • . Infection Control and Hospital Epidemiology 21:12, 780-785
CrossRef700
llse Grosch-W??rner, Axel Sch??fer, Michael Obladen, Rolf F. Maier, Karen Seel, Cornelia Feiterna-Sperling, Ralf Weigel. (2000) An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 14:18, 2903-2911
CrossRef701
Anne B. Morris, Susan Cu-Uvin, Joseph I. Harwell, Jane Garb, Carmen Zorrilla, Mark Vajaranant, Ana Rua Dobles, Theodore B. Jones, Stephen Carlan, Diane Y. Allen. (2000) Multicenter Review of Protease Inhibitors in 89 Pregnancies. JAIDS Journal of Acquired Immune Deficiency Syndromes 25:4, 306-311
CrossRef702
Homira Behbahani, Edwina Popek, Patricia Garcia, Jan Andersson, Anna-Lena Spetz, Alan Landay, Zareefa Flener, Bruce K. Patterson. (2000) Up-Regulation of CCR5 Expression in the Placenta Is Associated with Human Immunodeficiency Virus-1 Vertical Transmission. The American Journal of Pathology 157:6, 1811-1818
CrossRef703
Gregory S. Zaric, Ahmed M. Bayoumi, Margaret L. Brandeau, Douglas K. Owens. (2000) The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. Journal of Acquired Immune Deficiency Syndromes403-416
CrossRef704
Anne B. Morris, Susan Cu-Uvin, Joseph I. Harwell, Jane Garb, Carmen Zorrilla, Mark Vajaranant, Ana Rua Dobles, Theodore B. Jones, Stephen Carlan, Diane Y. Allen. (2000) Multicenter Review of Protease Inhibitors in 89 Pregnancies. Journal of Acquired Immune Deficiency Syndromes306-311
CrossRef705
Nicholas A. Kartsonis, Richard T. D'Aquila. (2000) CLINICAL MONITORING OF HIV-1 INFECTION IN THE ERA OF ANTIRETROVIRAL RESISTANCE TESTING. Infectious Disease Clinics of North America 14:4, 879-899
CrossRef706
Julia M. Dayton, Michael H. Merson. (2000) GLOBAL DIMENSIONS OF THE AIDS EPIDEMIC:. Infectious Disease Clinics of North America 14:4, 791-808
CrossRef707
Travis W. Waldrep, Kimberly K. Summers, Philippe A. Chiliade. (2000) Coinfection with HIV and HCV: More Questions than Answers?. Pharmacotherapy 20:12, 1499-1507
CrossRef708
Mark Russi, Martha Buitrago, Joseph Goulet, Diane Calello, James Perlotto, Dorothy van Rhijn, Esther Nash, Gerald Friedland, Walter Hierholzer. (2000) Antiretroviral Prophylaxis of Health Care Workers at Two Urban Medical Centers. Journal of Occupational and Environmental Medicine 42:11, 1092-1100
CrossRef709
K. DOMINGUEZ, J. BERTOLLI, M. FOWLER, V. PETERS, I. ORTIZ, S. MELVILLE, T. RAKUSAN, T. FREDERICK, H. HSU, P. D'ALMADA, Y. MALDONADO, C. WILFERT, . (2000) Lack of Definitive Severe Mitochondrial Signs and Symptoms among Deceased HIV-Uninfected and HIV-Indeterminate Children ≤ 5 Years of Age, Pediatric Spectrum of HIV Disease Project (PSD), USA. Annals of the New York Academy of Sciences 918:1, 236-246
CrossRef710
BLUMA G. BRENNER, MARK A. WAINBERG. (2000) The Role of Antiretrovirals and Drug Resistance in Vertical Transmission of HIV-1 Infection. Annals of the New York Academy of Sciences 918:1, 9-15
CrossRef711
Gemma Calamandrei, Aldina Venerosi, Angelina Valanzano, Enrico Alleva. (2000) Effects of prenatal AZT+3TC treatment on open field behavior and responsiveness to scopolamine in adult mice. Pharmacology Biochemistry and Behavior 67:3, 511-517
CrossRef712
MARY LOU LINDEGREN, PHILIP RHODES, LAURA GORDON, PATRICIA FLEMING, . (2000) Drug Safety during Pregnancy and in Infants: Lack of Mortality Related to Mitochondrial Dysfunction among Perinatally HIV-Exposed Children in Pediatric HIV Surveillance. Annals of the New York Academy of Sciences 918:1, 222-235
CrossRef713
MARY GLENN FOWLER. (2000) Prevention of Perinatal HIV Infection: What Do We Know? Where Should Future Research Go?. Annals of the New York Academy of Sciences 918:1, 45-52
CrossRef714
MARIANA GERSCHENSON, MIRIAM C. POIRIER. (2000) Fetal Patas Monkeys Sustain Mitochondrial Toxicity As a Result of in Utero Zidovudine Exposure. Annals of the New York Academy of Sciences 918:1, 269-281
CrossRef715
Joanne E. Embree, Simon Njenga, Pratibha Datta, Nico J. D. Nagelkerke, Jeckoniah O. Ndinya-Achola, Zeena Mohammed, Sue Ramdahin, Job J. Bwayo, Francis A. Plummer. (2000) Risk factors for postnatal mother???child transmission of HIV-1. AIDS 14:16, 2535-2541
CrossRef716
ARYE RUBINSTEIN. (2000) Advances in Antiretroviral, Immune-Based, and Gene Therapy for HIV Infection in Mothers and Infants: Implications for Future Use in Developing Countries. Annals of the New York Academy of Sciences 918:1, 27-35
CrossRef717
A. COUTSOUDIS. (2000) Influence of Infant Feeding Patterns on Early Mother-to-Child Transmission of HIV-1 in Durban, South Africa. Annals of the New York Academy of Sciences 918:1, 136-144
CrossRef718
B. K. Rajegowda, B. B. Das, R. Lala, S. Rao, D. F. Mc Neeley. (2000) Expedited human immunodeficiency virus testing of mothers and new-borns with unknown HIV status at time of labor and delivery. Journal of Perinatal Medicine 28:6, 458-463
CrossRef719
MARK MIROCHNICK. (2000) Antiretroviral Pharmacology in Pregnant Women and Their Newborns. Annals of the New York Academy of Sciences 918:1, 287-297
CrossRef720
Peckham, Catherine, Newell, Marie-Louise, . (2000) Preventing Vertical Transmission of HIV Infection. New England Journal of Medicine 343:14, 1036-1037
Full Text721
Lallemant, Marc, Jourdain, Gonzague, Le Coeur, Sophie, Kim, Soyeon, Koetsawang, Suporn, Comeau, Anne Marie, Phoolcharoen, Wiput, Essex, Max, McIntosh, Kenneth, Vithayasai, Vicharn, . (2000) A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1. New England Journal of Medicine 343:14, 982-991
Full Text722
Joseph P McGowan, Sanjiv S Shah. (2000) Management of HIV infection during pregnancy. Current Opinion in Obstetrics and Gynecology 12:5, 357-367
CrossRef723
Matthieu Saada, J??r??me Le Chenadec, Alain Berrebi, Andr?? Bongain, Jean-Fran??ois Delfraissy, Marie-Jeanne Mayaux, Laurence Meyer. (2000) Pregnancy and progression to AIDS: results of the French prospective cohorts. AIDS 14:15, 2355-2360
CrossRef724
M. J. Postma, E. J. Beck, C. A. Hankins, S. Mandalia, J. C. Jager, L. T. W. de Jong-van den Berg, M. D. S. Walters, L. Sherr. (2000) Cost effectiveness of expanded antenatal HIV testing in London. AIDS 14:15, 2383-2389
CrossRef725
Rodney J. Y. Ho, Kay Larsen, Tot Bui, Xiao Y. Wang, Arnd M. Herz, Cynthia Sherbert, Eric Finn, Connie Nosbisch, Ann Schmidt, David Anderson, Michael Agy, William R. Morton, Jashvant D. Unadkat. (2000) Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother-to-Fetus HIV Transmission in Macaques. JAIDS Journal of Acquired Immune Deficiency Syndromes 25:2, 140-149
CrossRef726
Dewey C. Scheid, Robert M. Hamm, Kevin W. Stevens. (2000) Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers. PharmacoEconomics 18:4, 355-368
CrossRef727
Mary Moschovi, Maria Theodoridou, Vassiliki Papaevangelou, Fotini Tzortzatou-Stathopoulou. (2000) Acute lymphoblastic leukaemia in an infant exposed to zidovudine in utero and early infancy. AIDS 14:15, 2410-2411
CrossRef728
Rodney J. Y. Ho, Kay Larsen, Tot Bui, Xiao Y. Wang, Arnd M. Herz, Cynthia Sherbert, Eric Finn, Connie Nosbisch, Ann Schmidt, David Anderson, Michael Agy, William R. Morton, Jashvant D. Unadkat. (2000) Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother-to-Fetus HIV Transmission in Macaques. Journal of Acquired Immune Deficiency Syndromes140-149
CrossRef729
Lipshultz, Steven E., Easley, Kirk A., Orav, E. John, Kaplan, Samuel, Starc, Thomas J., Bricker, J. Timothy, Lai, Wyman W., Moodie, Douglas S., Sopko, George, McIntosh, Kenneth, Colan, Steven D., . (2000) Absence of Cardiac Toxicity of Zidovudine in Infants. New England Journal of Medicine 343:11, 759-766
Full Text730
Mofenson, Lynne M., . (2000) Perinatal Exposure to Zidovudine — Benefits and Risks. New England Journal of Medicine 343:11, 803-805
Full Text731
Masato Homma, Karen Beckerman, Sandra Hayashi, Anura L Jayewardene, Kitaro Oka, John G Gambertoglio, Francesca T Aweeka. (2000) Liquid chromatographic determination of urinary 6β-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women. Journal of Pharmaceutical and Biomedical Analysis 23:4, 629-635
CrossRef732
RENEE SMITH, KATHLEEN MALEE, MANHATTAN CHARURAT, LARRY MAGDER, CLAUDE MELLINS, CAROL MACMILLAN, JOAN HITTLEMAN, TAMAR LASKY, ANTOLIN LLORENTE, JACK MOYE MD. (2000) Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Pediatric Infectious Disease Journal 19:9, 862-871
CrossRef733
(2000) Organizational predictors of prenatal HIV counseling and testing. American Journal of Public Health 90:9, 1448-1451
CrossRef734
Birgit H. B. van Benthem, Isabelle de Vincenzi, Marie-Christine Delmas, Christine Larsen, Anneke van den Hoek, Maria Prins. (2000) Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. AIDS 14:14, 2171-2178
CrossRef735
Anne Bardsley-Elliot, Caroline M. Perry. (2000) Nevirapine. Paediatric Drugs 2:5, 373-407
CrossRef736
Nancy L. Young, Nathan Shaffer, Thongpoon Chaowanachan, Tawee Chotpitayasunondh, Nirun Vanparapar, Philip A. Mock, Naris Waranawat, Kulkanya Chokephaibulkit, Rutt Chuachoowong, Punneeporn Wasinrapee, Timothy D. Mastro, R. J. Simonds. (2000) Early Diagnosis of HIV-1–Infected Infants in Thailand Using RNA and DNA PCR Assays Sensitive to Non-B Subtypes. Journal of Acquired Immune Deficiency Syndromes 24:5, 401-407
CrossRef737
Jeffrey S. A. Stringer, Dwight J. Rouse, Sten H. Vermund, Robert L. Goldenberg, Moses Sinkala, Aaron A. Stinnett. (2000) Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 24:4, 369-377
CrossRef738
Masahiko Fujinaga, Marta Schulte, Mark Holodniy. (2000) Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture system. Teratology 62:2, 108-114
CrossRef739
Lucia Ometto, Marisa Zanchetta, Monica Mainardi, Gian Luca De Salvo, Marie Cruz Garcia-Rodriguez, Linsay Gray, Marie Louise Newell, Luigi Chieco-Bianchi, Anita De Rossi. (2000) Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS 14:12, 1721-1729
CrossRef740
Ricardo Figueroa-Damian, Roberto Villagrana Zesati. (2000) Demographic and clinical profile of human immunodeficiency virus-infected postpartum women who undergo sterilization. Contraception 62:2, 79-82
CrossRef741
Jeffrey S. A. Stringer, Dwight J. Rouse, Sten H. Vermund, Robert L. Goldenberg, Moses Sinkala, Aaron A. Stinnett. (2000) Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:4, 369-377
CrossRef742
Nancy L. Young, Nathan Shaffer, Thongpoon Chaowanachan, Tawee Chotpitayasunondh, Nirun Vanparapar, Philip A. Mock, Naris Waranawat, Kulkanya Chokephaibulkit, Rutt Chuachoowong, Punneeporn Wasinrapee, Timothy D. Mastro, R. J. Simonds. (2000) Early Diagnosis of HIV-1–Infected Infants in Thailand Using RNA and DNA PCR Assays Sensitive to Non-B Subtypes. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:5, 401-407
CrossRef743
Sonia Napravnik, Rachel Royce, Emmanuel Walter, Wilma Lim. (2000) HIV-1 Infected Women and Prenatal Care Utilization: Barriers and Facilitators. AIDS Patient Care and STDs 14:8, 411-420
CrossRef744
Tucker A. Patterson, Zbigniew K. Binienda, Glenn D. Newport, George W. Lipe, Michael P. Gillam, William Slikker, Jennifer A. Sandberg. (2000) Transplacental pharmacokinetics and fetal distribution of 2?,3?-didehydro-3?-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques. Teratology 62:2, 93-99
CrossRef745
Janet Darbyshire. (2000) Therapeutic interventions in HIV infection - a critical view. Tropical Medicine and International Health 5:7, A26-A31
CrossRef746
Craig J. Newschaffer, James Cocroft, Carol E. Anderson, Walter W. Hauck, Barbara J. Turner. (2000) Prenatal Zidovudine Use and Congenital Anomalies in a Medicaid Population. Journal of Acquired Immune Deficiency Syndromes 24:3, 249-256
CrossRef747
Craig J. Newschaffer, James Cocroft, Carol E. Anderson, Walter W. Hauck, Barbara J. Turner. (2000) Prenatal Zidovudine Use and Congenital Anomalies in a Medicaid Population. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:3, 249-256
CrossRef748
Siripon Kanshana, Danai Thewanda, Achara Teeraratkul, Khanchit Limpakarnjanarat, Pornsinee Amornwichet, Nareeluck Kullerk, Somsak Akksilp, Vilai Sereesittipitak, Timothy D. Mastro, R. J. Simonds. (2000) Implementing short-course zidovudine to reduce mother???infant HIV transmission in a large pilot program in Thailand. AIDS 14:11, 1617-1623
CrossRef749
John D Stratigos, Evangelia Tzala. (2000) Global epidemiology of hiv infection and aids. Clinics in Dermatology 18:4, 381-387
CrossRef750
David T. Dunn, RJ Simonds, Marc Bulterys, Leslie A. Kalish, Jack Moye, Andrea de Maria, Christian Kind, Christoph Rudin, Erick Denamur, Anne Krivine, Clive Loveday, Marie-Louise Newell. (2000) Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples. AIDS 14:10, 1421-1428
CrossRef751
A.E. Ades, Julie Ratcliffe, Diana M. Gibb, Mark J. Sculpher. (2000) Economic Issues in the Prevention of Vertical Transmission of HIV. PharmacoEconomics 18:1, 9-22
CrossRef752
(2000) A change in approach to prenatal HIV screening. American Journal of Public Health 90:7, 1026-1027
CrossRef753
(2000) HIV prevention research: accomplishments and challenges for the third decade of AIDS. American Journal of Public Health 90:7, 1029-1032
CrossRef754
Teresita A Laude. (2000) Manifestations of HIV disease in children. Clinics in Dermatology 18:4, 457-467
CrossRef755
(2000) HIV-infected parents and their children in the United States. American Journal of Public Health 90:7, 1074-1081
CrossRef756
Minkoff, Howard, , Santoro, Nanette, . (2000) Ethical Considerations in the Treatment of Infertility in Women with Human Immunodeficiency Virus Infection. New England Journal of Medicine 342:23, 1748-1750
Full Text757
Ember L. Ewings, Mariana Gerschenson, Marisa C. St. Claire, Kunio Nagashima, Boris Skopets, Steven W. Harbaugh, Jeffery W. Harbaugh, Miriam C. Poirier. (2000) Genotoxic and Functional Consequences of Transplacental Zidovudine Exposure in Fetal Monkey Brain Mitochondria. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:2, 100-105
CrossRef758
Ricardo S. de Souza, Orlando Gómez-Marín, Gwendolyn B. Scott, Silvia Guasti, Mary Jo O'Sullivan, Ricardo Hugo Oliveira, Charles D. Mitchell. (2000) Effect of Prenatal Zidovudine on Disease Progression in Perinatally HIV-1–Infected Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:2, 154-161
CrossRef759
H. M. Coovadia. (2000) Prevention and treatment of perinatal HIV-1 infection in the developing world. Current Opinion in Infectious Diseases 13:3, 247-251
CrossRef760
Ricardo S. de Souza, Orlando Gómez-Marín, Gwendolyn B. Scott, Silvia Guasti, Mary Jo O'Sullivan, Ricardo Hugo Oliveira, Charles D. Mitchell. (2000) Effect of Prenatal Zidovudine on Disease Progression in Perinatally HIV-1–Infected Infants. Journal of Acquired Immune Deficiency Syndromes 24:2, 154-161
CrossRef761
Ember L. Ewings, Mariana Gerschenson, Marisa C. St. Claire, Kunio Nagashima, Boris Skopets, Steven W. Harbaugh, Jeffery W. Harbaugh, Miriam C. Poirier. (2000) Genotoxic and Functional Consequences of Transplacental Zidovudine Exposure in Fetal Monkey Brain Mitochondria. Journal of Acquired Immune Deficiency Syndromes 24:2, 100-105
CrossRef762
Lynne M Mofenson, James A McIntyre. (2000) Advances and research directions in the prevention of mother-to-child HIV-1 transmission. The Lancet 355:9222, 2237-2244
CrossRef763
Albert W. Wu, Allen Gifford, Steven Asch, Susan E. Cohn, Samuel A. Bozzette, Robin Yurk. (2000) Quality-of-Care Indicators for HIV/AIDS. Disease Management and Health Outcomes 7:6, 315-330
CrossRef764
Mariana Gerschenson, Stephen W . Erhart, Catherine Y. Paik, Marisa C. St. Claire, Kunio Nagashima, Boris Skopets, Steven W . Harbaugh, Jeffrey W . Harbaugh, Wing Quan, Miriam C. Poirier. (2000) Fetal Mitochondrial Heart and Skeletal Muscle Damage in Erythrocebus patas Monkeys Exposed in Utero to 3'-Azido-3'-Deoxythymidine. AIDS Research and Human Retroviruses 16:7, 635-644
CrossRef765
Ellen R. Cooper, Manhattan Charurat, David N. Burns, William Blattner, Rodney Hoff. (2000) Brief Report: Trends in Antiretroviral Therapy and Mother-Infant Transmission of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 24:1, 45-47
CrossRef766
A Vimercati. (2000) Maternal complications after caesarean section in HIV infected women. European Journal of Obstetrics & Gynecology and Reproductive Biology 90:1, 73-76
CrossRef767
Ellen R. Cooper, Manhattan Charurat, David N. Burns, William Blattner, Rodney Hoff. (2000) Brief Report: Trends in Antiretroviral Therapy and Mother-Infant Transmission of HIV. Journal of Acquired Immune Deficiency Syndromes 24:1, 45-47
CrossRef768
Fran??ois Dabis, Val??riane Leroy, Katia Castetbon, Rosemary Spira, Marie-Louise Newell, Roger Salamon. (2000) Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS 14:8, 1017-1026
CrossRef769
Robert Colebunders, Kristien Verdonck, Jean Nachega, Pravin Kothari. (2000) Impact of New Developments in Antiretroviral Treatment on AIDS Prevention and Care in Resource-Poor Countries. AIDS Patient Care and STDs 14:5, 251-257
CrossRef770
Mary Glenn Fowler. (2000) Follow-up of children exposed to perinatal antiretrovirals. Teratology 61:5, 395-396
CrossRef771
Ronald Bayer. (2000) Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena*. AIDS 14:8, 1051-1057
CrossRef772
Richard K. Miller, Bruno M. Polliotti, Todd Laughlin, Shelley Gnall, Sachio Iida, Marlene Carneiro, Kimberly Lord, Yan Ding, Asad U. Sheikh. (2000) Role of the placenta in fetal HIV infection. Teratology 61:5, 391-394
CrossRef773
Claire Thorne, Marie-Louise Newell. (2000) Epidemiology of HIV infection in the newborn. Early Human Development 58:1, 1-16
CrossRef774
Inara Espinelli Souza, M. Lucia Azevedo, Regina C. Succi, Daisy M. Machado, Ricardo S. Diaz. (2000) RNA Viral Load Test for Early Diagnosis of Vertical Transmission of HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 23:4, 358-360
CrossRef775
M. S. Avidan, N. Jones, A. L. Pozniak. (2000) The implications of HIV for the anaesthetist and the intensivist. Anaesthesia 55:4, 344-354
CrossRef776
Bhalchandra A Diwan, Ofelia A Olivero, Miriam C Poirier. (2000) Absence of structural or functional alterations in male and female reproductive organs of F1 and F2 generations derived from female mice exposed to 3′-azido-3′-deoxythymidine during pregnancy. Toxicology Letters 115:1, 9-15
CrossRef777
Inara Espinelli Souza, M. Lucia Azevedo, Regina C. Succi, Daisy M. Machado, Ricardo S. Diaz. (2000) RNA Viral Load Test for Early Diagnosis of Vertical Transmission of HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes 23:4, 358-360
CrossRef778
Rebecca H. Burpo. (2000) Common Antiviral Agents Used in Women's and Children's Care, Part 2. Journal of Obstetric, Gynecologic, <html_ent glyph="@amp;" ascii="&"/> Neonatal Nursing 29:2, 191-200
CrossRef779
Chaiporn Bhadrakom, R. J. Simonds, Joanne V. Mei, Suvanna Asavapiriyanont, Varaporn Sangtaweesin, Nirun Vanprapar, Katy H. P. Moore, Nancy L. Young, W. Harry Hannon, Timothy D. Mastro, Nathan Shaffer. (2000) Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. AIDS 14:5, 509-516
CrossRef780
Diana M. Gibb. (2000) Antenatal Screening for HIV Infection. AIDS Patient Care and STDs 14:3, 125-131
CrossRef781
Katherine Luzuriaga, John L. Sullivan. (2000) Prevention and Treatment of Pediatric HIV Infection (Contempo 1998: Updates Linking Evidence and Experience). Journal of HIV/AIDS Prevention & Education for Adolescents & Children 3:3, 101-107
CrossRef782
Catherine Peckham, Marie-Louise Newell. (2000) Mother-to-Child Transmission of HIV Infection: Nutrition/HIV Interactions. Nutrition Reviews 58, S38-S45
CrossRef783
Kathryn Joy Flake. (2000) HIV Testing During Pregnancy. AWHONN Lifelines 4:1, 13-16
CrossRef784
Seth L. Welles, Jane Pitt, Robert Colgrove, Kenneth McIntosh, Pei Hua Chung, Amy Colson, Shahin Lockman, Mary Glenn Fowler, Celine Hanson, Sheldon Landesman, John Moye, Kenneth C. Rich, Carmen Zorrilla, Anthony J. Japour. (2000) HIV-1 genotypic zidovudine drug resistance and the risk of maternal–infant transmission in the Women and Infants Transmission Study*. AIDS 14:3, 263-271
CrossRef785
Tracie L. Miller. (2000) Nutrition in paediatric human immunodeficiency virus infection. Proceedings of the Nutrition Society 59:01, 155-162
CrossRef786
(2000) Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women. American Journal of Public Health 90:2, 273-276
CrossRef787
Eduard J. Beck, Sundhiya Mandalia, Rebecca Griffith, Jeni Beecham, M. D. Walters, Mary Boulton, David L. Miller. (2000) Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre. PharmacoEconomics 17:1, 53-69
CrossRef788
Phillip J. Goldstein, Ren
Smit, Monique Stevens, John L. Sever. (2000) Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infectious Diseases in Obstetrics and Gynecology 8:2, 94-98
CrossRef789
Steven D. Pinkerton, David R. Holtgrave, Peter M. Layde. (2000) Incremental Cost-Effectiveness of Two Zidovudine Regimens to Prevent Perinatal HIV Transmission in the United States. Preventive Medicine 30:1, 64-69
CrossRef790
A. Mangano, J. Kopka, M. Batalla, R. Bologna, L. Sen. (2000) Protective Effect of CCR2-64I and Not of CCR5-Δ32 and SDF1-3´A in Pediatric HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes 23:1, 52-57
CrossRef791
Zuber Mitchla, Mike Sharland. (2000) Current treatment options to prevent perinatal transmission of HIV. Expert Opinion on Pharmacotherapy 1:2, 239-248
CrossRef792
Richard M. Grimes, Geetanjali Srivastava, Andrew W. Helfgott, Nancy L. Eriksen. (2000) A study to determine the incidence and prevalence of newly discovered human immunodeficiency virus infection during the prenatal care period. Infectious Diseases in Obstetrics and Gynecology 8:3-4, 172-175
CrossRef793
Uttam Bandyopadhyay, Atanu Biswas. (2000) A class of adaptive designs. Sequential Analysis 19:1-2, 45-62
CrossRef794
Asad U. Sheikh, Bruno M. Polliotti, Richard K. Miller. (2000) Human immunodeficiency virus infection: In situ polymerase chain reaction localization in human placentas after in utero and in vitro infection. American Journal of Obstetrics and Gynecology 182:1, 207-213
CrossRef795
Sayomporn Sirinavin, Winit Phaupradit, Surasak Taneepanichskul, Kalayanee Atamasirikul, Priyasuda Hetrakul, Ammarin Thakkinstian, Panyu Panburana. (2000) Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1. International Journal of Infectious Diseases 4:3, 148-152
CrossRef796
Donna B. Barnes, Audrey Alforque, Khalil Carter. 2000. “Like i just got a death sentence”: conditions affecting women's reactions to being told their hiv antibody test results and the impact on access to care. , 3-33.
CrossRef797
Gregory J. Moran. (2000) Emergency department management of blood and body fluid exposures. Annals of Emergency Medicine 35:1, 47-62
CrossRef798
Marie-Louise Newell. (2000) Vertical transmission of HIV-1 infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 94:1, 1-2
CrossRef799
A. Mangano, J. Kopka, M. Batalla, R. Bologna, L. Sen. (2000) Protective Effect of CCR2-64I and Not of CCR5-Δ32 and SDF1-3´A in Pediatric HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 23:1, 52-57
CrossRef800
Miriam C. Poirier, Tucker A. Patterson, William Slikker, Ofelia A. Olivero. (1999) Incorporation of 3´-Azido-3´-Deoxythymidine (AZT) Into Fetal DNA and Fetal Tissue Distribution of Drug After Infusion of Pregnant Late-Term Rhesus Macaques With a Human-Equivalent AZT Dose. Journal of Acquired Immune Deficiency Syndromes 22:5, 477
CrossRef801
C. Healton, S. Taylor, P. Messeri, G. Weinberg, M. Bamji. (1999) Effects of ZDV-based patient education on intentions toward ZDV use, HIV testing and reproduction among a US cohort of women. AIDS Care 11:6, 675-686
CrossRef802
Miriam C. Poirier, Tucker A. Patterson, William Slikker, Ofelia A. Olivero. (1999) Incorporation of 3´-Azido-3´-Deoxythymidine (AZT) Into Fetal DNA and Fetal Tissue Distribution of Drug After Infusion of Pregnant Late-Term Rhesus Macaques With a Human-Equivalent AZT Dose. JAIDS Journal of Acquired Immune Deficiency Syndromes 22:5, 477
CrossRef803
D.K. Henderson. (1999) Weighing the consequence of doing nothing versus those of doing something: post-exposure chemoprophylaxis for occupational exposures to HIV. Journal of Hospital Infection 43, S225-S233
CrossRef804
Z Temesgen, A J Wright. (1999) Antiretrovirals.. Mayo Clinic Proceedings 74:12, 1284-1301
CrossRef805
Cathy W. Critchlow, Nancy B. Kiviat. (1999) Detection of Human Immunodeficiency Virus Type 1 and Type 2 in the Female Genital Tract: Implications for the Understanding of Virus Transmission. Obstetrical & Gynecological Survey 54:Supplement, 187-196
CrossRef806
John R. Clarke, Ruth Braganza, Asiya Mirza, Christopher Stainsby, Mounir Ait-Khaled, Anne Wright, Hermione Lyall, David Parker, Myra O. McClure, Jonathan N. Weber, Graham P. Taylor. (1999) Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy. Journal of Medical Virology 59:3, 364-368
CrossRef807
Mark A Plessinger, Richard K Miller. (1999) Effects of Zidovudine (AZT) and dideoxyinosine (ddI) on human trophoblast cells. Reproductive Toxicology 13:6, 537-546
CrossRef808
William A. Grobman, Patricia M. Garcia. (1999) The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. American Journal of Obstetrics and Gynecology 181:5, 1062-1071
CrossRef809
Winit Phuapradit, Panyu Panburana, Adithep Jaovisidha, Nongluxana Vichitphun, Pahsuvadn Kongsin, Wasun Chantratita, Pisamai Bhodhiphala, Wantanit Pairoj. (1999) Maternal viral load and vertical transmission of HIV-1 in mid-trimester gestation. AIDS 13:14, 1927-1931
CrossRef810
T E Wilson, H Minkoff. (1999) Mandatory HIV testing of infants and rates of follow-up care.. American Journal of Public Health 89:10, 1583-1583
CrossRef811
Jeffrey S.A Stringer, Sten H Vermund. (1999) Prevention of mother-to-child transmission of HIV-1. Current Opinion in Obstetrics and Gynecology 11:5, 427-434
CrossRef812
Fauci, Anthony S., . (1999) The AIDS Epidemic — Considerations for the 21st Century. New England Journal of Medicine 341:14, 1046-1050
Full Text813
David N Burns, Lynne M Mofenson. (1999) Paediatric HIV-1 infection. The Lancet 354, SII1-SII6
CrossRef814
Elliot Marseille, James G Kahn, Francis Mmiro, Laura Guay, Philippa Musoke, Mary Glenn Fowler, J Brooks Jackson. (1999) Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. The Lancet 354:9181, 803-809
CrossRef815
Molly S. Parece, Guillermo A. Herrera, Rich F. Voigt, Steve L. Middlekauff, Kathleen L. Irwin. (1999) STD Testing Policies and Practices in U.S. City and County Jails. Sexually Transmitted Diseases 26:8, 431-437
CrossRef816
Laura A Guay, Philippa Musoke, Thomas Fleming, Danstan Bagenda, Melissa Allen, Clemensia Nakabiito, Joseph Sherman, Paul Bakaki, Constance Ducar, Martina Deseyve, Lynda Emel, Mark Mirochnick, Mary Glenn Fowler, Lynne Mofenson, Paolo Miotti, Kevin Dransfield, Dorothy Bray, Francis Mmiro, J Brooks Jackson. (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. The Lancet 354:9181, 795-802
CrossRef817
Chukwuemeka S. Okereke. (1999) Management of HIV-infected pregnant patients in malaria-endemic areas: Therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents. Clinical Therapeutics 21:9, 1456-1496
CrossRef818
Stéphane Blanche, Marc Tardieu, Pierre Rustin, Abdelhamid Slama, Béatrice Barret, Ghislaine Firtion, Nicole Ciraru-Vigneron, Catherine Lacroix, Christine Rouzioux, Laurent Mandelbrot, Isabelle Desguerre, Agnès Rötig, Marie-Jeanne Mayaux, Jean-Francois Delfraissy. (1999) Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. The Lancet 354:9184, 1084-1089
CrossRef819
Levine, Robert J., . (1999) The Need to Revise the Declaration of Helsinki. New England Journal of Medicine 341:7, 531-534
Full Text820
Mofenson, Lynne M., Lambert, John S., Stiehm, E. Richard, Bethel, James, Meyer, William A., Whitehouse, Jean, Moye, John Jr., Reichelderfer, Patricia, Harris, D. Robert, Fowler, Mary Glenn, Mathieson, Bonnie J., Nemo, George J., . (1999) Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine. New England Journal of Medicine 341:6, 385-393
Full Text821
Rogers, Martha F., Shaffer, Nathan, . (1999) Reducing the Risk of Maternal–Infant Transmission of HIV by Attacking the Virus. New England Journal of Medicine 341:6, 441-443
Full Text822
Garcia, Patricia M., Kalish, Leslie A., Pitt, Jane, Minkoff, Howard, Quinn, Thomas C., Burchett, Sandra K., Kornegay, Janet, Jackson, Brooks, Moye, John, Hanson, Celine, Zorrilla, Carmen, Lew, Judy F., . (1999) Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal Transmission. New England Journal of Medicine 341:6, 394-402
Full Text823
P. Morlat, G. Chêne. (1999) Apport de l'épidémiologie clinique à la prise en charge de l'infection par le VIH. La Revue de Médecine Interne 20:8, 681-692
CrossRef824
Mari McQuitty, William McFarland, Timothy A. Kellogg, Edward White, Mitchell H. Katz. (1999) Home Collection Versus Publicly Funded HIV Testing in San Francisco: Who Tests Where?. Journal of Acquired Immune Deficiency Syndromes 21:5, 417
CrossRef825
Olivier Chassany, Martin Duracinský. (1999) Ethics and clinical trials. Fundamental & Clinical Pharmacology 13:4, 437-444
CrossRef826
Mari McQuitty, William McFarland, Timothy A. Kellogg, Edward White, Mitchell H. Katz. (1999) Home Collection Versus Publicly Funded HIV Testing in San Francisco: Who Tests Where?. JAIDS Journal of Acquired Immune Deficiency Syndromes 21:5, 417
CrossRef827
Anna Coutsoudis, Kubendran Pillay, Elizabeth Spooner, Louise Kuhn. (1999) Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 13:12, 1517-1524
CrossRef828
Anna Coutsoudis, Kubendran Pillay, Elizabeth Spooner, Louise Kuhn, Hoosen M Coovadia. (1999) Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. The Lancet 354:9177, 471-476
CrossRef829
Loveleen C. Kang, Marci J. Kerben, Kenneth E. Ugen, Steven C. Specter. (1999) Modulation of ex Vivo Cytokine Production by Splenocytes Using in Vitro Combined Therapeutics in Murine Retroviral Model. DNA and Cell Biology 18:7, 585-592
CrossRef830
(1999) Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 13:11, 1377-1385
CrossRef831
P. Greco, A. Vimercati, J. R. Fiore, A. Saracino, G. Buccoliero, G. Loverro, G. Angarano, G. Pastore, L. Selvaggi. (1999) Reproductive choice in individuals HIV-1 infected in South Eastern Italy. Journal of Perinatal Medicine 27:3, 173-177
CrossRef832
Ofelia A Olivero, Riitta Parikka, Miriam C Poirier, Kirsi Vähäkangas. (1999) 3′-azido-3′-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 428:1-2, 41-47
CrossRef833
Sean Philpott, Harold Burger, Tina Charbonneau, Roger Grimson, Sten H. Vermund, Aloise Visosky, Sharon Nachman, Andrea Kovacs, Pamela Tropper, Henry Frey, Barbara Weiser. (1999) CCR5 Genotype and Resistance to Vertical Transmission of HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes 21:3, 189
CrossRef834
David E Shapiro, Rhoda S Sperling, Robert W Coombs. (1999) Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. The Lancet 354:9173, 156
CrossRef835
Jeffrey S. A. Stringer, Elizabeth McPhillips Stringer, Praphan Phanuphak, Paradorn Jetwana, Damrong Reinprayoon, Ellen M. Funkhouser, Sten H. Vermund. (1999) Prevention of Mother-to-Child Transmission of HIV in Thailand: Physicians' Attitudes on Zidovudine Use, Pregnancy Termination, and Willingness to Provide Care.. JAIDS Journal of Acquired Immune Deficiency Syndromes 21:3, 217
CrossRef836
Rolando M. Viani, Tore J. Gutteberg, Janet L. Lathey, Stephen A. Spector. (1999) Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS 13:10, 1273
CrossRef837
Zelalem Temesgen. (1999) Overview of HIV infection. Annals of Allergy, Asthma & Immunology 83:1, 1-7
CrossRef838
Lisa A. Eckenwiler. (1999) Pursuing Reform in Clinical Research: Lessons from Women's Experience. The Journal of Law, Medicine & Ethics 27:2, 158-170
CrossRef839
George D. McSherry, David E. Shapiro, Robert W. Coombs, Nuala McGrath, Lisa M. Frenkel, Paula Britto, Mary Culnane, Rhoda S. Sperling. (1999) The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). The Journal of Pediatrics 134:6, 717-724
CrossRef840
(1999) Prevention of vertical HIV-1 transmission. The Lancet 353:9171, 2240
CrossRef841
Michael E. Jones. (1999) HIV and the Returning Expatriate. Journal of Travel Medicine 6:2, 99-106
CrossRef842
(1999) Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. AIDS 13:8, 927-933
CrossRef843
Ofelia A. Olivero, Gene M. Shearer, Claire A. Chougnet, Andrea A.S. Kovacs, Alan L. Landay, Robin Baker, Alice M. Stek, Margaret M. Khoury, Laurie A. Proia, Harold A. Kessler, Beverly E. Sha, Robert E. Tarone, Miriam C. Poirier. (1999) Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS 13:8, 919-925
CrossRef844
Marléne Moussa, Barbara Mognetti, Sylvie Dubanchet, Elisabeth Menu, Pierre Roques, Gabriel Gras, Dominique Dormont, Françoise Barre-Sinoussi, Gérard Chaouat. (1999) Review: Vertical Transmission of HIV: Parameters Which Might Affect Infection of Placental Trophoblasts by HIV-1: A Review. American Journal of Reproductive Immunology 41:5, 312-319
CrossRef845
Catherine M Wilfert, James W Curran. (1999) Science, ethics, and future of research into maternal-infant transmission of HIV-1. The Lancet 353:9167, 1880
CrossRef846
Jeffrey S. Murray, Michael R. Elashoff, Lauren C. Iacono-Connors, Therese A. Cvetkovich, Kimberly A. Struble. (1999) The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS 13:7, 797-804
CrossRef847
A. Bergenstrom, L. Sherr. (1999) Women's HIV needs within a broader spectrum of reproductive health. Psychology, Health & Medicine 4:2, 143-155
CrossRef848
Cécile Chouquet, Sylvia Richardson, Marianne Burgard, Stéphane Blanche, Marie-Jeanne Mayaux, Christine Rouzioux, Dominique Costagliola. (1999) Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: Bayesian estimation using a mixture. Statistics in Medicine 18:7, 815-833
CrossRef849
The International Perinatal HIV Group. (1999) The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 — A Meta-Analysis of 15 Prospective Cohort Studies. New England Journal of Medicine 340:13, 977-987
Full Text850
Riley, Laura E., Greene, Michael F., . (1999) Elective Cesarean Delivery to Reduce the Transmission of HIV. New England Journal of Medicine 340:13, 1032-1033
Full Text851
I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Cooper, Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro. (1999) Lack of Tumors in Infants With Perinatal HIV-1 Exposure and Fetal/Neonatal Exposure to Zidovudine. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20:5, 463-467
CrossRef852
Wendy J Graham, Marie-Louise Newell. (1999) Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. The Lancet 353:9155, 836-839
CrossRef853
Stefan Z Wiktor, Ehounou Ekpini, John M Karon, John Nkengasong, Chantal Maurice, Sibailly T Severin, Thierry H Roels, Moise K Kouassi, Eve M Lackritz, Issa-Malick Coulibaly, Alan E Greenberg. (1999) Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. The Lancet 353:9155, 781-785
CrossRef854
Lynne M Mofenson. (1999) Short-course zidovudine for prevention of perinatal infection. The Lancet 353:9155, 766-767
CrossRef855
François Dabis, Philippe Msellati, Nicolas Meda, Christiane Welffens-Ekra, Bruno You, Olivier Manigart, Valériane Leroy, Arlette Simonon, Michel Cartoux, Patrice Combe, Amadou Ouangré, Rosa Ramon, Odette Ky-Zerbo, Crépin Montcho, Roger Salamon, Christine Rouzioux, Philippe Van de Perre, Laurent Mandelbrot. (1999) 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. The Lancet 353:9155, 786-792
CrossRef856
Nathan Shaffer, Rutt Chuachoowong, Philip A Mock, Chaiporn Bhadrakom, Wimol Siriwasin, Nancy L Young, Tawee Chotpitayasunondh, Sanay Chearskul, Anuvat Roongpisuthipong, Pratharn Chinayon, John Karon, Timothy D Mastro, RJ Simonds. (1999) Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. The Lancet 353:9155, 773-780
CrossRef857
Christophe Vayssière, Christiane Du Mazaubrun, Gérard Bréart. (1999) Human immunodeficiency virus screening among pregnant women in France: Results from the 1995 national perinatal survey. American Journal of Obstetrics and Gynecology 180:3, 564-570
CrossRef858
(1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The Lancet 353:9158, 1035-1039
CrossRef859
Philippa Musoke, Laura A. Guay, Danstan Bagenda, Mark Mirochnick, Clemensia Nakabiito, Thomas Fleming, Terry Elliott, Scott Horton, Kevin Dransfield, Joseph W. Pav, Amal Murarka, Melissa Allen, Mary Glenn Fowler, Lynne Mofenson, David Hom, Francis Mmiro, J. Brooks Jackson. (1999) A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). Aids 13:4, 479-486
CrossRef860
(1999) Science, ethics, and the future of research into maternal infant transmission of HIV-1. The Lancet 353:9155, 832-835
CrossRef861
Sharon E. Frey. (1999) HIV VACCINES. Infectious Disease Clinics of North America 13:1, 95-112
CrossRef862
CN Hudson. (1999) Elective caesarean section for prevention of vertical transmission of HIV-1 infection. The Lancet 353:9158, 1030-1031
CrossRef863
Richard M. Grimes, Edward P. Richards, Andrew W. Helfgott, Nancy L. Eriksen. (1999) Legal considerations in screening pregnant women for human immunodeficiency virus. American Journal of Obstetrics and Gynecology 180:2, 259-264
CrossRef864
CHRISTINA LANCIONI, TODD HARWELL, RICHARD M. RUTSTEIN. (1999) Prenatal Care and HIV Infection. AIDS Patient Care and STDs 13:2, 97-102
CrossRef865
Pietro L. Vernazza, Joseph J. Eron, Susan A. Fiscus, Myron S. Cohen. (1999) Sexual transmission of HIV: infectiousness and prevention. AIDS 13:2, 155-166
CrossRef866
R Colgrove, A Japour. (1999) A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance. Antiviral Research 41:1, 45-56
CrossRef867
A. E. Ades, Ramyani Gupta, Diana M Gibb, Trinh Duong, Angus Nicoll, David Goldberg, Judith Stephenson, Andrew Copas. (1999) Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. AIDS 13:2, 271-278
CrossRef868
(1999) Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection. Acta Paediatrica 88:2, 228-232
CrossRef869
COLEEN K. CUNNINGHAM, TINA T. CHARBONNEAU, KEMING SONG, DAVID PATTERSON, TIMOTHY SULLIVAN, THOMAS CUMMINS, BERNARD POIESZ. (1999) Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. The Pediatric Infectious Disease Journal 18:1, 30-35
CrossRef870
SIMONE S. JEAN, JEAN W. PAPE, ROSE-IRENE VERDIER, GEORGE W. REED, CECELIA HUTTO, WARREN D. JOHNSON, PETER F. WRIGHT. (1999) The natural history of human immunodeficiency virus 1 infection in Haitian infants. The Pediatric Infectious Disease Journal 18:1, 58-63
CrossRef871
Gemma Calamandrei, Aldina Venerosi, Igor Branchi, Flavia Chiarotti, Alessandra Verdina, Federica Bucci, Enrico Alleva. (1999) Effects of Prenatal AZT on Mouse Neurobehavioral Development and Passive Avoidance Learning. Neurotoxicology and Teratology 21:1, 29-40
CrossRef872
(1999) Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?. AIDS 13:1, 119-124
CrossRef873
Michel Duval, Albert Faye, Pierre Rohrlich, Martine Levine, Sophie Matheron, Richard Larchee, François Simon, Etienne Vilmer. (1999) Failure of Pediatric AIDS Prevention Despite Maternal HIV Screening in Paris, France. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20:1, 100-101
CrossRef874
Robert L Goldenberg, Sten H Vermund, Alice R Goepfert, William W Andrews. (1998) Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission?. The Lancet 352:9144, 1927-1930
CrossRef875
Patrizio Lorenzi, Virginie Masserey Spicher, Birgit Laubereau, Bernard Hirschel, Christian Kind, Christoph Rudin, Olivier Irion, Laurent Kaiser. (1998) Antiretroviral therapies in pregnancy. AIDS 12:18, F241-F247
CrossRef876
Michel Cartoux, Nicolas Meda, Philippe Van de Perre, Marie Louise Newell, Isabelle de Vincenzi, François Dabis. (1998) Acceptability of voluntary HIV testing by pregnant women in developing countries. AIDS 12:18, 2489-2493
CrossRef877
Mare Tardien. (1998) HIV-1 and the developing central nervous system. Developmental Medicine & Child Neurology 40:12, 843-846
CrossRef878
Jane Pitt, Mark Schluchter, Hal Jenson, Andrea Kovacs, Philip LaRussa, Kenneth McIntosh, Pamela Boyer, Ellen Cooper, Johanna Goldfarb, Hunter Hammill, David Hodes, Hannah Peavy, Rhoda Sperling, Ruth Tuomala, William Shearer. (1998) Maternal and Perinatal Factors Related to Maternal-Infant Transmission of HIV-1 in the P2C2 HIV Study: The Role of EBV Shedding. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:5, 462-470
CrossRef879
Gwendolyn B. Scott, Ruth Tuomala. (1998) Combination antiretroviral therapy during pregnancy. AIDS 12:18, 2495-2497
CrossRef880
Marianne Garland, Hazel H. Szeto, Salha S. Daniel, Pamela J. Tropper, Michael M. Myers, Raymond I. Stark. (1998) Implications of the Kinetics of Zidovudine in the Pregnant Baboon Following Oral Administration. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:5, 433-440
CrossRef881
S CARLTON, T EVANS, S TYRING. (1998) New antiviral agents for dermatologic disease. Seminars in Cutaneous Medicine and Surgery 17:4, 243-255
CrossRef882
McIntosh, Kenneth, . (1998) Short (And Shorter) Courses of Zidovudine. New England Journal of Medicine 339:20, 1467-1468
Full Text883
Wade, Nancy A., Birkhead, Guthrie S., Warren, Barbara L., Charbonneau, Tina T., French, P. Tyler, Wang, Ling, Baum, Jeanne B., Tesoriero, James M., Savicki, Robert, . (1998) Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. New England Journal of Medicine 339:20, 1409-1414
Full Text884
Gayle Newshan, Mary Jo Hoyt. (1998) Use of COMBINATION ANTIRETROVIRAL THERAPY In Pregnant Women With HIV Disease. MCN, The American Journal of Maternal/Child Nursing 23:6, 307-312
CrossRef885
Lynn Morris, Desmond J. Martin, Thomas C. Quinn, Richard E. Chaisson. (1998) The importance of doing HIV research in developing countries. Nature Medicine 4:11, 1228-1229
CrossRef886
Robert S. Hogg, Amy E. Weber, Kevin J.P. Craib, Aslam H. Anis, Michael V. OʼShaughnessy, Martin T. Schechter, Julio S.G. Montaner. (1998) One world, one hope. AIDS 12:16, 2203-2209
CrossRef887
Robert C. Colgrove, Jane Pitt, Pei Hua Chung, Seth L. Welles, Anthony J. Japour. (1998) Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 12:17, 2281-2288
CrossRef888
Gordon C. Douglas, Fatemeh Fazely, JinJie Hu. (1998) Transmission of HIV to the placenta, fetus and mother and implications of gametic infection. Journal of Reproductive Immunology 41:1-2, 321-329
CrossRef889
Françoise Cazein, Françoise F. Hamers, Jean-Baptiste Brunet. (1998) HIV Prevalence in Pregnant Women in Europe: Differences in Assessment Methods and Prevalence Levels Across Countries. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:3, 296-305
CrossRef890
Annas, George J., . (1998) Protecting Patients from Discrimination — The Americans with Disabilities Act and HIV Infection. New England Journal of Medicine 339:17, 1255-1259
Full Text891
Penny J. Miller, Paul J. Torzillo. (1998) Private business: the uptake of confidential HIV testing in remote Aboriginal communities on the Ananau Pitiantiatiara Lands. Australian and New Zealand Journal of Public Health 22:6, 700-703
CrossRef892
Stephen Kravcik, Gary Victor, Sandra Houston, Donald Sutherland, Gary E. Garber, Nanci Hawley-Foss, Jonathan B. Angel, D. William Cameron. (1998) Effect of Antiretroviral Therapy and Viral Load on the Perceived Risk of HIV Transmission and the Need for Safer Sexual Practices. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:2, 124-129
CrossRef893
Rhoda S. Sperling, David E. Shapiro, George D. McSherry, Paula Britto, Bethann E. Cunningham, Mary Culnane, Robert W. Coombs, Gwendolyn Scott, Russell B. Van Dyke, William T. Shearer, Eleanor Jimenez, Clemente Diaz, Duane D. Harrison, Jean-Francois Delfraissy. (1998) Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 12:14, 1805-1813
CrossRef894
Dace S. Svikis, Sharon Gorenstein, Pat Paluzzi, Michael Fingerhood. (1998) Personality Characteristics of Treatment-Seeking HIV+ Pregnant Drug Dependent Women. Journal of Addictive Diseases 17:3, 91-111
CrossRef895
Marie-Louise Newell, Francois Dabis, Keith Tolley, David Whynes. (1998) Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. AIDS 12:13, 1571-1580
CrossRef896
Koen K. A. Van Rompay, Christopher J. Berardi, Nancy L. Aguirre, Norbert Bischofberger, Paul S. Lietman, Niels C. Pedersen, Marta L. Marthas. (1998) Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS 12:9, F79-F83
CrossRef897
Craig V. Towers, Audra Deveikis, Tamerou Asrat, Carol Major, Michael P. Nageotte. (1998) A “bloodless cesarean section” and perinatal transmission of the human immunodeficiency virus. American Journal of Obstetrics and Gynecology 179:3, 708-714
CrossRef898
Zhihua Zhang, Bhalchandra A. Diwan, Lucy M. Anderson, Daniel Logsdon, Ofelia A. Olivero, Diana C. Haines, Jerry M. Rice, Stuart H. Yuspa, Miriam C. Poirier. (1998) Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3′-azido-2′,3′-dideoxythymidine. Molecular Carcinogenesis 23:1, 45-51
CrossRef899
ANDREA MANGANO, GABRIELA PITTIS, CECILIA GALINDEZ, ROSA BOLOGNA, LUISA SEN. (1998) Reliability of Laboratory Markers of HIV-1 Infection in Argentinean Infants at Risk of Perinatal Infection. AIDS Patient Care and STDs 12:9, 691-696
CrossRef900
STEPHEN C. PISCITELLI, MICHAEL A. POLIS. (1998) An Update on Drug Interactions with Zidovudine. AIDS Patient Care and STDs 12:9, 687-690
CrossRef901
David Wilkinson, Katherine Floyd, Charles F. Gilks. (1998) Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa. AIDS 12:13, 1675-1682
CrossRef902
Brian M. Casey, Roger E. Bawdon. (1998) Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model. American Journal of Obstetrics and Gynecology 179:3, 758-761
CrossRef903
Peter F. Wright, Penelope F. Wright. (1998) Infectious diseases in early life in industrialized countries. Vaccine 16:14-15, 1355-1359
CrossRef904
(1998) Women's Health LiteratureWatch & Commentary. Journal of Women's Health 7:6, 763-777
CrossRef905
W. M. Simpson, F. D. Johnstons, G. J. Hart, F. M. Boyd, D. J. Goldberg. (1998) To test or not to test? What makes pregnant women decide to take an HIV test?. Psychology, Health & Medicine 3:3, 327-335
CrossRef906
Howard L. Minkoff. (1998) Human immunodeficiency virus infection in pregnancy. Seminars in Perinatology 22:4, 293-308
CrossRef907
T. A. Duffy, C. D. A. Wolfe, C. Varden, J. Kennedy, I. L. Chrystie. (1998) Women's knowledge and attitudes, and the acceptability of voluntary antenatal HIV testing. BJOG: An International Journal of Obstetrics and Gynaecology 105:8, 849-854
CrossRef908
Catherine Hankins, Thang Tran, Normand Lapointe. (1998) Sexual Behavior and Pregnancy Outcome in HIV-Infected Women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:5, 479-487
CrossRef909
Winit Phuapradit. (1998) Timing and Mechanism of Perinatal Human Immunodeficiency Virus-1 Infection. The Australian and New Zealand Journal of Obstetrics and Gynaecology 38:3, 293-297
CrossRef910
Winit Phuapradit, Sayomporn Sirinavin, Surasak Taneepanichskul, Achara Chaovavanich, Amompun Wiratchai, Rujanee Sunthornkachit, Orawan Puchaiwatanon. (1998) Maternal and Umbilical Cord Serum Zidovudine Levels in Human Immunodeficiency Virus Infection. The Australian and New Zealand Journal of Obstetrics and Gynaecology 38:3, 288-292
CrossRef911
Maurizio de Martino, Luisa Galli, Francesco Chiarelli, Maria Elisabetta Rossi, Alberto Vierucci. (1998) Do Nucleoside Analogues Directly Influence T-Lymphocyte Subset Counts? The Pediatric Model. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:4, 391-392
CrossRef912
Rebecca French, Peter Brocklehurst. (1998) The effect of pregnancy on survival in women infected with HIV a systematic review of the literature and meta-analysis. BJOG: An International Journal of Obstetrics and Gynaecology 105:8, 827-835
CrossRef913
V Puro. (1998) Women attending human immunodeficiency virus counselling and testing site because of pregnancy, and prevalence of newly diagnosed infections. European Journal of Obstetrics & Gynecology and Reproductive Biology 79:1, 51-55
CrossRef914
Julie Ratcliffe, A E. Ades, Diana Gibb, Mark J. Sculpher, Andrew H. Briggs. (1998) Prevention of mother-to-child transmission of HIV-1 infection. AIDS 12:11, 1381-1388
CrossRef915
P Msellati, R Ramon, I Viho, V Noba, L Mandelbrot, F Dabis, C Welffens Ekra. (1998) Prevention of mother-to-child transmission of HIV in Africa. AIDS 12:10, 1257-1258
CrossRef916
(1998) Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. BJOG: An International Journal of Obstetrics and Gynaecology 105:7, 704-709
CrossRef917
PHILIPPE LEPAGE, ROSEMARY SPIRA, SAM KALIBALA, KUBEN PILLAY, CARLO GIAQUINTO, KATIA CASTETBON, CONNIE OSBORNE, CHRISTIAN COURPOTIN, FRANÇOIS DABIS. (1998) REPORT OF A WORKSHOP FOR CLINICAL RESEARCH. The Pediatric Infectious Disease Journal 17:7, 581-586
CrossRef918
MARIANNE GARLAND, HAZEL H. SZETO, SALHA S. DANIEL, PAMELA J. TROPPER, MICHAEL M. MYERS, RAYMOND I. STARK. (1998) Placental Transfer and Fetal Metabolism of Zidovudine in the Baboon. Pediatric Research 44:1, 47-53
CrossRef919
KOEN K.A. VAN ROMPAY, MARTA L. MARTHAS, JEFFREY D. LIFSON, CHRISTOPHER J. BERARDI, GABRIELA M. VASQUEZ, ELMO AGATEP, ZIA A. DEHQANZADA, KENNETH C. CUNDY, NORBERT BISCHOFBERGER, NIELS C. PEDERSEN. (1998) Administration of 9-[2-(Phosphonomethoxy)propyl] adenine (PMPA) for Prevention of Perinatal Simian Immunodeficiency Virus Infection in Rhesus Macaques. AIDS Research and Human Retroviruses 14:9, 761-773
CrossRef920
Mark Atkins, Padraig Strappe, Steve Kaye, Clive Loveday, James E. McLaughlin, Margaret A. Johnson, Richard S. Tedder, Paul D. Griffiths, Vincent C. Emery. (1998) Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients. Journal of Medical Virology 55:2, 138-146
CrossRef921
Despina G. Contopoulos-Ioannidis, John P.A. Ioannidis. (1998) Maternal Cell-Free Viremia in the Natural History of Perinatal HIV-1 Transmission. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:2, 126-135
CrossRef922
Mary Cafferkey, Margaret Philbin, Eilish McDonnell, Peter McKenna. (1998) Screening for HIV-1 in pregnancy. The Lancet 351:9119, 1893-1894
CrossRef923
James C. Ha, Connie Nosbisch, Janis L. Abkowitz, Suzanne H. Conrad, N. Karle Mottet, Gerald C. Ruppenthal, Renee Robinette, Gene P. Sackett, Jashvant D. Unadkat. (1998) Fetal, Infant, and Maternal Toxicity of Zidovudine (Azidothymidine) Administered Throughout Pregnancy in Macaca nemestrina. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:1, 27-38
CrossRef924
Frank Johnstone, David Goldberg, David Tappin, Lindsay Mathie, Sheila Cameron, Ariene Brown, Sheila Burns, Barbara Hamilton, Glen Codere, R W. Anthony Girdwood. (1998) The incidence and prevalence of HIV infection among childbearing women living in Edinburgh city, 1982–1995. AIDS 12:8, 911-918
CrossRef925
Leslie A. Kalish, Kenneth Boyer, Gina Brown, David Burns, Clemente Diaz, Celine Hanson, Sheldon Landesman, Elaine Matzen, Ruth Tuomala. (1998) Cigarette Smoking and Maternal-Child HIV Transmission. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:1, 86-88
CrossRef926
Suwanee Surasiengsunk, Suchada Kiranandana, Kua Wongboonsin, Geoffrey P. Garnett, Roy M. Anderson, Godfried (Frits) J.P. van Griensven. (1998) Demographic impact of the HIV epidemic in Thailand. AIDS 12:7, 775-784
CrossRef927
Ellen R. Cooper, Celine Hanson, Clemente Diaz, Hermann Mendez, Rasha Abboud, Robert Nugent, Jane Pitt, Kenneth Rich, Evelyn M. Rodriguez, Vincent Smeriglio. (1998) Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. The Journal of Pediatrics 132:5, 808-812
CrossRef928
Wendy J. Watson, Timothy P. Stevens, Geoffrey A. Weinberg. (1998) PROFOUND ANEMIA IN A NEWBORN INFANT OF A MOTHER RECEIVING ANTIRETROVIRAL THERAPY. The Pediatric Infectious Disease Journal 17:5, 435-436
CrossRef929
J.RODRIGO OYARZUN, JOSEPH V. COTRONEO, ROBERTO M. DiONATO, JOHN R. McCORMICK, MARY BERRY LE BOEUF, FRED DI CARLO, JAMES OLESKE. (1998) The Role of Lung Biopsy in Children with Perinatally Acquired AIDS. AIDS Patient Care and STDs 12:5, 367-371
CrossRef930
Leon G. Epstein. (1998) HIV neuropathogenesis and therapeutic strategies. Pediatrics International 40:2, 107-111
CrossRef931
S S Abdool Karim. (1998) Placebo controls in HIV perinatal transmission trials: a South African's viewpoint.. American Journal of Public Health 88:4, 564-566
CrossRef932
G J Annas, M A Grodin. (1998) Human rights and maternal-fetal HIV transmission prevention trials in Africa.. American Journal of Public Health 88:4, 560-563
CrossRef933
Laurent Mandelbrot. (1998) Vertical transmission of viral infections. Current Opinion in Obstetrics and Gynaecology 10:2, 123-128
CrossRef934
(1998) Ethics of Placebo-Controlled Trials of Zidovudine to Prevent the Perinatal Transmission of HIV in the Third World. New England Journal of Medicine 338:12, 836-841
Full Text935
Phanuphak, Praphan, . (1998) Ethical Issues in Studies in Thailand of the Vertical Transmission of HIV. New England Journal of Medicine 338:12, 834-835
Full Text936
P. Scalfaro, J. J. Chesaux, P. A. Buchwalder, J. Biollaz, J. L. Micheli. (1998) Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Medicine 24:3, 247-250
CrossRef937
Dominique Rey, Maria-Patrizia Carrieri, Yolande Obadia, Christian Pradier, Jean-Paul Moatti. (1998) Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. BJOG: An International Journal of Obstetrics and Gynaecology 105:3, 269-274
CrossRef938
Dava Klirsfeld. (1998) HIV DISEASE AND WOMEN. Medical Clinics of North America 82:2, 335-357
CrossRef939
Ellen Mason, Karen Rosene-Montella, Raymond Powrie. (1998) MEDICAL PROBLEMS DURING PREGNANCY. Medical Clinics of North America 82:2, 249-269
CrossRef940
Beatriz H. Tess, Laura C. Rodrigues, Marie-Louise Newell, David T. Dunn, Tania D.G. Lago. (1998) Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. AIDS 12:5, 513-520
CrossRef941
Danielle Mercey, Angus Nicoll. (1998) We should routinely offer HIV screening in pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology 105:3, 249-251
CrossRef942
RM. RUTSTEIN, D.L. KERSHAW, T.S. HARWELL, B.J. RUDY, M.A. RICKSECKER, M.R. SPENCE. (1998) Pediatric Primary Care Provider's Knowledge of HIV/AIDS Care. AIDS Patient Care and STDs 12:3, 217-225
CrossRef943
WENDY A. MILLS, DAWN L. MARTIN, JOLENE R. BERTRAND, EDWARD A. BELONGIA. (1998) Physiciansʼ Practices and Opinions Regarding Prenatal Screening for Human Immunodeficiency Virus and Other Sexually Transmitted Diseases. Sexually Transmitted Diseases 25:3, 169-175
CrossRef944
Marie-Louise Newell, Fabio Parazzini, Laurent Mandelbrot, Catherine Peckham, Augusto Semprini, Brigitte Bazin, Janet Darbyshire, Emilia Sanchez, Giorgio Pardi. (1998) A randomised trial of mode of delivery in women infected with the human immunodeficiency virus. BJOG: An International Journal of Obstetrics and Gynaecology 105:3, 281-285
CrossRef945
Donald P. Kotler. (1998) HIV IN PREGNANCY. Gastroenterology Clinics of North America 27:1, 269-280
CrossRef946
K KALTENBACH. (1998) OPIOID DEPENDENCE DURING PREGNANCYEffects and Management. Obstetrics and Gynecology Clinics of North America 25:1, 139-151
CrossRef947
Siobhan O'Shea, Marie-Louise Newell, David T. Dunn, Marie-Cruz Garcia-Rodriguez, Isabel Bates, Jane Mullen, Timothy Rostron, Karen Corbett, Swati Aiyer, Karina Butler, Robert Smith, Jangu E. Banatvala. (1998) Maternal viral load, CD4 cell count and vertical transmission of HIV-1. Journal of Medical Virology 54:2, 113-117
CrossRef948
Jane Pitt, Johanna Goldfarb, Mark Schluchter, Andrea Kovacs, Ellen Cooper, David Hodes, Kenneth McIntosh, Hannah Peavy, William Shearer. (1998) HIV Vertical Transmission Rate Determinations Are Subject to Differing Definitions and Therefore Different Rates. Journal of Clinical Epidemiology 51:2, 159-164
CrossRef949
Warren A. Andiman. (1998) Medical management of the pregnant woman infected with human immunodeficiency virus type 1 and her child. Seminars in Perinatology 22:1, 72-86
CrossRef950
R J. Simonds, Richard Steketee, Steven Nesheim, Pamela Matheson, Paul Palumbo, Lindsay Alger, Elaine J. Abrams, Sherry Orloff, Michael Lindsay, Arlene D. Bardeguez, Peter Vink, Robert Byers, Martha Rogers. (1998) Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 12:3, 301-308
CrossRef951
C. B. Nourse, K. M. Butler. (1998) Perinatal transmission of hiv and diagnosis of hiv infection in infants: A review. Irish Journal of Medical Science 167:1, 28-32
CrossRef952
Duane Alexander. (1998) Prevention of mental retardation: Four decades of research. Mental Retardation and Developmental Disabilities Research Reviews 4:1, 50-58
CrossRef953
D Rey. (1998) HIV screening for pregnant women in South Eastern France: evolution 1992–1994–1996. European Journal of Obstetrics & Gynecology and Reproductive Biology 76:1, 5-9
CrossRef954
Olaf Müller, Tumani Corrah, Elly Katabira, Frank Plummer, David Mabey. (1998) Antiretroviral therapy in sub-Saharan Africa. The Lancet 351:9095, 68
CrossRef955
Matthew G. Law, Angela M. Downs, Jean-Baptiste Brunet, John M. Kaldor. (1998) Time trends in HIV infection among pregnant women in Europe. AIDS 12:2, 211-215
CrossRef956
Judy F. Lew, Mary Glenn Fowler. (1998) Perinatal HIV-1 transmission in the United States and internationally. Placenta 19, 85-101
CrossRef957
Ruth B. Merkatz. (1998) Inclusion of Women in Clinical Trials: A Historical Overview of Scientific, Ethical, and Legal Issues. Journal of Obstetric, Gynecologic, <html_ent glyph="@amp;" ascii="&"/> Neonatal Nursing 27:1, 78-84
CrossRef958
Bruno M. Polliotti, Asad U. Sheikh, Shambavi Subbarao, Scott S. Keesling, George R. Lee, Joseph Caba, Maurice Panigel, Richard Reichman, André J. Nahmias, Richard K. Miller. (1998) HIV-1 infection of human placental villous tissue in vitro. Placenta 19, 205-223
CrossRef959
Mark A. Wainberg, D. William Cameron. (1998) HIV resistance to antiviral drugs: public health implications. Drug Resistance Updates 1:2, 104-108
CrossRef960
Christian Kind, Christoph Rudin, Claire-Anne Siegrist, Claire-Anne Wyler, Kurt Biedermann, Urs Lauper, Olivier Irion, Jörg Schüpbach, David Nadal. (1998) Prevention of vertical HIV transmission. AIDS 12:2, 205-210
CrossRef961
NANCY VanDEVANTER, PAUL D. CLEARY, JAN MOORE, ANN STUART THACKER, THOMAS R. O'BRIEN. (1998) Reproductive Behavior in HIV-Discordant Heterosexual Couples: Implications for Counseling. AIDS Patient Care and STDs 12:1, 43-49
CrossRef962
MARIE-LAURE CHAIX-BAUDIER, COLOMBE CHAPPEY, MARIANNE BURGARD, FRANCK LETOURNEUR, JANINE IGUAL, SENTOB SARAGOSTI, CHRISTINE ROUZIOUX. (1998) First Case of Mother-to-Infant HIV Type 1 Group O Transmission and Evolution of C2V3 Sequences in the Infected Child. AIDS Research and Human Retroviruses 14:1, 15-23
CrossRef963
Samuel Parry, Joanne Holder, Jerome F. Strauss. (1997) Mechanisms of trophoblast-virus interaction. Journal of Reproductive Immunology 37:1, 25-34
CrossRef964
Andrew Maguire, Emilia Sánchez, Claudia Fortuny, Jordi Casabona. (1997) Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain. AIDS 11:15, 1851-1857
CrossRef965
Linda S. Forst, Barbara Fletcher. (1997) HIV Prophylaxis for Health Care Workers. Journal of Occupational & Environmental Medicine 39:12, 1212-1219
CrossRef966
(1997) Immunological markers in HIV-infected pregnant women. AIDS 11:15, 1859???1865
CrossRef967
Reva E. Edelstein, Laura A. Manns Arcuino, James P. Hughes, Ann J. Melvin, Kathleen M. Mohan, Peggy D. King, Connie L. McLellan, Barbra L. Murante, Barbara P. Kassman, Lisa M. Frenkel. (1997) Risk of Mother-to-Infant Transmission of HIV-1 Is Not Reduced in CCR5/Δ32ccr5 Heterozygotes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 16:4, 243-246
CrossRef968
John A. Jacquez. (1997) Mother-to-Child Transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 16:4, 284-292
CrossRef969
B Stanton. (1997) Good news for everyone?. American Journal of Public Health 87:12, 1917-1919
CrossRef970
H BURGER, B WEISER. (1997) BIOLOGY OF HIV-1 IN WOMEN AND MEN. Obstetrics and Gynecology Clinics of North America 24:4, 731-742
CrossRef971
V ANDERSON. (1997) THE PLACENTAL BARRIER TO MATERNAL HIV INFECTION. Obstetrics and Gynecology Clinics of North America 24:4, 797-820
CrossRef972
M AUGENBRAUN, H MINKOFF. (1997) ANTIRETROVIRAL THERAPY IN THE PREGNANT WOMAN. Obstetrics and Gynecology Clinics of North America 24:4, 833-854
CrossRef973
R TUOMALA. (1997) PREVENTION OF TRANSMISSIONPharmaceutical and Obstetric Approaches. Obstetrics and Gynecology Clinics of North America 24:4, 785-795
CrossRef974
L MOFENSON. (1997) MOTHER-CHILD HIV-1 TRANSMISSIONTiming and Determinants. Obstetrics and Gynecology Clinics of North America 24:4, 759-784
CrossRef975
J RIPS. (1997) ESTABLISHING A SUCCESSFUL HIV COUNSELING AND TESTING SERVICEA Blueprint for Preventing Pediatric HIV Infections and Translating Research into Clinical Practice. Obstetrics and Gynecology Clinics of North America 24:4, 873-897
CrossRef976
E COOPER. (1997) HIV DISEASE IN PREGNANCYEthics, Law, and Policy. Obstetrics and Gynecology Clinics of North America 24:4, 899-910
CrossRef977
A MELVIN, L FRENKEL. (1997) PEDIATRIC HIV-1 INFECTION. Obstetrics and Gynecology Clinics of North America 24:4, 911-924
CrossRef978
Cardo, Denise M., Culver, David H., Ciesielski, Carol A., Srivastava, Pamela U., Marcus, Ruthanne, Abiteboul, Dominique, Heptonstall, Julia, Ippolito, Giuseppe, Lot, Florence, McKibben, Penny S.Bell, David M., the Centers for Disease Control and Prevention Needlestick Surveillance Group. (1997) A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. New England Journal of Medicine 337:21, 1485-1490
Full Text979
Amos Toren, Michal Einat, Ina Fabian, Arnon Nagler. (1997) Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: A potential model for autologous transplantations in HIV-infected newborns. American Journal of Hematology 56:3, 161-167
CrossRef980
Peter Aaby, Abdel Babiker, Janet Darbyshire, Andrew Nunn, Sandhi Barreto, Pedro Alonso, Roberto Badaro, Fernando Barms, Cesar Victoria, Fred Binka, Benon Biryahwaho, Charles Byabainazima, Sylvester Sempala, Benon Tuguine, Pontiano Kalebu, Jane Kengeya-Kayondo, Jimmy Whitworth, Lynn Paxton, Jacinto Convit, Tumani Corrah, Keith McAdam, Manjula Datta, Yahya Dowlati, Paul Fine, Andy Hall, Richard Hayes, Shabbar Jaffar, David Ross, Peter Smith, Andreas de Francisco, Tore Godal, Jacob John, Mary Ann Lansang, Tessa Tan-Torres, Richard Morrow, Angus Nicoll, Catherine Peckham, David Serwadda, Marcel Tanner. (1997) Ethics of HIV trials. The Lancet 350:9090, 1546
CrossRef981
J. Gray. (1997) HIV in the neonate. Journal of Hospital Infection 37:3, 181-198
CrossRef982
Ibtissam Loussert-Ajaka, Laurent Mandelbrot, Marie-Christine Delmas, Huguette Bastian, Jean-Louis Benifla, Isabelle Farfara, Isabelle de Vincenzi, Sophie Matheron, François Simon, Françoise Brun-Vezinet. (1997) HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS 11:13, 1575-1581
CrossRef983
(1997) Mandatory HIV Testing for the Mentally Ill. New England Journal of Medicine 337:14, 1014-1015
Full Text984
JB ZIEGLER, P PALASANTHIRAN. (1997) Paediatric HIV update. Journal of Paediatrics and Child Health 33:5, 373-377
CrossRef985
ANDREW W. LEE, DEBASHIS MITRA, JEFFREY LAURENCE. (1997) Interaction of Pregnancy Steroid Hormones and Zidovudine in Inhibition of HIV Type 1 Replication in Monocytoid and Placental Hofbauer Cells: Implications for the Prevention of Maternal-Fetal Transmission of HIV. AIDS Research and Human Retroviruses 13:14, 1235-1242
CrossRef986
Lurie, Peter, Wolfe, Sidney M., . (1997) Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries. New England Journal of Medicine 337:12, 853-856
Full Text987
Debra Oldenettel, Timothy D. Dye, Raul Artal. (1997) Prenatal HIV Screening in Pregnant Women: A Medical-Legal Review. Birth 24:3, 165-172
CrossRef988
PETER L. HAVENS, BARBARA E. CUENE, JANICE R. HAND, JAMES E. GERN, BRADLEY W. SULLIVAN, MICHAEL J. CHUSID. (1997) Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin. The Pediatric Infectious Disease Journal 16:9, 871-875
CrossRef989
Padmini S. Kedar, Katherine Arden, Marie Foyle, John H. Pope, Steven L. Zeichner. (1997) Umbilical cord blood mononuclear cell HIV-1 LTR binding activities. Journal of Biomedical Science 4:5, 217-228
CrossRef990
K CHOPRA, S TYRING. (1997) Current antiretroviral therapy in the treatment of HIV infection. Seminars in Cutaneous Medicine and Surgery 16:3, 224-234
CrossRef991
B DATTEL. (1997) ANTIRETROVIRAL THERAPY DURING PREGNANCYBeyond AZT (ZDV). Obstetrics and Gynecology Clinics of North America 24:3, 645-657
CrossRef992
Steven L. Gortmaker, Paul H. Wise. (1997) The First Injustice: Socioeconomic Disparities, Health Services Technology, and Infant Mortality. Annual Review of Sociology 23:1, 147-170
CrossRef993
TINA T. CHARBONNEAU, NANCY A. WADE, LEONARD WEINER, JACKSON OMENE, LISA FRENKEL, JUDITH A. WETHERS, STEPHEN ARPADI, MARUKH BAMJI, HENRY M. FREY, ASHA GUPTA, JAMES M. CONROY. (1997) Vertical Transmission of HIV in New York State: A Basis for Statewide Testing of Newborns. AIDS Patient Care and STDs 11:4, 227-236
CrossRef994
A Krivine, S Le Bourdelles, G Firtion, P Lebon. (1997) Viral kinetics in HIV-1 perinatal infection. The Lancet 350:9076, 493
CrossRef995
Surasak Taneepanichskul MD, Sayomporn Sirinavin, Winit Phuapradit, Kamhaeng Chaturachinda. (1997) Effect of Zidovudine Treatment in Late Pregnancy on HIV-1 In Utero Transmission. The Australian and New Zealand Journal of Obstetrics and Gynaecology 37:3, 329-331
CrossRef996
José Ramon Fiore, Yi-Jun Zhang, Åsa Björndal, Mariantonietta Di Stefano, Gioacchino Angarano, Giuseppe Pastore, Eva Maria Fenyö. (1997) Biological correlates of HIV-1 heterosexual transmission. AIDS 11:9, 1089-1094
CrossRef997
Julie E Mangino, Robert J Fass. (1997) Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy. The Lancet 350:9071, 150
CrossRef998
Karolynn Siegel, Eileen Gorey. (1997) HIV-infected women: Barriers to AZT use. Social Science & Medicine 45:1, 15-22
CrossRef999
Englund, Janet A., Baker, Carol J., Raskino, Claire, McKinney, Ross E., Petrie, Barbara, Fowler, Mary Glenn, Pearson, Deborah, Gershon, Anne, McSherry, George D., Abrams, Elaine J., Schliozberg, Jenny, Sullivan, John L., Behrman, RachelConnor, James C.Hetherington, SethLifschitz, Marta H.McLaren, ColinMendez, HermanMillison, KarenMoye, JackNozyce, MollyO'Donnell, KarenPurdue, LynetteSchoenfeld, DavidScott, GwendolynnSpector, Stephen A.Wara, Diane W.. (1997) Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children. New England Journal of Medicine 336:24, 1704-1712
Full Text1000
Peter M. Grob, Yunzhen Cao, Elizabeth Muchmore, David D. Ho, Steve Norris, Joseph W. Pav, Cheng-Kon Shih, Julian Adams. (1997) Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. Nature Medicine 3:6, 665-670
CrossRef1001
Diana M. Gibb, Sandra E. MacDonagh, Pat A. Tookey, Trinh Duong, Angus Nicoll, David J. Goldberg, Christopher N. Hudson, Catherine S. Peckham, A E. Ades. (1997) Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland. AIDS 11:7, F53-F58
CrossRef1002
LAURENT MANDELBROT. (1997) Timing of In Utero HIV Infection: Implications for Prenatal Diagnosis and Management of Pregnancy. AIDS Patient Care and STDs 11:3, 139-147
CrossRef1003
Denise M. Cardo, David M. Bell. (1997) BLOODBORNE PATHOGEN TRANSMISSION IN HEALTH CARE WORKERS. Infectious Disease Clinics of North America 11:2, 331-346
CrossRef1004
Stephen A. Spector, Suzette Blanchard, Diane W. Wara, James M. Oleske, Kenneth McIntosh, David Hodes, Wayne M. Dankner, Miklos Salgo, James McNamara. (1997) COMPARATIVE TRIAL OF TWO DOSAGES OF ZALCITABINE IN ZIDOVUDINE-EXPERIENCED CHILDREN WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS DISEASE. The Pediatric Infectious Disease Journal 16:6, 623-626
CrossRef1005
Carole Limata, Edgar J. Schoen, Dena Cohen, Steven B. Black, Charles P. Quesenberry. (1997) Compliance With Voluntary Prenatal HIV Testing in a Large Health Maintenance Organization (HMO). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 15:2, 126-130
CrossRef1006
S Swindells. (1997) Non-nucleoside reverse transcriptase inhibitors in the treatment of human immunodeficiency virus infection. Expert Opinion on Emerging Drugs 2:1, 155-174
CrossRef1007
SIMONE S. JEAN, GEORGE W. REED, ROSE-IRENE VERDIER, JEAN W. PAPE, WARREN D. JOHNSON, PETER F. WRIGHT. (1997) Clinical manifestations of human immunodeficiency virus infection in Haitian children. The Pediatric Infectious Disease Journal 16:6, 600-606
CrossRef1008
PETER L. HAVENS, BARBARA E. CUENE, DAVID R. HOLTGRAVE. (1997) Lifetime cost of care for children with human immunodeficiency virus infection. The Pediatric Infectious Disease Journal 16:6, 607-610
CrossRef1009
J. Rivero, M. Fraga, I. Cancio, J. Cuervo, P. López-Saura. (1997) Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals. Biotherapy 10:2, 107-113
CrossRef1010
Dominique Kerouedan. (1997) Access to antiviral therapies in African countries. The Lancet 349:9066, 1704
CrossRef1011
&NA;. (1997) Risk Factors for HIV-1 Infection Among Pregnant Women in French Guiana. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 15:2, 177-178
CrossRef1012
A. van Vliet, J. van Roosmalen. (1997) Worldwide Prevention of Vertical Human Immunodeficiency Virus (HIV) Transmission. Obstetrical & Gynecological Survey 52:5, 301-309
CrossRef1013
Marc Bulterys, Sheldon Landesman, David N. Burns, Arye Rubinstein, James J. Goedert. (1997) Sexual Behavior and Injection Drug Use During Pregnancy and Vertical Transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 15:1, 76-82
CrossRef1014
A.M.L. Lever. (1997) HIV genetic variation: Clinical importance. Journal of Infection 34:3, 195-199
CrossRef1015
Yunzhen Cao, Paul Krogstad, Bette T. Korber, Richard A. Koup, Mark Muldoon, Catherine Macken, Jia-Li Song, Zhanqun Jin, Jla-Qi Zhao, Sheila Clapp, Irvin S.Y. Chen, David D. Ho, Arthur J. Ammann. (1997) Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Medicine 3:5, 549-552
CrossRef1016
Cathy W. Critchlow, Nancy B. Kiviat. (1997) Detection of Human Immunodeficiency Virus Type 1 and Type 2 in the Female Genital Tract. Obstetrical & Gynecological Survey 52:5, 315-324
CrossRef1017
Alejandro Dorenbaum, Kodumudi S. Venkateswaran, Gang Yang, Anne Marie Comeau, Diane Wara, Girish N. Vyas. (1997) Transmission of HIV-1 in Infants Born to Seropositive Mothers. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 15:1, 35-42
CrossRef1018
D. Moodley, R. A. Bobat, H. M. Coovadia, T. Doorasamy, S. Munsamy, E. Gouws. (1997) Lymphocyte subset changes between 3 and 15 months of age in infants born to HIV-seropositive women in South Africa. Tropical Medicine & International Health 2:5, 415-421
CrossRef1019
Salha S. Daniel, Marianne Garland, Raymond I. Stark, Michael M. Myers, Pamela J. Tropper. (1997) Effect of zidovudine on blood composition of the pregnant and fetal baboon. American Journal of Obstetrics and Gynecology 176:5, 1095-1098
CrossRef1020
Barbara J. Turner, Walter W. Hauck, Thomas R. Fanning, Leona E. Markson. (1997) Cigarette Smoking and Maternal-Child HIV Transmission. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14:4, 327-337
CrossRef1021
PRISCILLA D. ABERCROMBIE, KAREN M. BOOTH. (1997) Prevalence of Human Immunodeficiency Virus Infection and Drug Use in Pregnant Women: A Critical Review of the Literature. Journal of Women's Health 6:2, 163-187
CrossRef1022
Ehounou R Ekpini, Stefan Z Wiktor, Glen A Satten, Georgette T Adjorlolo-Johnson, Toussaint S Sibailly, Chin-Yih Ou, John M Karon, Kari Brattegaard, J Patrick Whitaker, Emmanuel Gnaore, Kevin M De Cock, Alan E Greenberg. (1997) Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire. The Lancet 349:9058, 1054-1059
CrossRef1023
Sarah V. Thackway, Virginia Furner, Anne Mijch, David A. Cooper, David Holland, Patricia Martinez, David Shaw, Ingrid van Beek, Edwina Wright, Kate Clezy, John M. Kaldor. (1997) Fertility and reproductive choice in women with HIV-1 infection. AIDS 11:5, 663-667
CrossRef1024
Stéphane Blanche, Marie-Louise Newell, Marie-Jeanne Mayaux, David T. Dunn, Jean Paul Teglas, Christine Rouzioux, Catherine S. Peckham. (1997) Morbidity and Mortality in European Children Vertically Infected by HIV-1. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:5, 442-450
CrossRef1025
Kathryn Anastos, Risa Denenberg, Laurie Solomon. (1997) HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN WOMEN. Medical Clinics of North America 81:2, 533-553
CrossRef1026
Donald M. Thea, Richard W. Steketee, Vadim Pliner, Katherine Bornschlegel, Teresa Brown, Sherry Orloff, Pamela B. Matheson, Elaine J. Abrams, Mahrukh Bamji, Genevieve Lambert, Ellie A. Schoenbaum, Pauline A. Thomas, Margaret Heagarty, Marcia L. Kalish. (1997) The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 11:4, 437-444
CrossRef1027
Carmen D. Zorrilla. (1997) OBSTETRIC FACTORS AND MOTHER-TO-INFANT TRANSMISSION OF HIV-1. Infectious Disease Clinics of North America 11:1, 109-118
CrossRef1028
Isabelle De Vincenzi, Corinne Jadand, Elisabeth Couturier, Jean-Baptiste Brunet, Hervé Gallais, Jean-Albert Gastaut, Cécile Goujard, Christiane Deveau, Laurence Meyer. (1997) Pregnancy and contraception in a French cohort of HIV-infected women. AIDS 11:3, 333-338
CrossRef1029
A. J. Melvin, S. K. Burchett, D. H. Watts, J. Hitti, J. P. Hughes, C. L. McLellan, P. D. King, E. J. Johnson, B. L. Williams, L. M. Frenkel, R. W. Coombs. (1997) Effect of Pregnancy and Zidovudine Therapy on Viral Load in HIV-1-Infected Women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:3, 232-236
CrossRef1030
B. Joyce Simpson, Eugene D. Shapiro, Warren A. Andiman. (1997) Reduction in the Risk of Vertical Transmission of HIV-1 Associated with Treatment of Pregnant Women with Orally Administered Zidovudine Alone. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:2, 145-152
CrossRef1031
Howard Minkoff, Michael Augenbraun. (1997) Antiretroviral therapy for pregnant women. American Journal of Obstetrics and Gynecology 176:2, 478-489
CrossRef1032
S. E. Macdonagh, P. A. Tookey, D. M. Gibb. (1997) A comment on ‘Antenatal testing—which way forward?’. Psychology, Health & Medicine 2:1, 87-88
CrossRef1033
Michael W Adler. (1997) HIV: the other dimension. The Lancet 349:9050, 498-500
CrossRef1034
Steven L. Bloom, Keryn M. Dias, Roger E. Bawdon, Larry C. Gilstrap. (1997) The maternal-fetal transfer of lamivudine in the ex vivo human placenta. American Journal of Obstetrics and Gynecology 176:2, 291-293
CrossRef1035
Kathryn A. Phillips, Kathleen R. Morrison, Seema S. Sonnad, Thomas Bleecker. (1997) HIV Counseling and Testing of Pregnant Women and Women of Childbearing Age by Primary Care Providers. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:2, 174-178
CrossRef1036
William A. Paxton, Richard A. Koup. (1997) Mechanisms of resistance to HIV infection. Springer Seminars in Immunopathology 18:3, 323-340
CrossRef1037
Patricia O'Campo, Melanie de Boer, Ruth Faden, Nancy Kass, Andrea Gielen, Marguerite Barbacci. (1997) Confirmation of self-report of HIV testing among a cohort of pregnant women. Journal of Clinical Epidemiology 50:1, 57-61
CrossRef1038
O. Coll, M. Hernandez, C. A. B. Boucher, C. Fortuny, B. M. de Tejada, Y. Canet, I. Caragol, J. Tijnagel, J. M. Bertran, T. Espanol. (1997) Vertical HIV-1 Transmission Correlates with a High Maternal Viral Load at Delivery. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14:1, 26-30
CrossRef1039
Debra Oldenettel, Timothy D. Dye, Raul Artal. (1997) Prenatal HIV Screening in Pregnant Women: A Medical-Legal Review. Birth 24:3, 165
CrossRef1040
Geeta K. Gupta. (1996) Human immunodeficiency virus testing and counseling: Nuts and bolts. American Journal of Obstetrics and Gynecology 175:6, 1502-1510
CrossRef1041
Frank D. Johnstone. (1996) HIV and pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology 103:12, 1184-1190
CrossRef1042
Peri H. Alkas, Wayne X. Shandera. (1996) HIV and AIDS in Africa. Journal of Legal Medicine 17:4, 527-546
CrossRef1043
Michael R. Bye. (1996) HIV IN CHILDREN. Clinics in Chest Medicine 17:4, 787-796
CrossRef1044
Larry I. Lutwick. (1996) POSTEXPOSURE PROPHYLAXIS. Infectious Disease Clinics of North America 10:4, 899-915
CrossRef1045
JON S. ABRAMSON. (1996) Society for Pediatric Research Presidential Address 1996: Star Wars Empiricism-Will The Empire (SPR) Strike Back?1. Pediatric Research 40:6, 784-789
CrossRef1046
Wilfert, Catherine M., . (1996) Beginning to Make Progress against HIV. New England Journal of Medicine 335:22, 1678-1680
Full Text1047
Sperling, Rhoda S., Shapiro, David E., Coombs, Robert W., Todd, John A., Herman, Steven A., McSherry, George D., O'Sullivan, Mary Jo, Van Dyke, Russell B., Jimenez, Eleanor, Rouzioux, Christine, Flynn, Patricia M., Sullivan, John L., Spector, Stephen A.Diaz, Clemente, Rooney, James, Balsley, James, Gelber, Richard D., Connor, Edward M., . (1996) Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. New England Journal of Medicine 335:22, 1621-1629
Full Text1048
Danielle Mercey, Barbara A. Helps, Andrew Copas, Ann Petruckevitch, Anne M. Johnson, John Spencer. (1996) Voluntary universal antenatal HIV testing. BJOG: An International Journal of Obstetrics and Gynaecology 103:11, 1129-1133
CrossRef1049
J. R. Smith, S. E. Barton, F. C. Boag, P. J. Steer. (1996) Antenatal testing for HIV: to opt in or opt out, that is the question. BJOG: An International Journal of Obstetrics and Gynaecology 103:11, 1059-1060
CrossRef1050
Leona E. Markson, Barbara J. Turner, Robert Houchens, Neil S. Silverman, Leon Cosler, Baffour K. Takyi. (1996) Association of Maternal HIV Infection with Low Birth Weight. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13:3, 227-234
CrossRef1051
JANET A. ENGLUND, CAROL J. BAKER, CLAIRE RASKINO, ROSS E. MCKINNEY, MARTA H. LIFSCHITZ, BARBARA PETRIE, MARY GLENN FOWLER, JAMES D. CONNOR, HERMANN MENDEZ, KAREN O'DONNELL, DIANE W. WARA. (1996) Clinical and Laboratory Characteristics of a Large Cohort of Symptomatic, Human Immunodeficiency Virus-infected Infants and Children. The Pediatric Infectious Disease Journal 15:11, 1025-1036
CrossRef1052
(1996) The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: Design and methods. Journal of Clinical Epidemiology 49:11, 1285-1294
CrossRef1053
BARBARA B. MITTLEMAN, GENE M. SHEARER. (1996) Mother-to-Infant Transmission of HIV Type 1: Role of Major Histocompatibility Antigen Differences. AIDS Research and Human Retroviruses 12:15, 1397-1400
CrossRef1054
Ronith Elk, Robert Andres, Andrew Helfgott, Howard Rhoades, Lorna Mangus, Iman Mirza, Ramona Burroughs, John Grabowski. (1996) AIDS-Related Knowledge and High-Risk Behaviors of Pregnant, Substance-Dependent Women. The American Journal on Addictions 5:4, 292-300
CrossRef1055
Tracey E. Wilson, James Jaccard, Howard Minkoff. (1996) HIV-Antibody Testing: Beliefs Affecting the Consistency Between Women's Behavioral Intentions and Behavior1. Journal of Applied Social Psychology 26:19, 1734-1748
CrossRef1056
E. E. Mannick, J. N. Udall, M. Kaiser, G. Fuchs, R. Suskind. (1996) Nutrition and HIV infection in children. The Indian Journal of Pediatrics 63:5, 615-632
CrossRef1057
James J Lipsky. (1996) Antiretroviral drugs for AIDS. The Lancet 348:9030, 800-803
CrossRef1058
Deborah A. Pearson, Marilyn D. Doyle, Larry K. Pickering, Juliana Ortegon. (1996) Pediatric HIV infection: A review of epidemiology, clinical manifestations, and current intervention. Journal of Developmental and Physical Disabilities 8:3, 179-210
CrossRef1059
Laurent Mandelbrot, Yves Brossard, Jean-Thierry Aubin, Christiane Bignozzi, Anne Krivine, François Simon, Marc Dommergues. (1996) Testing for in utero human immunodeficiency virus infection with fetal blood sampling. American Journal of Obstetrics and Gynecology 175:2, 489-493
CrossRef1060
Christopher Duke, IIya Z Kovar. (1996) HIV and the paediatrician as the child's advocate. The Lancet 348:9022, 247-249
CrossRef1061
Barbara J. Turner, Linda J. McKee, Neil S. Silverman, Walter W. Hauck, Thomas R. Fanning, Leona E. Markson. (1996) Prenatal Care and Birth Outcomes of a Cohort of HIV-Infected Women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12:3, 259-267
CrossRef1062
Suraiya Rasheed, Zhiliang Li, Dong Xu, Andrea Kovacs. (1996) Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus - infected women. American Journal of Obstetrics and Gynecology 175:1, 122-130
CrossRef1063
Barbara Wise. (1996) Antiretroviral Therapy in Adults. Journal of the American Academy of Nurse Practitioners 8:7, 329-341
CrossRef1064
R Gopalakrishnan. (1996) Antiretroviral Therapy in the 1990's: Recent Advances. Antimicrobics and Infectious Diseases Newsletter 15:7, 43-46
CrossRef1065
CHERYL COX, C.N.L. MACPHERSON. (1996) MODIFIED INFORMED CONSENT IN A VIRAL SEROPREVALENCE STUDY IN THE CARIBBEAN. Bioethics 10:3, 222-232
CrossRef1066
Thomas C Quinn. (1996) Global burden of the HIV pandemic. The Lancet 348:9020, 99-106
CrossRef1067
ROGER H. MILLER, STEVEN R. TURK, ROBERTA J. BLACK, SANDRA BRIDGES, NAVA SARVER. (1996) Conference Summary: Novel HIV Therapies—From Discovery to Clinical Proof of Concept. AIDS Research and Human Retroviruses 12:10, 859-865
CrossRef1068
RAZIYA BOBAT, HOOSEN COOVADIA, ANNA COUTSOUDIS, DHAYENDRE MOODLEY. (1996) Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. The Pediatric Infectious Disease Journal 15:7, 604-610
CrossRef1069
Landesman, Sheldon H., Kalish, Leslie A., Burns, David N., Minkoff, Howard, Fox, Harold E., Zorrilla, Carmen, Garcia, Pat, Fowler, Mary Glenn, Mofenson, Lynne, Tuomala, Ruth, . (1996) Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child. New England Journal of Medicine 334:25, 1617-1623
Full Text1070
Landers, Daniel V., Sweet, Richard L., . (1996) Reducing Mother-to-Infant Transmission of HIV — The Door Remains Open. New England Journal of Medicine 334:25, 1664-1665
Full Text1071
STEVEN R. NESHEIM. (1996) The Diagnosis and Management of Perinatal HIV Infection. Clinical Obstetrics and Gynecology 39:2, 396-410
CrossRef1072
Raelene Darlington, Sandra C. Thompson, Jocelyn R. L. Forsyth. (1996) Is HIV screening being requested appropriately? The experience of a Victorian public health laboratory. Australian and New Zealand Journal of Public Health 20:3, 247-253
CrossRef1073
FRANK A. CHERVENAK, LAURENCE B. McCULLOUGH. (1996) Common Ethical Dilemmas Encountered in the Management of HIV-Infected Women and Newborns. Clinical Obstetrics and Gynecology 39:2, 411-419
CrossRef1074
MARTA GWINN, PASCALE M. WORTLEY. (1996) Epidemiology of HIV Infection in Women and Newborns. Clinical Obstetrics and Gynecology 39:2, 292-304
CrossRef1075
LYNNE M. MOFENSON. (1996) The Role of Antiretroviral Therapy in the Management of HIV Infection in Women. Clinical Obstetrics and Gynecology 39:2, 361-385
CrossRef1076
ARLENE D. BARDEGUEZ. (1996) Management of HIV Infection for the Childbearing Age Woman. Clinical Obstetrics and Gynecology 39:2, 344-360
CrossRef1077
SHERRY L. ORLOFF, R. J. SIMONDS, RICHARD W. STEKETEE, MICHAEL E. LOUIS. (1996) Determinants of Perinatal HIV-1 Transmission. Clinical Obstetrics and Gynecology 39:2, 386-395
CrossRef1078
MICHAEL K. LINDSAY. (1996) Routine Voluntary Antepartum HIV Antibody Counseling and Testing: A Sound Public Health Prevention Strategy. Clinical Obstetrics and Gynecology 39:2, 305-315
CrossRef1079
R.J Biggar, J.J Goedert, P.G Miotti, T.E Taha, L Mtimavalye, A Justesen, J.D Chiphangwi, R Broadhead, F Yellin, G Liomba, W Miley, D Waters. (1996) Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. The Lancet 347:9016, 1647-1650
CrossRef1080
MARGARET E. SPRAUVE. (1996) Substance Abuse and HIV in Pregnancy. Clinical Obstetrics and Gynecology 39:2, 316-332
CrossRef1081
Arthur J. Ammann. (1996) Mother–infant HIV transmission: Making the most of what we know. Nature Medicine 2:5, 490-490
CrossRef1082
Giuseppe Ippolito, Michele Stegagno, Enrico Girardi, Francesco Costa, Lucilla Ravà, Maria L. Aebischer, Elio Guzzanti. (1996) Temporal and Geographical Trends of Anti-HIV-1 Antibodies Screening Among Newborns in Italy, 1990-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12:1, 63-68
CrossRef1083
CYLLENE R. MORRIS, LALEKAN ARABA-OWOYELE, STEPHEN A. SPECTOR, YVONNE A. MALDONADO. (1996) Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal 15:4, 321-328
CrossRef1084
Tove Tuntland, Connie Nosbisch, William L. Baughman, Joseph Massarella, Jashvant D. Unadkat. (1996) Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrina. American Journal of Obstetrics and Gynecology 174:3, 856-863
CrossRef1085
Jeffrey L. Ecker. (1996) The cost-effectiveness of human immunodeficiency virus screening in pregnancy. American Journal of Obstetrics and Gynecology 174:2, 716-721
CrossRef1086
Marianne Garland, Hazel H. Szeto, Salha S. Daniel, Pamela J. Tropper, Michael M. Myers, Raymond I. Stark. (1996) Zidovudine Kinetics in the Pregnant Baboon. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11:2, 117-127
CrossRef1087
Gijs Walraven, Angus Nicoll, Mathew Njau, Ian Timaeus. (1996) The impact of HIV-1 infection on child health in sub-Saharan Africa: the burden on the health services. Tropical Medicine & International Health 1:1, 3-14
CrossRef1088
Pascale M. Wortley, Patricia L. Fleming, Mary-Lou Lindegren, Patricia A. Sweeney, Susan Davis. (1996) Using HIV/AIDS Surveillance to Monitor Public Health Efforts to Reduce Perinatal Transmission of HIV. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11:2, 205
CrossRef1089
L. Sherr, S. Jefferies, C. Victor, J. Chase. (1996) Antenatal HIV testing—which way forward?. Psychology, Health & Medicine 1:1, 99-111
CrossRef1090
SAMUEL GRUBMAN, R. J. SIMONDS. (1996) Preventing Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children: new guidelines for prophylaxis. The Pediatric Infectious Disease Journal 15:2, 165-168
CrossRef1091
Stormy Schevis. (1996) The challenge of providing choices to women. Journal of the Association of Nurses in AIDS care 7:1, 13
CrossRef1092
Pier-Angelo Tovo, Maurizio de Martino, Clara Gabiano, Luisa Galli, Nazario Cappello, Ezia Ruga, Silvia Tulisso, Alberto Vierucci, Anna Loy, Gian Vincenzo Zuccotti, Anna Maria Bucceri, Anna Plebani, Paola Marchisio, Desireé Caselli, Susanna Liviadotti, Paola Dallacasa. (1996) Mode of Delivery and Gestational Age Influence Perinatal HIV-1 Transmission. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11:1, 88-94
CrossRef1093
C.O. Dimian, J.S. Bingham. (1996) Sexually transmitted diseases and pregnancy. Journal of the European Academy of Dermatology and Venereology 6:1, 1-10
CrossRef1094
DONALD P. FRANCIS. (1996) Every Person Infected With HIV-1 Should Be in a Lifelong Early Intervention Program. Sexually Transmitted Diseases 23:5, 351-352
CrossRef1095
NEWTON G. OSBORNE. (1996) HIV Exposure. Journal of Gynecologic Surgery 12:3, 223-224
CrossRef1096
F.J. Havens, A.C. Mellins, D. Pilowski. (1996) Mental health issues in HIV-affected women and children. International Review of Psychiatry 8:2-3, 217-225
CrossRef1097
Susanne Lindgren, Claes Martin, Bo Anzén, Helena Strand, Ulla Bredberg-Rådén, Anneka Ehrnst. (1996) Pattern of HIV Viraemia and CD4 Levels in Relation to Pregnancy in HIV-1 Infected Women. Scandinavian Journal of Infectious Diseases 28:5, 425-433
CrossRef1098
CHARLENE E. BUSH, RICHARD M. DONOVAN, ODETTE MANZOR, DWAYNE BAXA, ELLEN MOORE, FLOSSIE COHEN, LOUIS D. SARAVOLATZ. (1996) Comparison of HIV Type 1 RNA Plasma Viremia, p24 Antigenemia, and Unintegrated DNA as Viral Load Markers in Pediatric Patients. AIDS Research and Human Retroviruses 12:1, 11-15
CrossRef1099
Donald R. Hoover, Meg C. Doherty, David Vlahov, Paolo Miotti. (1996) Incidence and risk factors for HIV-1 infection—a summary of what is known and the psychiatric relevance. International Review of Psychiatry 8:2-3, 137-148
CrossRef1100
Maureen A. Gallagher, Carrie Klima. (1996) The challenge of maternal-infant transmission of HIV. Journal of the Association of Nurses in AIDS care 7:1, 47-49
CrossRef1101
S.C. Robson. (1995) Fetal drug therapy. Current Obstetrics & Gynaecology 5:4, 230-238
CrossRef1102
Marie-Louise Newell, Clive Loveday, David Dunn, Steve Kaye, Richard Tedder, Catherine Peckham, Andrea De Maria, Carlo Giaquinto, Felix Omenaca, Cipriano Canosa, Antonio M??r. (1995) Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothers. Journal of Medical Virology 47:4, 330-335
CrossRef1103
Claire Thorne, Marie-Louise Newell, David Dunn, Catherine Peckham, . (1995) The European Collaborative Study: clinical and immunological characteristics of HIV 1-infected pregnant women. BJOG: An International Journal of Obstetrics and Gynaecology 102:11, 869-875
CrossRef1104
M. ROBB, S. BRIDGES, F. MMIRO, M.G. FOWLER, P. FAST, J. McNAMARA. (1995) Report of the Prevention of Perinatal HIV Type 1 Transmission Workshop: Conference Summary. AIDS Research and Human Retroviruses 11:10, 1301-1303
CrossRef1105
Marilyn Doyle. (1995) HIV Infection in Children Born Before and After Immigration to Belgium. Journal of Travel Medicine 2:3, 151-152
CrossRef1106
Philippe Perre, Michel Cartoux. (1995) Retroviral Transmission and Breast-feeding. Clinical Microbiology and Infection 1:1, 6-12
CrossRef1107
Peckham, Catherine, Gibb, Diana, . (1995) Mother-to-Child Transmission of the Human Immunodeficiency Virus. New England Journal of Medicine 333:5, 298-303
Full Text1108
Anne C. Beal, Irwin Redlener. (1995) Enhancing perinatal outcome in homeless women: The challenge of providing comprehensive health care. Seminars in Perinatology 19:4, 307-313
CrossRef1109
Jan Welch. (1995) Sexually transmitted infection in women. Sexual and Marital Therapy 10:2, 149-167
CrossRef1110
S. Emery, D. A. Cooper. (1995) Antiretro viral therapy of human immunodeficiency virus type-1 (HIV-1) infection. Australian and New Zealand Journal of Medicine 25:4, 344-349
CrossRef1111
D.A.A Verkuyl. (1995) Practising obstetrics and gynaecology in areas with a high prevalence of HIV infection. The Lancet 346:8970, 293-296
CrossRef1112
Christian Kind, , D. Nadal, C. -A. Wyler, C. -A. Siegrist, J. J. Cheseaux, B. Vaudaux, C. -L. Fawer, C. Rudin, U. B. Schaad, C. Aebi, C. Baumgartner, H. E. Gnehm, G. Schubiger, J. Klingler, U. Hunziker, H. F. Kuchler, M. P. Gianinazzi, U. Bühlmann, K. Biedermann, O. Irion, G. Spoletin, J. Schüpbach, J. Boni, J. Jendis, Z. Tomasik. (1995) Mother-to-child transmission of human immunodeficiency virus type 1: Influence of parity and mode of delivery. European Journal of Pediatrics 154:7, 542-545
CrossRef1113
P. Van de Perre. (1995) The epidemiology of HIV infection and AIDS in Africa. Trends in Microbiology 3:6, 217-222
CrossRef1114
Arthur Zucker. (1995) Law and ethics. Death Studies 19:3, 293-298
CrossRef1115
Michael R. Bye. (1995) Human immunodeficiency virus infections and the respiratory system in children. Pediatric Pulmonology 19:4, 231-242
CrossRef1116
(1995) Ethical Issues in the Use of Zidovudine to Reduce Vertical Transmission of HIV. New England Journal of Medicine 332:13, 891-892
Full Text1117
McIntosh, Kenneth, Burchett, Sandra K., . (1995) Clearance of HIV — Lessons from Newborns. New England Journal of Medicine 332:13, 883-884
Full Text1118
(1995) Maternal –Infant Transmission of HIV-1. New England Journal of Medicine 332:13, 890-891
Full Text1119
Simonds, R.J., Lindegren, Mary Lou, Thomas, Polly, Hanson, Debra, Caldwell, Blake, Scott, Gwendolyn, Rogers, Martha, . (1995) Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States. New England Journal of Medicine 332:12, 786-790
Full Text1120
Richard Horton. (1995) Women as women with HIV. The Lancet 345:8949, 531-532
CrossRef1121
Jeffrey Spike, Jane Greenlaw. (1994) Ethics Consultation. The Journal of Law, Medicine & Ethics 22:4, 347-350
CrossRef1122
Rogers, Martha F., Jaffe, Harold W., . (1994) Reducing the Risk of Maternal-Infant Transmission of HIV: A Door Is Opened. New England Journal of Medicine 331:18, 1222-1223
Full Text1123
Bayer, Ronald, . (1994) Ethical Challenges Posed by Zidovudine Treatment to Reduce Vertical Transmission of HIV. New England Journal of Medicine 331:18, 1223-1225
Full Text
- Letters
